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Tissue engineered devices aim to emerge as feasible alternatives to organ or 
tissue transplants, which are very limited in availability. As combination products, they 
are composed of both a biomaterial (scaffold) and biological component (cells, proteins, 
etc). Upon implantation into the body, the host response to this construct will be a 
combination of both a non-specific inflammatory response to the biomaterial and an 
antigen-specific immune response toward an allo- or xenogeneic biologic (Babensee et 
al. 1998). Recently, it has been shown that the response to the biomaterial component 
may influence the immune response to the co-delivered cellular component. More 
specifically, there is evidence of a biomaterial adjuvant effect as poly(lactic-co-glycolic) 
acid (PLGA) scaffolds or microparticles increase an immune response to a model 
antigen, ovalbumin (Matzelle and Babensee 2004; Bennewitz and Babensee 2005; 
Norton et al. 2010). 
It is hypothesized that dendritic cells (DCs), the major antigen-presenting cells of 
the body, play an important role in this response as they serve to link the inflammatory 
response to an adaptive immune response. Activation (or maturation) of DCs in the 
presence of the biomaterial-delivered biologic component may facilitate increased 
humoral immunity. In support of this, PLGA film or microparticle (MP) treatment alone is 
capable of inducing DC maturation while a biomaterial film, which does not support an 
adjuvant effect (e.g. agarose) (Norton et al. 2010) does not support DC maturation in 
vitro (Yoshida and Babensee 2004; Yoshida and Babensee 2006; Yoshida and 
Babensee 2006). Therefore, elucidating how DCs recognize and respond to biomaterials 
may be a critical factor in understanding how biomaterials modulate immune responses. 
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The mechanism of DC recognition and response to biomaterials is unknown, and 
the major intended goal of the research presented herein was to further elucidate the 
manner of biomaterial-induced DC maturation. It was hypothesized that the host 
response to a biomaterial implant may be mediated by ‘danger signals’ (endogenous 
molecules), which are capable of eliciting inflammation and simultaneously acting as 
adjuvants. To examine the potential role of ‘danger signals’ in the host response to a 
biomaterial, polyethylene terephthalate (PET) discs were implanted for 16hr in the 
peritoneal cavity (as a measurement of acute inflammation) or for 2 weeks 
subcutaneously (as a measurement of chronic inflammation) in wild-type or toll-like-
receptor 4 (TLR4)-deficient mice (CHAPTER 4). Following 16hr implantation, there was 
no difference in either total or differential lavage leukocyte profiles; however, there was 
significant delayed inflammatory response in the TLR4-deficient mice as seen in the 
altered biomaterial-adherent leukocyte profile (CHAPTER 4). TLR4-deficient mice show 
a significant reduction in monocyte/macrophage presence as well as a significant 
increase in neutrophil presence on the biomaterial surface, as compared to wild-type 
controls. However, both strains exhibited similar pro-inflammatory cytokine production 
(TNF-!) in the peritoneal cavity in response to the biomaterial implant in a TLR4-
independent manner (CHAPTER 4). Following 2 weeks subcutaneous implantation, both 
strains induced similar fibrous capsule thickness implying that there were compensatory 
mechanisms during the chronic inflammatory response (CHAPTER 4). Therefore, it 
appeared that TLR4 / ‘danger signal’ interactions may have only contributed to the host 
response to a biomaterial during an immediate to early time frame during which they aid 
in directing the adhesive leukocyte profile.   
To isolate the role of biomaterial-induced TLR4 signaling in the form of nuclear 
factor (NF)-"B and activator protein (AP)-1 transcription factor activation, TLR4-
expressing human embryonic kidney (HEK) 293 cells were used, as were MyD88-
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silenced transformed TLR4-expressing HEK293 cells and wild-type HEK293 cells for 
negative controls (CHAPTER 5). TLR4-expressing HEK293 cells were found to respond 
to LPS treatment as seen in increases in activated NF-"B and AP-1 family members in 
nuclear extracts as well as induction of IL-8 secretion (CHAPTER 5). Interestingly, PLGA 
and agarose films only induced significant activation of AP-1 (but not NF-"B) family 
members and while not inducing IL-8 production (CHAPTER 5). To assure the role of 
TLR4, TLR4-expressing HEK293 cells were stably silenced for MyD88 expression to 
inhibit TLR4-induced signaling. However, MyD88-silenced TLR4-expressing HEK293 
cells were still able to respond to LPS as seen in activation of NF-"B (CHAPTER 5). This 
may be due to LPS/TLR4 signaling through a known MyD88-independent pathway. 
Regardless, PLGA or agarose treated wild-type HEK293 cells, which have been shown 
to express little to no TLR4, were still found to have significant induction of AP-1 
activation (CHAPTER 5). Therefore, though HEK293 cells seemed to respond to 
biomaterials through AP-1, this appeared to be in a TLR4-independent manner. 
Upon examination into the role of TLR4 in the response of DCs to biomaterials, 
bone marrow derived DCs (BMDC) from TLR4+ mice were found to show signs of 
maturation (increase in CD86 expression) when treated with PLGA films, which was not 
found in BMDCs from TLR4- mice (CHAPTER 5). Also, PLGA films and MPs induced 
significant signs of early apoptosis in a TLR4-dependent manner. However, neither 
PLGA films nor MPs induced significant amounts of TNF-! secretion from TLR4+ 
BMDCs as was found when stimulated with ultrapure-LPS (CHAPTER 5). This may have 
been due, in part, to BMDC pre-activation as was detected in their expression of high 
levels of major histocompatibility complex (MHC) class II molecules and CD80/CD86, 
prior to biomaterial treatment (CHAPTER 6). Upon further investigation, it was found that 
during BMDC development, adherent BMDCs are substantially more responsive to 
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maturation-inducing stimuli than non/loosely adherent BMDCs, which had been 
previously only been investigated (CHAPTER 6). This was found in BMDCs across three 
separate strains of mice (C57BL/6, C57BL/10 and C57BL/10ScSn) in response to 
ultrapure-LPS, PLGA films or PLGA MPs (CHAPTER 6). Therefore, the role of TLR4 in 
biomaterial-induced DC maturation was further examined analyzing the response of both 
adherent and non/loosely adherent BMDC fractions to PLGA film or MP treatment 
(CHAPTER 6). Adherent BMDCs from TLR4+ mice were more responsive to both 
ultrapure-LPS and PLGA film treatment as anticipated; however, adherent BMDCs from 
TLR4- mice still showed signs of biomaterial-induced DC maturation when treated with 
PLGA films (CHAPTER 6). Therefore, the role of TLR4 in DC-biomaterial recognition 
was inconclusive using this particular TLR4-deficient strain and appropriate control 
strains. 
To examine the potential role of other TLRs, gene expression of all TLRs 
following biomaterial treatment was investigated in human monocyte-derived DCs. It was 
anticipated that TLRs involved in the response to biomaterial would be down regulated 
following treatment. However, ultrapure-LPS (a TLR4 specific ligand) induced down-
regulation of several TLRs (including TLR4) indicating that it may not be possible to 
further deduce specific TLR involvement in biomaterial recognition even if biomaterial 
treatment resulted in down-regulation of a TLR family member (CHAPTER 5). However, 
TLR-related gene expression patterns induced by PLGA were found to loosely match 
that of ultrapure-LPS treatment while patterns induced by agarose closely matched that 
of untreated controls. This further verified PLGA as a stimulatory biomaterial, which 
induced overall gene expression patterns similar to that of a bacterial by-product. 
Agarose treatment influenced overall gene expression minimally and implied that 
agarose may maintain DCs in an immature phenotype (CHAPTER 5). Differential 
transcription factor up-regulation by LPS (NF-"B), PLGA (Elk-1) or agarose (cFos/AP-1) 
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was attempted to be validated via western blotting. However, only NF-"B, and not Elk-1 
nor cFos, was found to match increased RNA expression with increased total or 
activated protein expression (CHAPTER 5).  
Dendritic cells were found to readily adhere to the activating biomaterial PLGA 
but not to tissue culture polystyrene (CHAPTER 7). Therefore, the role of adhesion to 
biomaterial-induced DC maturation was investigated. Using a human monocyte-derived 
DC culture, DCs were found to preferentially adhere to PLGA, while other contaminating 
cells (e.g. B cells) were not found to adhere as determined via immunofluorescence 
(CHAPTER 7). Human DCs cultured on PLGA (but not agarose) showed increases in 
integrin expression across both $1 and $2 family members (CHAPTER 7). However, 
using antibody-blocking methods, anti-$2 (but not anti-$1) treatments inhibited adhesion 
to biomaterials (CHAPTER 7). Furthermore, $2 integrin mediated DC adhesion was 
found to play a significant role in controlling levels of DC maturation when cultured on 
biomaterials (CHAPTER 7). The significant decreases in the level of DC adhesion during 
anti-$2 treatment resulted in significantly higher presence of immature DCs (lower CD86 
expression) (CHAPTER 7). Dendritic cells also showed significant presence of $2 
integrins in podosomes that directly interacted with biomaterial surfaces, which was not 
found with $1 integrins (CHAPTER 7).  
Overall, these findings illustrate that an adhesive biomaterial such as PLGA may 
induce maturation in a $2 integrin adhesion dependent manner, which may potentially 
allow for other stimulatory receptor (e.g. TLR4) engagement. Using hydrogel 
biomaterials such as agarose for tissue-engineered devices, which may inhibit protein 
adsorption and subsequent cellular adhesion due hydrophilic properties, may prevent $2 







Upon introduction to the body, biomaterials induce a concerted host response 
stemming from the recognition of the implant as a foreign object. This response often 
limits the efficacy of the material to fulfill its intended therapeutic application due to a 
non-specific inflammatory. Biomaterials have been employed as scaffolds for tissue-
engineering devices as well as for vaccine delivery vehicles. Tissue-engineered devices, 
which combine biological and biomaterial components, aim to alleviate the dramatic 
shortage of transplants needed for organ and tissue loss/failure (Langer and Vacanti 
1993). For these combination products, there is an inherent need to not only minimize 
the non-specific inflammatory response to the biomaterial component but also reduce 
the antigen-specific immune response directed toward the biologic to assure therapeutic 
efficacy (Babensee et al. 1998). The immune response is particularly relevant during the 
delivery of allo- or xenogeneic biological components, which are likely candidates or 
therapy in order to assure “off-the-shelf” availability of devices (Nerem 2006). This is in 
contrast to biomaterial-delivered vaccines which seek to maximize a humoral immune 
response toward the biologic (Babensee 2008). 
Previously, it has been shown that a biomaterial may contribute to directing the 
immune response toward an antigen. While certain biomaterials act as an adjuvant (e.g. 
PLGA), others actually minimize the immune response to a co-delivered protein (e.g. 
agarose) (Matzelle and Babensee 2004; Bennewitz and Babensee 2005; Norton et al. 
2010). Subsequently, it was hypothesized that DCs may provide an explanation, in part, 
for the adjuvant effect of biomaterials. Human DCs mature upon contact with tissue-
engineering relevant biomaterials such as chitosan, PLGA and alginate while other 
materials such as hyaluronic acid (HA) or agarose minimize or potentially inhibit DC 
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maturation in vitro (Yoshida and Babensee 2004; Babensee and Paranjpe 2005; 
Yoshida and Babensee 2006). It is believed that this biomaterial-manipulation of DC 
phenotype in vivo may control the adaptive immune response to a co-delivered antigen 
due to increased or decreased T cell stimulatory capacity of DCs which influence T cell 
proliferation with subsequent effects of increased antibody production by B cells. 
Currently, the mechanism by which DCs recognize and respond to biomaterials, as with 
many biomaterial-mediated cellular responses, is unknown.  
The objective of this research was to further understand how DCs 
recognize and respond to biomaterials. The central hypothesis was that biomaterial-
adsorbed proteins facilitate the recognition of a biomaterial as a foreign object, and 
these molecules propagate the activation of cells both in vitro and in vivo through direct 
receptor recognition. More specifically, there was an interest in determining the role of 
‘danger signals’ in this recognition, which are molecules capable of directly stimulating 
host and DC responses. After recognizing the biomaterial as a foreign object via the 
adsorbed protein layer, DCs may respond through signaling pathways to induce 
increased gene expression of molecules associated with DC maturation such as co-
stimulatory, major histocompatibility molecules and cytokines. It was hypothesized that 
an activating biomaterial surface (such as PLGA) may present or act as a depot for 
stimulatory ‘danger signal’ molecules from serum (in vitro) or from host blood/tissues (in 
vivo, following implantation) that elicits the recognition and response of a biomaterial as 
a foreign object, particularly by DCs. 
 
Specific Aim 1: Determine the relevance of ‘danger signals’ on biomaterial 
surfaces from the DC response to biomaterials through TLR4 in vitro and the role 
of TLR4 to participate in the acute and chronic inflammatory response to a 
biomaterial implant. The working hypothesis for this aim was that cells recognize and 
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respond to adsorbed ‘danger signals’ on the surface of biomaterials. Particularly, the role 
of Toll-like Receptor (TLR) 4 was hypothesized to play a role in this process because of 
its known recognition of many endogenous molecules and contribution to the host 
response following tissue damage. The role of TLR4 in biomaterial-induced DC 
maturation was investigated using bone marrow-derived DCs (BMDCs) from TLR4-
deficient mice. Dendritic cells were cultured with biomaterial PLGA films or 
microparticles (MP). Non/loosely adherent and adherent BMDCs were examined for 
maturation marker expression for biomaterial treatment by flow cytometry and pro-
inflammatory cytokine secretion and compared to that of DCs from two appropriate 
TLR4-wild type control mice. TLR4-induced biomaterial signaling was isolated away from 
DCs through the use of three model cell lines cultured on biomaterial (PLGA or agarose) 
films: 1. TLR4-expressing HEK293 cells, 2. TLR4-expressing HEK293 cells, which have 
been stably silenced for MyD88; 3. Wild-type HEK293 cells which express little to no 
surface TLR4. NF-"B and AP-1 transcription factor activation was examined in nuclear 
extracts, interleukin (IL)-8 secretion was characterized and apoptosis markers caspase 8 
and 3 were also analyzed. The gene expression of TLRs and TLR-related molecules 
was also investigated in PLGA or agarose treated human DCs to attempt to determine 
other potential TLRs involved in the biomaterial recognition process. 
Lastly, the most relevant context to study ‘danger signals’ role in the response to 
a biomaterial is an in vivo setting where implantation-induced damage causes release of 
intracellular molecules and extracellular tissue fragments. These ‘danger signals’ may 
induce activation of various cell types through TLR4 (or other TLRs). The role of TLR4 in 
the acute and chronic host response to a biomaterial implant was studied using a model 
biomaterial (polyethylene terephthalate, PET) implanted intraperitoneally (i.p.) or 
subcutaneously (s.c.) in TLR4-deficient mice. Leukocyte recruitment, differential cell 
counts and cytokine presence was assessed following 16 hr (i.p.) along with fibrous 
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encapsulation following 2-week implantation (s.c.) and compared to that of naïve and 
sham surgery controls.  
 
Specific Aim 2: Determine the role of integrin-mediated adhesion in 
biomaterial-induced DC maturation.  The working hypothesis for this aim was that DC 
maturation caused by biomaterials is, in part, directed by integrin-mediated adhesion. 
Integrins family member gene expression was investigated in PLGA or agarose treated 
human DCs to determine putative integrins involved in biomaterial adhesion. Antibody-
blocking studies were utilized to determine the functional role of $1 and $2 integrin family 
members in DC/biomaterial interaction. The role of integrins was investigated in both DC 
adhesion to biomaterials as well as biomaterial-induced DC maturation via cell counting 
and flow cytometry for maturation marker expression, respectively.  Lastly, cross-linking 
DCs to the biomaterial surface and performing immunofluorescence for $ integrin family 








Tissue-engineered devices aim to alleviate the dramatic shortage of available 
organ transplants by providing an engineered source of tissues using cells/biologics in 
combination with material scaffolds (Langer and Vacanti 1993; Stock and Vacanti 2001; 
Griffith and Naughton 2002; Vacanti 2006). Biomaterials for tissue-engineering, either 
naturally or synthetically-derived, serve to provide a directional substrate for cell 
adhesion and host integration upon engraftment to aid in replacing or repairing lost or 
damaged tissues (Stock and Vacanti 2001). However, it is essential that such 
combination products elicit an appropriate recipient host response, which will be a 
mixture of a non-specific inflammatory response toward the biomaterial component and 
a potential adaptive immune response toward an immunogenic cellular component 
(Babensee et al. 1998). It is believed that the host inflammatory response to the 
biomaterial may manipulate the immune response (Babensee 2008); therefore, material 
selection for use in tissue-engineered devices is likely critical for the success of the 
therapeutic biologic.  
In this context, biomaterials commonly used in tissue-engineered combination 
products (PLGA) have been shown to act as adjuvants while others such as agarose 
maintain minimal immune response to a co-delivered model antigen (Matzelle and 
Babensee 2004; Norton et al. 2010), and even the physical form of the biomaterial-
carrier can alter the response (Bennewitz and Babensee 2005). It has been 
hypothesized that biomaterials induce activation (or maturation) of antigen-presenting 
cells (APC) such as DCs in vivo during the innate/non-specific inflammatory host 
response to the material. Since DCs link innate and adaptive immunity, the two major 
branches of the immune system, it is believed that biomaterial-induced DC maturation in 
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vivo during the host response may lead to increased T cell presentation/activation 
toward any associated foreign antigen. In support of this, adjuvant-inducing biomaterials 
(e.g. PLGA, chitosan) have been found to induce DC maturation and subsequent 
increase in T cell activation in vitro while non-adjuvant biomaterials (e.g agarose) do not 
(Yoshida and Babensee 2004; Babensee and Paranjpe 2005; Yoshida and Babensee 
2006; Yoshida et al. 2007). Understanding this differential DC response across materials 
may be critical to elucidating how a biomaterial-component may modulate an immune 
response to a combination product. This would further strengthen the criteria for material 
selection for tissue-engineered devices, which seek to minimize a biomaterial adjuvant 
effect and also contribute to the growing field of biomaterial vaccine vehicles, which seek 
to maximize this immune response. 
The aim of this work was to improve understanding of how DCs recognize and 
respond to biomaterials. The major goal is to elucidate families of receptors that involved 
in mediating DC responses to biomaterials.  With the knowledge of cellular recognition in 
hand, biomaterials may be designed or chosen based on the specific application for the 
combination product. For tissue-engineered constructs, a biomaterial scaffold could be 
selected which limits the recognition by these critical DC receptors with the aim of 
minimizing an adaptive immune response to co-delivered cellular components. In 
contrast, vaccine delivery vehicles could be designed to engage these receptors to 







3.1. Innate and Adaptive Immunity 
 
 Innate immunity involves the sentinel cells of the immune system that are initial 
responders upon microbe entry into the body. Leukocytes (neutrophils, 
monocytes/macrophages, dendritic cells, natural killer (NK) cells, etc) respond to 
pathogens using PRRs which recognize pathogen-associated molecular patterns 
(PAMPs) common across many microorganisms (Akira et al. 2006). The effector 
functions of these receptors include responding to opsonization (including pathogen-
bound complement or IgG), triggering phagocytosis and activating inflammatory 
signaling cascades (Janeway and Medzhitov 2002). PRRs present on DCs include 
calcium dependent (C-type) lectins (van Vliet et al. 2006), Toll-like receptors (TLRs) 
(Kaisho and Akira 2001; Visintin et al. 2001; Janeway and Medzhitov 2002; Kawai and 
Akira 2006; van Vliet et al. 2007), scavenger receptors (SRs) (Peiser et al. 2002), as well 
as integrins / complement receptors (CRs) (Carroll 1998) and Fc-receptors (Nimmerjahn 
and Ravetch 2008). If an infection (or foreign antigen presence) is long-lived, an innate 
immune response will yield an antigen-specific adaptive immune response leading to the 
production of antibodies against the infecting pathogen. The adaptive immune response 
involves the clonal expansion of naïve T-lymphocytes (T cells) that respond to 
processed antigen presented by mature APCs in association with major 
histocompatibility complex (MHC) molecules.  Depending on how the antigen is 
processed, it may either be displayed on MHC class I or class II molecules which 
coordinates with the T cell receptor (TCR) on cytotoxic (CD8+) or helper T cells (CD4+), 
respectively (Abbas et al. 2007). Along with MHC molecules, APCs also express co-
stimulatory molecules (such as CD80 and CD86), which act as secondary signals for T 
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cell stimulation in the lymph nodes. Upon stimulation/proliferation, T cells help activate 
naïve B-lymphocytes (B cells) that are specific to the particular antigen by secreting 
cytokines (such as IL-4) inducing B-cell expansion. B cells subsequently proliferate and 
mature into antibody-secreting cells known as plasma cells that produce opsonizing 
antibodies specific for the antigenic organism originally captured and presented by 
APCs. This opsonization aids the recognition process of the effector cells of the innate 
immune response by marking the microbe for clearance via PRRs such as Fc-receptors 
(Bajtay et al. 2006).  
 
3.2. Dendritic Cells and Endogenous Adjuvants (‘danger signals’)  
 
 Dendritic cells are professional APCs that process foreign-entities for antigen-
capture and presentation to T cells. Dendritic cells are more potent APCs compared to 
other cell types such as macrophages or B cells due to expressing higher levels of MHC 
and co-stimulatory molecules following maturation (Banchereau and Steinman 1998). 
They are located in specific tissues (such as skin), which are common entryways of 
infection (Steinman and Banchereau 2007), where they exist in an ‘immature’ state 
(Banchereau and Steinman 1998). In this state they have a high capacity for 
endocytosis, low surface expression of MHC and co-stimulatory molecules, high surface 
levels of many PRRs such as Fc-receptors (Banchereau and Steinman 1998) and 
macrophage mannose receptor (Figdor et al. 2002).  It is believed that DCs switch from 
an ‘immature’ state to a ‘mature’ state after encountering molecules known as adjuvants 
(PAMPs or ‘danger signals’) that induce high levels of maturation in DCs (Abbas et al. 
2007). Mature DCs display ‘dendritic’ processes, high levels of co-stimulatory and MHC 
class II molecules for increased stimulation of T cells at lymph nodes, increased cytokine 
production for autocrine and paracrine stimulation of T cells and other cell types, and 
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increased chemokine receptor expression such CCR7 (Sanchez-Sanchez et al. 2006) 
for homing to lymph nodes (Banchereau and Steinman 1998).  
 Adjuvants (such as Freund’s Adjuvant in mice) are delivered in association with 
an antigen to increase the antigen-specific humoral immune response (for vaccine 
purposes) by containing TLR-binding ligands that induce DC maturation through PRRs 
(e.g lipopolysaccharide, LPS, triggers maturation through TLR4). Along with microbial 
products, host-derived stimuli have been found to trigger DC maturation (termed ‘danger 
signals’ or endogenous adjuvants).  
 The danger model, proposed by Polly Matzinger, suggests that a host organizes 
an immune response to non-self antigens only when associated with cell or tissue 
damage (Matzinger 1994; Matzinger 2002). For example, the model proposes that an 
organ transplant may be rejected, in part, because DCs are activated by the release of 
host molecules such as intracellular molecules normally sequestered in the cytoplasm 
but released due to necrosis induced by the implantation procedure. Active ‘danger 
signals’ (or damage-associated molecular patterns, DAMPs) have also come to include 
fragmented or damaged extracellular matrix (ECM) molecules displaying hidden 
antigens that are typically unseen by immune cells in an organized scaffold (Rock and 
Kono 2008). As such, DCs are activated by endogenous molecules from stressed/dying 
cells, and these molecules act as adjuvants to increase the antibody production to a 
model antigen in vivo (Gallucci et al. 1999). Since this discovery, the mechanism behind 
‘danger signal’-mediated DC maturation has been further investigated.  
 Toll-like receptors (particularly TLR4 but also TLR2) have been implicated in the 
recognition of many endogenous molecules (Fig. 3-1). For TLR4 alone these include: 
plasmin (Ward et al. 2006), fibronectin (Okamura et al. 2001), elastase (Devaney et al. 
2003), high mobility group box (HMGB)1 (Yu et al. 2006),  hyaluronic acid fragments 
(Termeer et al. 2002; Jiang et al. 2005; Taylor et al. 2007), fibrinogen (Smiley et al. 
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2001), heat shock protein (HSP)60 (El Mezayen et al. 2007) and heparan sulfate 
(Takeda et al. 2003). Interestingly, many of these molecules are not intracellular (as is 
HSP60 and HMGB1) but are ubiquitous plasma proteins (fibrinogen, fibronectin, 
plasmin) that may serve to augment the inflammatory response toward infection or injury 




Figure 3-1:  Exogenous (PAMP) and endogenous (DAMP) TLR recognition. TLRs 
respond to both exogenous (PAMPs) and endogenous (DAMPs) molecules through 




 Due to the wide variety of putative ‘danger signal’ ligands, TLR4’s role in the 
inflammatory response following sterile injury has also been investigated (Bettinger et al. 
1994; Paterson et al. 2003; Barsness et al. 2004; Jiang et al. 2005; Mollen et al. 2006; 
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Kaczorowski et al. 2008; Sabroe et al. 2008; Zhang et al. 2008). For example, systemic 
inflammation as marked by pro-inflammatory cytokine (tumor necrosis factor (TNF)-! 
and IL-6) serum presence was found to be dependent on TLR4 following femur fracture 
(or sham surgery) (Levy et al. 2006). Also, endotoxin resistant mice (C3H/HeJ) have 
decreased TNF-! content surrounding a linear wound at one day which correlated to 
increased collagen production and wound strength at 7 days following wound in 
comparison to wild-type (C3H/HeN) mice (Bettinger et al. 1994). Neutrophil 
accumulation following bleomycin-induced acute lung injury depended on a combination 
of TLR4 and TLR2 via signaling through MyD88 (see section 3.5.1) (Jiang et al. 2005). 
Burn injury in mice induced increased sensitivity to TLR ligands suggesting that injury 
may also prime the responsiveness of TLRs (Paterson et al. 2003). Lastly, neutrophil 
and monocyte recruitment in the peritoneal cavity following injection of necrotic cells 
depended on MyD88, TLR4/TLR2 and/or IL-1R (Chen et al. 2007). Therefore, 
endogenous molecules released or accumulated following injury seem to induce and 
augment a pro-inflammatory host reaction and aid in directing the wound healing 
response.  
 Support for a ‘danger signal’-induced adjuvant effect was found with the only 
clinically approved adjuvant ‘alum’, composed of insoluble aluminum salts, as well as 
PLGA microparticles which both induce IL-1$ mediated DC inflammation via the 
intracellular nucleotide-binding oligomerization domain-like (Nod-like) receptor, NALP3, 
activation of caspase-1 (Li et al. 2007; Sharp et al. 2009). Furthermore, alum and PLGA 
particulate adjuvant effects through NALP3 are found to be dependent on the presence 
of ‘danger signals’ such as HSPs (Sharp et al. 2009).  
 Several integrins or CRs (see section 3.5.2) recognize endogenous molecules 
such as opsonizing complement components (e.g. C3b) as well as fibrinogen as part of 
the innate immune response to a pathogen or tissue damage, respectively (Wright et al. 
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1988; Gasque 2004). APCs, such as DCs, may use these integrins as both an instigator 
of antigen uptake and maturation to initiate an adaptive immune response (Carroll 2004). 
However, there is conflicting evidence since CR3 (!M$) ligation on DCs resulted in 
increased MHC class II and co-stimulatory molecule expression but decreased cytokine 
secretion (Behrens et al. 2007).  
 
 
3.3. Host Response to a Biomaterial Implant  
 
The host response to a biomaterial implantation includes sequentially, injury, 
blood/material interactions, provisional matrix deposition, acute and chronic 
inflammatory response, granulation tissue onset, foreign body reaction and fibrous 
encapsulation (Anderson et al. 2008) with durations of each stage dependent on 
biomaterial properties. The inflammatory response toward a material is inherently linked 
with injury to vascularized connective tissue (Anderson 2001). Initial blood/material 
interactions yield a deposited plasma protein profile on the material to subsequently 
direct the host response. Therefore, it is generally regarded that the host responds not to 
a biomaterial itself but to the adsorbed protein layer. Specifically, proteins which bind 
with higher affinity to a biomaterial will likely contribute to cellular recognition as over 
time these proteins remain adsorbed as dictated through the Vroman effect (Vroman and 
Adams 1969). Numerous plasma proteins have been found to a play a role, in part, in 
the biomaterial-mediated host response. These include, for example, fibrinogen (Tang 
and Eaton 1993; Hu et al. 2001; Tang et al. 2002; Zdolsek et al. 2007), plasminogen 
(Busuttil et al. 2004), fibronectin (Keselowsky et al. 2007), vitronectin (Wilson et al. 
2005), various complement proteins (Gorbet and Sefton 2004), thrombospondin 2 
(Kyriakides et al. 1999) and immunoglobulins (Anderson et al. 2008). The adsorbed 
protein profile deposited on the material surface directs recruitment and activation of 
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cells and subsequently leads to foreign body reaction and fibrous encapsulation 
depending on the material size. 
Neutrophil and monocyte recruitment to the peritoneal cavity has been found to 
be induced by ‘danger signal’ presence (Chen et al. 2007) during an acute inflammatory 
response which persists at the site of injury/implantation temporarily for approximately 
24hr (Anderson 2001). Following this response, macrophages, which differentiate from 
monocytes after leaving the vasculature, are recruited to the implant site and may 
maintain their presence for months (Anderson 2001). Macrophages are the dominant 
cell type believed to be responsible for directing the wound healing response to an 
implantation. They do so by secreting pro-inflammatory cytokines/chemokines (such as 
TNF-!) if classically activated (M1) (Duffield 2003) by TLR ligands. A balance between 
macrophage phenotypes at the site of injury has also been found in which M1 
macrophages aid in clearance of necrotic cells and damaged matrix while macrophages 
alternatively activated (M2) by anti-inflammatory cytokines such as IL-4 help direct the 
wound healing response through further release of anti-inflammatory cytokines that in 
turn help induce vascularization, matrix deposition and induce proliferation of fibroblasts 
locally (Duffield 2003; Mosser and Edwards 2008). Fibroblasts produce primarily type I 
collagen (Anderson 2001) that forms both the initial granulation tissue (scar formation) 
and subsequent fibrous capsule which surrounds an implant (Anderson et al. 2008) 
To study proteins and receptors involved in the host response to a biomaterial 
using genetically altered mouse models, implantation of polyethylene terephthalate 
(PET) (Dacron™) discs is often used as a model biomaterial implant (Tang et al. 1998; 
Hu et al. 2001; Tang et al. 2002; Busuttil et al. 2004; Keselowsky et al. 2007; Zdolsek et 
al. 2007). PET yields a robust acute inflammatory response at 16hr when implanted into 
the peritoneal cavity in mice eliciting high levels of phagocyte accumulation (neutrophils 
and monocytes) on the surface (Tang and Eaton 1993). When examining the chronic 
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host response, PET implanted subcutaneously for two weeks induces a typical fibrotic 
reaction (encapsulation) (Tang et al. 2002; Keselowsky et al. 2007). 
 
3.4 Complement Pathway 
 
Serum complement proteins opsonize foreign microbes/materials for clearance 
(Abbas et al. 2007). There are three main pathways for complement activation: the 
classical, the alternative and the lectin pathway (Abbas et al. 2007). The classical 
pathway involves complement protein C1 binding at least two opsonizing IgG molecules, 
while the alternative pathway involves C3 binding covalently (C3b) to the microbe or 
biomaterial surface directly through hydroxyl or amine groups (Gorbet and Sefton 2004). 
Lastly, the lectin pathway is activated by circulating lectins binding to carbohydrate 
moieties (particularly mannose) on the surface of microbes which in turn activates 
complement proteins C4b/C2 to covalently tag the microbe (Abbas et al. 2007). 
Irrespective of initiation, the complement activation pathways merge at the level of 
formation of a membrane attack complex (MAC) which serves to induce cell lysis of the 
microbe (Muller-Eberhard 1986). Biomaterial presence in vivo may trigger complement 
activation via the alternative pathway or the classical pathway as seen on chromium or 
titanium surfaces (Walivaara et al. 1996; Walivaara et al. 1996). DCs, and other 
leukocytes, possess specialized integrins (or CRs), which are capable of recognizing 
these complement-opsonized entities. Nanoparticle biomaterial vaccines have been 
successfully designed to take advantage of the complement pathway (through C3b 
binding to hydroxylated surfaces) to induce an increased immune response toward an 
associated antigen (Reddy et al. 2007).  
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3.5. Dendritic Cell Receptors: TLRs, Integrins, and Other Receptor Signaling 
 
3.5.1 Toll-like Receptors 
Toll-like receptors (TLRs), the most characterized of the PRRs, are integral 
membrane proteins containing varying amounts of leucine-rich repeats in their 
extracellular domains thought to be involved in the ligand-recognition process (Kawai 
and Akira 2006). Currently, twelve TLR family members have been discovered in 
mammals (Akira et al. 2006) which recognize a variety of bacterial and viral PAMPs. 
Examples of microbial or viral ligands for TLRs include LPS (TLR4) (Poltorak et al. 1998; 
Hirschfeld et al. 2000; Guha and Mackman 2001; Brunn et al. 2005) lipopeptides and 
lipoproteins (TLR2) (Hirschfeld et al. 2000), double-stranded viral RNA (TLR3) (Kawai 
and Akira 2006) and bacterial flagellin (TLR5) (Hayashi et al. 2001). TLRs such as 
TLR4, TLR2 and TLR5, which recognize extracellular pathogen components, are found 
across the plasma membrane while others such as TLR3 and TLR9, which recognize 
pathogen intracellular molecules, are localized to endosomes owing to necessary 
pathogen degradation prior to engaging the receptors.  
As stated previously, TLRs (particularly TLR4) have also been shown to be 
involved in various ‘danger signal’-mediated signaling. Most TLR signaling propagation 
occurs through MyD88, an adaptor protein common for nearly all TLRs (except TLR3). 
TLR4, however, is the only TLR that can signal in a MyD88 dependent and independent 
manner (Kaisho and Akira 2001). TLRs share cytoplasmic homology to IL-1 receptor (IL-
1R), and thus the adaptor molecules and signaling pathways are also shared. In short, 
upon ligation TLRs stimulate three main signaling pathways: 1. IKK complex (inhibitor of 
nuclear factor-"B (I"B)-kinase complex) activation results in the phosphorylation of I"B 
(which subsequently becomes degraded via ubiquitinylation) and results in the release 
and activation of NF-"B transcription factor family (p65, p50, p52, RelB, and cRel) 
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normally sequestered in the cytoplasm; 2. Mitogen-activated protein kinase (MAPK) 
family (c-Jun N-terminal kinase, JNK; p38, and extracellular-signal-regulated kinase, 
ERK) activation results in the subsequent phosphorylation/activation of AP-1 
transcription factor family (cJun, cFos, FosB, Fra-1, Fra-2, JunB, JunD); 3. MyD88-
independent pathways signal through an adaptor molecule Toll/IL-1R domain-containing 
adapter molecule (Trif) which leads to the activation of interferon regulatory factor 3 
(IRF3) transcription factor to induce interferon production (Kawai and Akira 2006) (Fig. 3-
2). Though NF-"B and AP-1 independently control the expression of co-stimulatory 
molecules and inflammatory cytokines particularly in DCs, balanced activation of both 
NF-"B and AP-1 seems to yield optimal inflammatory response (Kriehuber et al. 2005; 
Papa et al. 2006). Upon activation of TLR4 by LPS, TLR4 surface expression is down-






Figure 3-2: Representative TLR signaling pathways. TLR4 and TLR3, shown. Image 
adapted from (Kawai and Akira 2006).  TLR mediated responses yield typical 
inflammatory responses through the activation of NF-"B and AP-1 transcription factors.  
 
 
In regards to biomaterial-mediated responses, TLR4, in particular, has been 
shown to play a role in the inflammatory reaction to hydroxyapatite particles (Grandjean-
Laquerriere et al. 2007) and alginate oligosaccharides (Iwamoto et al. 2005) in 
macrophages. Also, TLRs expressed by several cell types (e.g. endothelial cells, 
macrophages) are found in the interface membrane of loosening-hip implants (Takagi et 
al. 2007). Intracellular Nod-like receptors, which possess similar leucine-rich repeats to 
TLRs, have been found to account for PLGA MP induced adjuvanticity through DC 
inflammasome activation (Sharp et al. 2009). Recently, DCs treated with various 
biomaterials were found to induce signs of DC maturation and subsequent T cell 
stimulation in a TLR-dependent manner as DCs from MyD88-/- or TLR4-/- mice show 
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deficiencies in their response to biomaterials (Shokouhi et al. 2010). Thus, TLRs are 
relevant receptors for investigation into the DC recognition of biomaterials. 
 
3.5.2 Integrins 
Integrins are trans-membrane adhesion receptors composed of heterodimers of 
at least 24 combinations of distinct ! and $ subunits, which mediate cell-cell adhesion 
and adhesion to surrounding tissues through binding of extracellular matrix proteins to 
support cell migration (Abram and Lowell 2009). Families of integrins are often 
designated by a common $ subunit and differ in their ligand specificity through the 
assortment of ! subunits. Integrins are capable of recognizing a wide variety of 
physiological ligands such as fibronectin, vitronectin and fibrinogen as well as many cell 
surface molecules (Arnaout et al. 2005). While many cell types possess $1 integrin family 
members, only leukocytes, including DCs, possess the $2 (or CD18) family of integrins 
(Springer 1990; Ginsberg et al. 1992; Dib and Andersson 2000). $2 is known to pair with 
four ! subunits (!L, !M, !X or !D) and is also known to mediate responses to infection or 
inflammation by supporting transmigration through endothelium by leukocytes 
(Gahmberg et al. 1998). Inflammation-induced activation of leukocytes via chemokines is 
capable of inducing an inside-out signaling transformation of integrins (Rose et al. 2007) 
to a high affinity confirmation capable of supporting binding to its ligand. Activated 
leukocytes have increased binding capacity of integrins due to shifting the integrin state 
from a closed to an open form (Abram and Lowell 2009). Once integrins bind to a ligand, 
integrin clustering occurs and further leads to adhesion-induced cell signaling (Rose et 
al. 2007). 
Expressed on human DCs, $2 family members include !L$2 (lymphocyte function-
associated antigen, LFA-1), !M$2 (or CR type 3, CR3; macrophage-1 antigen, MAC-1) or 
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!X$2 (CR type 4, CR4) (Bajtay et al. 2006). $2 integrins such !M$2 or !X$2 may facilitate 
host recognition of both complement-opsonized microbes through inactivated (i)-C3b or 
biomaterials through adsorbed fibrinogen (Lee and Kim 2007). Monocyte adhesion to 
biomaterials is dependent on C3-opsonization and !M$2 (McNally and Anderson 1994; 
McNally and Anderson 2002). $2 integrins have also been found to recognize 
biomaterial-adsorbed fibrinogen and explain, in part, the host recognition of biomaterials 
(Tang and Eaton 1993; Tang et al. 1996; Tang et al. 1998). Regardless, $2-mediated 
adhesion to biomaterials by mononuclear cells such as monocytes/macrophages is 
believed to be important in the initiation of the host response (Anderson 2001).  
Integrin-ligand binding leads to outside-in signaling which may further maintain 
the activation state of the integrin and lead to both actin polymerization and gene 
transcription. Kinases involved in the integrin signaling are Src, focal adhesion kinase 
(FAK) and spleen tyrosine kinase (Syk) which is recruited by phosphorylated 
immunoreceptor tyrosine-based activation motifs (ITAMs) (Fig. 3-3) (Abram and Lowell 
2009). Furthermore, a link between an integrin signaling pathway and TLRs has been 
shown. !M induced signaling results in Syk phosphorylation, which in turn directly 
phosphorylates MyD88 and Trif and marks them for ubiquitin addition (Han et al. 2010). 
This process leads to proteasomal degradation of the two key adaptor molecules for 
TLR signaling. Therefore, integrin !M engagement leads to an inhibition in TLR-induced 
activation (Han et al. 2010). 
The role of integrins for DC biomaterial recognition is less characterized, but 
similar to monocyte/macrophages DC adhesion to distinct plasma proteins, which is 
believed to be integrin mediated, does contribute to signs of maturation (Acharya et al. 
2008). Also, it is known that biomaterial-adsorbed fibrinogen induces DC cytokine 
secretion in a $2-dependent manner (Thacker and Retzinger 2008). Furthermore, as 
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stated previously !M$2 ligation in DCs induces increased co-stimulatory and MHC class 
II molecule expression while decreasing cytokine secretion (Behrens et al. 2007). 
 
 
Figure 3-3: Active integrin signaling pathway, adapted and simplified from (Abram 
and Lowell 2009). Integrin-ligand recognition results in activation Src family kinases 
(SFK), ITAMs, talin (which is directly bound to cytoskeleton), and also FAK. Integrin 
binding leads to both transcription and actin polymerization. 
 
 
3.5.3 C-type Lectins 
C-type lectins receptors (CLRs) contain carbohydrate recognition domains 
(CRDs) which depend on Ca++ for both ligand binding and maintaining structural integrity 
(Cambi et al. 2005). CLRs recognize carbohydrate moieties present on pathogens but 
also altered carbohydrate structures found on apoptotic and necrotic cells (Gijzen et al. 
2006) that are marked for clearance. On pathogens CLRs recognize specific 
carbohydrates such as mannose structures using the mannose receptor (MR) family 
which facilitate uptake and antigen processing. Other family members of C-type lectins 
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include collectins, and type II receptors such as dendritic cell-specific ICAM3 grabbing 
non-integrin (DC-SIGN). DC-SIGN is involved in binding to intercellular adhesion 
molecule-3 (ICAM-3) on T-cells which helps mediate DC induced T-Cell activation 
(Figdor et al. 2002). Similar to TLRs, C-type lectins have been implicated in ‘danger 
signal’ interactions by recognizing apoptotic cells with modified carbohydrate residues 
(Peiser et al. 2002; Gijzen et al. 2006). The signaling pathways of lectins are less 
characterized than TLRs though some pathways have been shown. Dectin-1, a type II 
receptor, binding by ß-glycan has been found to stimulate NF-"B activation through its 
intracellular ITAM and subsequent spleen tyrosine kinase (Syk) activation (Brown 2006; 
Gijzen et al. 2006). The role of C-type lectins in recognizing endogenous/aberrant 
glycosylations found in association with biomaterial surfaces is unknown but is also 
being investigated in the Babensee laboratory. 
 
3.5.4 Scavenger Receptors 
Scavenger receptors (SR) consist of a wide range of integral membrane proteins 
involved in the recognition of polyanionic ligands (Peiser et al. 2002) and were originally 
believed to mediate endocytosis of oxidized low-density lipoproteins (Abbas et al. 2007). 
Similar to CLRs and TLRs, SRs have recently been implicated in pathogen recognition 
and the clearance of apoptotic cells (Peiser et al. 2002). SRs (such as CD91 and SR-A) 
respond to endogenous intracellular HSPs such as HSPgp96, HSP70 and HSP90 
(Facciponte et al. 2005) many of which have been found to stimulate TLR signaling. 
 
3.5.5 Fc-Receptors 
Dendritic cell Fc-receptors recognize fragment crystallizable (Fc) regions of host 
immunoglobulin molecules that opsonize antigens and help mediate phagocytosis. 
Depending on the presence of ITAM or immunoreceptor tyrosine-based inhibition motifs 
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(ITIM), Fc-receptors are grouped into two classes: activating or inhibiting receptors, 
respectively. ITAM-containing receptors can induce DC maturation through NF-"B 
activation while ITIM-containing receptors block ITAM-mediated maturation (Bajtay et al. 
2006). ITAM-mediated signaling by Fc-receptors, similar to CLRs, is through Syk 
(Nimmerjahn and Ravetch 2008). Since immunoglobulin opsonization occurs on the 
surface of biomaterials (Anderson et al. 2008), it is foreseeable that Fc-receptors on DCs 
may mediate the recognition of a biomaterial and may even coordinate with CLRs 
through ITAM-containing based signaling.  
 




Poly (lactic-co-glycolic) acid (PLGA) is a synthetic co-polymer with 
biocompatible/natural by-products widely utilized in the field tissue engineering as for cell 
scaffolds. Lactic and glycolic acid are covalently linked via an ester bond, which allows 
for direct hydrolysis in vivo and in vitro yielding its biodegradability (Kim and Mooney 
1998). The degradation rate of PLGA may be fine-tuned by increasing glycolide content 
of the polymer (i.e. increasing the ratio of glycolide to lactide) (Wu and Ding 2004). Often 
mole ratios between 50:50 to 85:15 (lactide:glycolide) are used due to preferable in vivo 
half-lives of scaffolds which range from 2 weeks for 50:50 PLGA to 12 weeks for 85:15 
PLGA  (Lu et al. 2000). An appropriate amount of time is needed in order to allow for 
tissue integration, which will depend on the particular application and location in the 
body. For PLGA, perspective tissues range from bone and cartilage to liver tissues (Kim 
and Mooney 1998).  Due to its natural base components, PLGA by-products are 
biocompatible and thus used in a wide variety of FDA approved devices.  
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PLGA may also be used as a controlled release delivery vehicle in the form of 
MP (or particulate), which gradually release their loaded components, such as proteins 
during bulk hydrolysis (Blanco and Alonso 1998). PLGA MPs have also been utilized as 
both vesicle and adjuvant as they may increase an immune response to the delivered 
product (Ertl et al. 1996; Bennewitz and Babensee 2005; Schlosser et al. 2008; Sharp et 
al. 2009) potentially through intracellular DC inflammasome activation (Sharp et al. 
2009). However, the biomaterial adjuvant effect toward a co-delivered antigen has also 
been seen with PLGA in scaffold form which cannot be internally processed (Matzelle 
and Babensee 2004; Bennewitz and Babensee 2005); although microparticles are 
degradation products of the scaffolds upon contact with the aqueous environment in 
vivo. Therefore, further elucidating the host response to PLGA is necessary to 
understand its adjuvant effect. 
 
3.6.2 Agarose 
Agarose is a natural seaweed-derived polysaccharide containing disaccharides 
of D-galactopyranose and 3,6-anhydro-L-galactopyranose capable of forming thermally 
reversible physically-crosslinked gel (Lee and Mooney 2001; Liang et al. 2006). Agarose 
scaffolds and/or hydrogels have been used for tissue engineered devices ranging from 
nerve repair (Balgude et al. 2001; Stokols et al. 2006) to cartilage replacement strategies 
(Rahfoth et al. 1998). Due to its hydrophilic nature, it has an extremely low contact angle 
(Yoshida and Babensee 2006). Unlike PLGA scaffolds, agarose scaffolds do not 
contribute to an adjuvant effect toward a co-delivered antigen and maintain a humoral 
immune response equivalent to that of injection of antigen alone (Matzelle and 
Babensee 2004; Norton et al. 2010). Unlike other natural polymers used in tissue- 
engineered devices such as hyaluronan (Leach et al. 2004) which consist inherently in 
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their chemistry of receptor-recognizable motifs e.g. via CD44 or integrins, agarose does 
not possess a carbohydrate moiety recognizable by cellular receptors.  
 
3.7. Biomaterial-induced DC Maturation 
 
The relationship between innate and adaptive immunity in the context of a 
combination product, which elicits a response from both branches of the immune system 
(non-specific innate and antigen-specific adaptive response), has only recently been 
investigated. It was believed that the innate response toward a biomaterial might 
influence the subsequent adaptive immune response toward the co-delivered biologic. 
PLGA scaffolds, commonly utilized in tissue-engineered devices (Section 3.6.1), have 
been found to act as an adjuvant toward a co-delivered model antigen (ovalbumin, OVA) 
(Matzelle and Babensee 2004; Bennewitz and Babensee 2005; Norton et al. 2010). The 
implantation of the material scaffold (as opposed to the injection of PLGA MP) in 
association with antigen induced a higher and longer lasting humoral immune response 
(antibody production) to the model antigen possibly due to tissue injury induced 
endogenous adjuvants presence to prime the implantation site for a biomaterial adjuvant 
effect (Matzelle and Babensee 2004; Bennewitz and Babensee 2005; Norton et al. 
2010). Upon tissue injury, DAMP presence increases (Section 3.2), which may aid in the 
propagation of an innate immune response through TLR recognition of molecules such 
as HMGB1 being released from cells or production of fragments of extracellular 
molecules such as FN. In fact, HGMB1 is found in higher presence in tissue exudates 
from subcutaneously implanted PLGA scaffolds (with or without OVA) in comparison to 
naïve controls suggesting its potential role in biomaterial-induced adjuvant effect 
(Babensee 2008).  
It was hypothesized that DCs play a part in the biomaterial adjuvant effect as 
DCs are innate immune cells which serve to initiate an adaptive immune response. To 
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this extent, human monocyte-derived DCs were treated with biomaterials commonly 
used in tissue-engineering applications. It was found that DC maturation occurred in the 
presence of films prepared of materials such as PLGA and chitosan, did not occur in the 
presence of agarose films, and DC maturation was inhibited by treatment with hyaluronic 
acid films (Babensee and Paranjpe 2005). Also, treatment of DCs with PLGA or agarose 
films induced NF-"B activation in human DCs (Yoshida and Babensee 2006) though 
agarose seems to induce higher levels than PLGA film treatment. BMDCs from C57BL/6 
mice have also been shown to mature in the presence of PLGA films or MP (Yoshida et 
al. 2007). PLGA film induction of DC maturation in vitro matches its adjuvanticity in vivo. 
Similarly, the minimal DC response to agarose film in vitro mimics the lack of agarose 
scaffold adjuvant effect (Matzelle and Babensee 2004; Bennewitz and Babensee 2005; 
Norton et al. 2010). Therefore, the response of DCs to the biomaterial component of a 
combination product may be critical and utilized to manipulate the subsequent host 




THE ROLE OF ‘DANGER SIGNAL’-TLR4 INTERACTIONS IN THE HOST RESPONSE 





Biomaterials used for medical devices elicit a response from the body that is 
often detrimental to the efficacy of their intended function. Simply, the host response to a 
biomaterial implantation includes injury, blood/material interactions, coagulation and 
provisional matrix deposition, acute inflammatory response, granulation tissue onset, 
foreign body reaction and fibrous encapsulation (Anderson et al. 2008). The implantation 
procedure inherently produces tissue and vasculature damage causing blood 
components to infiltrate the implant region. The inflammatory response toward a device 
is directed by these interactions between blood/tissue components and material, which 
results in immediate protein adsorption to the surface.  
A variety of proteins mediate the localization of leukocytes to biomaterials 
through adhesion receptors (Wilson et al. 2005). Particularly, complement proteins 
(McNally and Anderson 1994; Brodbeck et al. 2003; Gorbet and Sefton 2004) as well as 
a major component of the clotting cascade, fibrinogen (Tang and Eaton 1993; Tang et al. 
1998; Hu et al. 2001), have been shown to mediate phagocyte adhesion to materials 
through $2 (CD18) integrins (McNally and Anderson 1994; Tang et al. 1996; Hu et al. 
2001; McNally and Anderson 2002). This adhesion is a critical step in the recognition of 
a biomaterial. However, there are potentially additional initial events in the inflammatory 
response to an implant that may prime phagocytes such as neutrophils and 
monocyte/macrophages for adhesion. Recent literature has brought to light the role of 
‘danger signals’ in the inflammatory response following injury, which elicit leukocyte 
                                                
* Modified from Rogers T, Babensee JE “Altered adherent leukocyte profile on biomaterials in 
Toll-like receptor 4 deficient mice” Biomaterials, 2010 31(4) 594-601 
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activation primarily through binding to pattern recognition receptors (PRRs). These 
ligand-receptor interactions would precede (or occur simultaneously with) leukocyte 
adhesion, but the role of these factors in the host response to a biomaterial is unknown. 
‘Danger signals’ or damage-associated molecular patterns (DAMPs) (Matzinger 
1994; Matzinger 2002) are endogenous intracellular or extracellular components that are 
normally hidden from the environment or are present at low concentrations. Upon 
cellular necrosis and/or tissue damage, these occult motifs can become strong activators 
of inflammation, aid in the body’s recognition of dying cells and can act as adjuvants 
through direct activation of immune cells such as dendritic cells (DCs) and macrophages 
(Gallucci et al. 1999). Numerous endogenous DAMPs have been linked to leukocyte 
activation through the PRR Toll-like receptor 4 (TLR4) (Rock and Kono 2008) as well as 
the PAMP lipopolysaccharide (LPS). 
The TLR family is composed of at least ten TLRs (TLR1-TLR10) in humans 
(Akira et al. 2006) and are integral membrane proteins containing leucine-rich repeats in 
the extracellular domain which are believed to be involved in the ligand-recognition 
process. Immune cells (along with other cell types) possess TLRs, which canonically 
bind conserved pathogen-associated molecular patterns (PAMPs) to aid in the initiation 
of an innate immune response toward a pathogen (Medzhitov and Janeway 1997; 
Janeway and Medzhitov 2002; Lee and Kim 2007). TLR activation stimulates innate 
effector functions such as increases in pro-inflammatory cytokine/chemokine production 
(e.g. TNF-!), increases in co-stimulatory molecules for antigen-presenting cells, and up-
regulation of integrin expression (Sabroe et al. 2003). TLR4/DAMP interactions have 
been investigated in the wound healing response to sterile injury in various applications 
ranging for hemorrhage and drug-induced lung injury to sterile skin incisions and 
systemic inflammation following femur fracture (Bettinger et al. 1994; Barsness et al. 
2004; Jiang et al. 2005; Levy et al. 2006). Following injury, it is believed that TLR4 
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initiates inflammatory signaling via cytokine communication (Mollen et al. 2006) to 
provide necessary cues during wound repair. Neutrophil and monocyte recruitment to 
the peritoneal cavity has been found to be induced by DAMP presence (Chen et al. 
2006). These findings are relevant to biomaterials as many aspects of wound healing 
are connected to the host response to materials (Anderson 2001; Anderson et al. 2008).  
Biomaterial particulates delivered with PAMP ligands for TLR4 have been 
investigated for directing cancer vaccines (Hamdy et al. 2008; Schlosser et al. 2008); 
however, we and others have found that biomaterials themselves are capable of acting 
as adjuvants inducing a strong humoral immune response toward a co-delivered antigen  
(Matzelle and Babensee 2004; Bennewitz and Babensee 2005; Babensee 2008; Sharp 
et al. 2009) in the absence of PAMP TLR ligands. Therefore, in an endotoxin-free 
environment, TLR4 may interact with biomaterial-associated DAMPs to propagate an 
innate inflammatory response and offers an explanation of the biomaterial-induced 
adjuvant effect previously seen.  
Several groups have studied the role of TLR4 in the cellular response to 
biomaterials in vitro. Macrophage cytokine secretion in response to oligosaccharides of 
alginate is believed to be TLR4/2 dependent (Iwamoto et al. 2005). Pro-inflammatory 
cytokine production (TNF-!) but not NF-"B activation in macrophages treated with 
hydroxyapatite particles was found to be TLR4-dependent (Grandjean-Laquerriere et al. 
2007). However, as to date no studies have examined the role of TLRs (specifically 
TLR4) in the in vivo host response to biomaterials. Therefore, this study sought to 
examine the role of TLR4 and endogenous DAMP molecule interactions in the acute and 
chronic inflammatory response to a biomaterial implant. 
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Materials and Methods 
 
Biomaterial Preparation 
PET implants were prepared by punching 10mm discs from a 0.5mm thick PET 
sheet (AIN Plastics, Kennesaw, GA). Discs were sterilized by rinsing with 70% ethanol 
for 24hr followed by three 30 min rinses in endotoxin-free water (Lonza, Basel, 
Switzerland). After drying in a tissue culture hood, discs were autoclaved prior to 
implantation. Endotoxin content of equivalently prepared PET discs (5mm) was 
assessed using the Limulus Ameobocyte Lysate (LAL) assay (QCL-1000 Chromogenic 
LAL Endpoint assay, Lonza) in endotoxin-free test tubes (Lonza). PET discs were tested 
in the presence of both LAL and the chromogenic substrate and compared to a 
simultaneously developed endotoxin standard curve (between 0.1 and 1.0 EU/mL). 
Implanted PET discs tested below 0.1 EU/ml, the lower limit for this assay.  
 
IP Implantation and Analysis 
All animal procedures were approved by IACUC committee prior to use (Protocol 
044-2008, Emory University). Mice were 6-7 weeks old and age-matched for each 
experiment performed across TLR4+ (C57BL/10, The Jackson Laboratory, Bar Harbor, 
ME) and TLR4- (C57BL/10ScN, The Jackson Laboratory) strains. For IP implantation 
model, survival surgeries were completed in a laminar flow hood using sterilized surgical 
instruments in combination with a peri-operative dose of nalbuphine (6mg/kg) under 
isofluorane (Baxter, Deerfield, IL) anesthetic. Two PET discs were implanted IP per 
mouse for 16hr through a midline incision followed by suturing of muscle and skin (n = 7-
9 mice, see Table 4-1). Sham surgeries with no implants (but with incision and suturing) 
were also performed simultaneously (see Table 4-1). At 16hr, mice were anesthetized 
and 1ml Dulbecco’s Phosphate Buffered Saline (Invitrogen, Carlsbad, CA) [D-
PBS]/heparin (Abraxis Bioscience, Los Angeles, CA) (50 U/ml) was injected IP for 
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collection of lavage by sterile transfer pipette. Discs were collected and transferred to 
1ml PBS on ice until analysis. Lastly, cardiac puncture (using 100 U heparin preloaded 
in a 1mL syringe with a 21g needle) was performed to subsequently determine 
circulating leukocyte population.  
Lavage supernatants were collected, volume estimated for concentration 
calculation and stored at -20oC following centrifugation of lavages at 400g for 5 min.  
Lavage cells were resuspended in 1ml of D-PBS and a small aliquot (10"l) was analyzed 
for cell counts (6-20"m) using Multisizer 3 Coulter Counter (Beckman Coulter, Fullerton, 
CA). The remaining cells were resuspended at a concentration of 1*106 per milliliter and  
 
Table 4-1: Number of animals (n) analyzed per strain using the indicated endpoint 
analyses for the three treatment groups in the IP implantation study. Lavage total cell 
counts and cytospin analysis were performed on all mice including those with PET 
implants which were also analyzed for total adherent cells and cell types (see method for 
detailed description). Cardiac punctures were performed on all mice to assess circulating 
leukocyte populations 
 




































200"L used for one cytospin analysis per mouse/lavage using Shandon Cytospin 3 
(Thermo Scientific, Waltham, MA). Cytospins were stained with Hema 3 (Fisher 
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Scientific, Pittsburgh, PA) and differential cell counts (300 cells counted per sample) 
performed by microscopy.    
The first explanted disc was stained immediately after recovery using Hema 3. 
From the second recovered disc, adherent cells were collected by placing the disc in 
trypsin/EDTA (0.25%) (Sigma-Aldrich, St. Louis, MO) at 37oC. To assure complete 
removal of adherent cells, a cell scraper was lightly passed over both sides of the disc 
after it had been placed in RPMI 1640 media (Invitrogen) supplemented with 10% heat-
inactivated FBS (Mediatech, Manassas, VA) to inactivate trypsin. Collected adherent 
cells were counted and stained using the identical procedure described previously for 
lavage cells (one cytospin analysis per disc, n = 8-9 samples per group, see Table 4-1). 
This implant was stained directly to assure complete removal of cells had been 
achieved. The trypsinized disc possessed no adherent cells on either side compared to 
the implant stained immediately after removal which was extensively covered with cells 
as assessed by microscopy.  
Cardiac punctures were collected and immediately a blood smear prepared using 
HemaPrep (J.P. Gilbert Company, Boyertown, PA) and stained using Hema 3. Red 
blood cells were lysed with warmed ammonium chloride solution to assess total 
circulating leukocyte concentrations using a Multisizer 3 Coulter Counter (Beckman 
Coulter). 
Naïve lavages and cardiac punctures were also performed in age-matched 
TLR4+ and TLR4- mice that had not undergone any surgical procedure (n = 7-8 mice, 
see Table 4-1). 
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SC Implantation and Analysis 
For SC implantation model, survival surgeries were completed in a laminar flow 
hood using sterilized surgical instruments in combination with peri-operative dose of 
nalbuphine (6mg/kg) and isofluorane (Baxter) anesthetic. Two PET discs were implanted 
subcutaneously on the dorsum (one to the left and one to the right of the spine) of TLR4+ 
(n=6) or TLR4- (n=7) mice. At 2 weeks, mice were anesthetized using isofluorane and 
cardiac punctures performed/analyzed as described above. Discs with surrounding 
tissue were explanted and immediately fixed in 10% (v/v) buffered formalin (Fisher 
Scientific) until processing. Tissue explants were embedded in paraffin and 5"m 
sections were prepared for staining. For analysis of fibrous capsule thickness, sections 
were deparaffinized and stained with Van Gieson stain (American Master Tech 
Scientific, Lodi, CA); otherwise, sections were stained with hematoxylin and eosin 
(H&E). Fibrous capsule thickness (as seen by dark red collagen staining) was 
determined on both skin or muscle side of implants from five sections per mouse using 
Image Pro Plus (Media Cybernetics, Bethesda, MD) calibrated software using sections 
taken vertically from the center of the explanted disc. 
 
TNF-! ELISA Analysis 
Cleared lavage supernatants from implant, sham or naïve treatment groups were 
assessed for TNF-! concentration using an ELISA (R&D Systems, Minneapolis, MN). 
Samples were run undiluted and analyzed following manufacturer’s instructions. Values 
that were below blank of the assay were taken as zero. 
 
Statistical Analysis 
All statistical analysis was performed using one-way ANOVA (Prism v5.0a, 
GraphPad Software Inc, La Jolla, CA) with animals nested within treatment. Comparison 
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across groups was accomplished using a Tukey post-test with a 95% confidence interval 





Using an established TLR4-deficient mouse strain, C57BL/10ScN (Poltorak et al. 
1998; Netea et al. 2003; Paterson et al. 2003; Takeda et al. 2003; Netea et al. 2005; 
Khan et al. 2006), which possesses a complete deletion of the tlr4 gene, along with an 
appropriate wild-type control strain (C57BL/10) as recipients of biomaterial implants, the 
role of TLR4 in the host response to a biomaterial implant was examined. Discs of PET, 
as a model synthetic implant, have been used extensively (Tang et al. 1998; Hu et al. 
2001; Tang et al. 2002; Busuttil et al. 2004; Keselowsky et al. 2007; Zdolsek et al. 2007) 
and yield robust phagocyte accumulation (neutrophils and monocyte/macrophages) in 
response to biomaterial in the peritoneal cavity at 16hr (Tang and Eaton 1993). To study 
the role of DAMPs/TLR4 interactions in the acute inflammatory response to biomaterials, 
PET discs were implanted IP for 16hr in TLR4- or TLR4+ mice and total leukocyte 
concentrations and differential leukocyte profiles were analyzed in IP lavages and 
adherent cells harvested from the PET discs. Sham surgeries and naïve mice were used 
as controls to isolate the role DAMPs/TLR4 interaction plays in the recruitment of 
leukocytes due to the biomaterial itself. The dependence of the fibrous capsule formation 
on DAMPs/TLR4 interactions was assessed following 2 weeks of PET disc implantation 
subcutaneously in TLR4- or TLR4+ mice. 
Total leukocyte concentrations were determined in IP lavages collected from 
TLR4+ or TLR4- mice receiving a PET disc implant, sham surgery or in the naïve control 
group (Fig. 4-1). Implantation of a PET disc induced recruitment of leukocytes into the 
peritoneal cavity of TLR4- mice with higher total leukocyte concentrations as compared 
to that of the respective naïve mice.  This trend was also present upon PET disc 
implantation into TLR4+ mice but was not found to be statistically significant. Sham 
surgery induced leukocyte recruitment into the peritoneal cavity of either mouse strain to 
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levels which were between those found for naïve or implant groups of either mouse 
strain, though not-statistically different from either group (Fig. 4-1).  
The differential leukocyte profiles in IP lavages for TLR4+ or TLR4- mice were 
determined and found to be similar for both mouse strains for the various treatment 
groups (Fig. 4-2). The majority of leukocytes in the peritoneal cavity at 16hr were 
neutrophils for both mouse strains regardless of treatment; however, there was a 
significantly lower fraction of neutrophils in naïve TLR4- than all TLR4+ treatments (Fig. 
4-2A). TLR4- mice tended to have a slightly higher fraction of monocyte/macrophage 
than TLR4+ mice (Fig. 4-2B); however, no significant differences were found between  
 
 
Figure 4-1: Total leukocyte concentrations in IP lavages for TLR4+ or TLR4- mice.  
Mice received a PET disc implant, sham surgery or were in naïve control group. Star; 
p<0.05 in comparison to either naïve group, n=7-9 mice per group. Bars represent 
mean+SD. 
 
implant groups of the two strains. Eosinophil and lymphocyte fractions from both strains 
were found to be similar (Fig. 4-2C, 4-2D, respectively). To examine if a TLR4 deficiency 
affected circulating leukocyte concentrations, which would certainly have affected 
recruitment into the IP space, total circulating leukocyte concentrations were determined 
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in lysed whole blood obtained from cardiac punctures. No differences were found across 
all treatments (data not shown) for both TLR4+ and TLR4- mice. 
 As a potent pro-inflammatory cytokine often produced upon TLR4 signaling, 
TNF-! controls numerous cellular actions in the acute inflammatory response. The 
concentration of TNF-! in peritoneal cavity was determined to assess if it was induced in 





Figure 4-2:  Differential leukocyte profiles for TLR4+ or TLR4- mice. Fractions of (A) 
Neutrophils, (B) Monocyte/Macrophages, (C) Eosinophils, (D) Lymphocytes in IP 
lavages for TLR4+ or TLR4- mice receiving a PET disc implant, sham surgery or naïve 
control. Brackets indicate significant differences between groups (p<0.05), n=7-9 mice 




significantly detected in the peritoneal cavity upon implantation of a PET disc since little 
to no TNF-a was detected in IP lavages of sham or naïve groups from both TLR4+ and 
TLR4- mice (Fig. 4-3). However, this response was found to be TLR4-independent as 
both strains elicited similar production of the cytokine upon PET disc implantation. 
 
 
Figure 4-3: TNF-!  concentrations in IP lavages for TLR4+ (+) or TLR4- (-) mice 
receiving a PET disc implant (Implant), sham surgery (Sham) or naïve control (Naïve). 
Individual murine concentrations are plotted as points with horizontal lines representing 
mean with standard deviations. Brackets indicate statistical difference (p<0.05) between 
group, n=7-9 mice per group.  
 
The role of TLR4 in controlling the adherent leukocyte profile on the IP implanted 
PET disc was assessed by determining the total number and differential profiles of 
leukocytes harvested by trypsinization from discs. The total numbers of leukocytes 
recovered as adherent to the biomaterial were similar in TLR4+ and TLR4- mice (Fig. 4-
4A). However, the differential leukocyte profiles recovered from the surface of the 
material were distinct between strains (Fig. 4-4B). Implants in TLR4+ mice possessed 
equivalent fractions of harvested adherent neutrophils and monocyte/macrophages while 
implants in TLR4- mice had significantly higher fractions of harvested adherent 
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neutrophils than monocyte/macrophages (Fig. 4-4B and Fig. 4-5).  Furthermore, both of 
these fractions were significantly different between the two strains (Fig. 4-4B). 
 
 
Figure 4-4: Adherent leukocyte profiles on PET discs following 16hr of IP 
implantation into TLR4+ or TLR4- mice. (A) Total number of adherent leukocytes 
collected from implants in either strain. No statistical difference was found between 
strains (p=0.27); n=7-9 mice per group. (B) Adherent leukocyte profiles showing 
fractions of neutrophils, monocyte/macrophages, eosinophils, and lymphocytes. 
Brackets indicate significant differences between groups (p<0.05); n=7-9 mice per 
group. All treatments significantly different from each other except for lymphocyte and 
eosinophil fractions from either strain as well as neutrophil and monocyte/macrophage 
fractions from TLR4+ strain. 
 
 
Figure 4-5: Representative cytospins of adherent leukocytes collected from PET 
discs implanted for 16hr. Found in TLR4+ (A) or TLR4- (B) mice. Bar indicates 10"m. 
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To examine whether TLR4 presence affected the fibrous encapsulation of an 
implanted biomaterial, PET discs were implanted subcutaneously in TLR4+ or TLR4- for 
2 weeks and the resultant thicknesses assessed in histological sections. Tissue 
surrounding the implants was stained with Van Gieson to highlight the collagen content 
of the capsule. TLR4+ and TLR4- mice displayed no noticeable differences in collagen 
content at the implant interfaces. Both strains elicited strong a tissue reaction (Fig. 4-6A-
D) as well as a thick fibrous capsule on the dermal side as opposed to the muscle, which 
was thin (Fig. 4-6E-F & Fig. 4-7). The capsule on the dermal side was determined to be 
16±4 µm for TLR4+ mice and 18±2 µm for TLR4- mice while the capsule adjacent to 
muscle was 8±2 µm for TLR4+ mice and 9±2 µm for TLR4- mice. There were no 
differences in the thicknesses of the fibrous capsules on either side between the two 
mouse strains (Fig. 4-7). 
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Figure 4-6: Representative H&E and Van Gieson stained tissue sections of PET 
discs implanted SC for 2 weeks. Shown are 10X images of representative H&E 
stained sections from a TLR4+ (A) or a TLR4- (B) mouse (bar indicates 100"m)  as well 
as 40X magnifications TLR4+ (C) or a TLR4- (D) (bar indicates 10"m). Also shown are 
10X images of Van Gieson (collagen) stained sections from a TLR4+ (E) or a TLR4- (F) 
mouse (bar indicates 100"m). No noticeable differences in fibrous capsule formation 





Figure 4-7: Fibrous capsule thickness surrounding PET discs implanted for 2 
weeks SC in TLR4+ or TLR4- mice assessed on the skin and muscle sides. 
Thicknesses were averaged for the skin side or the muscle side of the implant for each 
animal and individual determinations are plotted as points with horizontal lines 
representing mean with standard deviations; n=4-7 mice per group. Brackets indicate 





For the first time, this research demonstrates that TLR4 plays a role in the host 
response to a biomaterial in vivo. Specifically, mice lacking TLR4 had an altered 
differential leukocyte profile recovered from PET surfaces following a 16hr 
intraperitoneal implantation as compared to mice possessing wild-type TLR4 (Fig. 4-4B). 
Hence, TLR4 appears to affect the differential profile of biomaterial-adherent leukocytes 
while not having an effect on the differential profile of leukocytes recruited into the 
peritoneal cavity that were recovered in the peritoneal lavages (Fig. 4-1 and Fig. 4-2). 
While there were differences in the profile of adherent leukocytes following an IP 
implantation for 16hr, in the SC site, after 2 weeks of implantation of a PET disc, there 
was no dependence on TLR4 of the resultant fibrous capsule (Fig. 4-6 and Fig. 4-7). 
Therefore, TLR4 may be necessary for optimal activation and adhesion of early 
responders such as neutrophils, but the chronic inflammatory response is unaffected by 
the absence of TLR4.  
TLRs are used by the body to respond to PAMPs and DAMPs (Takeda et al. 
2003; Pandey and Agrawal 2006). TLR4 has been highlighted for recognition of 
numerous DAMPs (Tsan and Gao 2004) contributing to normal inflammatory 
homeostasis during wound repair following sterile injury by sensing ‘danger’/damage 
(Mollen et al. 2006; Zhang and Schluesener 2006; Kaczorowski et al. 2008). Also, injury 
primes TLR4 for activation by increasing its responsiveness to its ligands (Paterson et al. 
2003). In this study, it was hypothesized that that a lack of TLR4 in the context of a 
biomaterial implant would lead to lower recruitment of leukocytes following an 
implantation procedure as neutrophil accumulation and TNF-! production following 
hemorrhage-induced lung injury was lessened in TLR4-defective mice (Barsness et al. 
2004). Also, macrophage-mediated inflammation following acute lung injury occurs via 
TLR4/TLR2 interactions with hyaluronic acid fragments (Jiang et al. 2005). Furthermore, 
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it was hypothesized that mice lacking TLR4 would show an altered chronic inflammatory 
response (fibrous capsule formation) to a biomaterial as TLR4-deficient mice exhibit a 
stronger wound healing response following a sterile incision (Bettinger et al. 1994).  
It was hypothesized that a lack of TLR4 in the context of a biomaterial implant 
would lead to lower recruitment of leukocytes following an implantation procedure as 
neutrophil accumulation and TNF-! production following hemorrhage-induced lung injury 
was lessened in TLR4-defective mice (Barsness et al. 2004). Also, macrophage-
mediated inflammation following acute lung injury occurs via TLR4/TLR2 interactions 
with hyaluronic acid fragments (Jiang et al. 2005). However, mice possessing wild-type 
TLR4 or lacking TLR4 elicited similar leukocyte recruitment to the peritoneal cavity 
following biomaterial implantation (Fig. 4-1). Sham and implant treatment groups for both 
strains were also similar (Fig. 4-1) implying that surgery alone may have accounted for a 
significant aspect of the inflammatory response. However, no statistical difference was 
found for leukocyte concentrations for lavages from sham or naïve groups. Others have 
noted that the total number of macrophages and neutrophils following a sham surgery 
procedure at 18hr was found to be similar to naive mice (Busuttil et al. 2004) and did not 
account for the majority of inflammation to PET implanted IP. However, in this study 
lavages (which exhibited similar total leukocyte concentrations) from sham surgeries or 
biomaterial implantation contained similar profiles of neutrophils (Fig. 4-2A) and 
monocyte/macrophages (Fig. 4-2B) for both TLR4+ and TLR4- mice. 
It was unanticipated that only in the presence of a biomaterial implant would 
TNF-! be detected IP (Fig. 4-3), furthermore in a TLR4-independent manner, wherein 
sham and naïve mice had essentially no detectable levels of the pro-inflammatory 
cytokine. Others have found that peritoneal macrophages from TLR4-defective mice 
produce significantly less TNF-! mRNA in vitro in response to hydroxyapatite particles 
than TLR4+ mice (Grandjean-Laquerriere et al. 2007). In vivo a biomaterial likely 
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presents many other DAMPs than presented by a biomaterial in vitro, and these may 
activate cytokine production through other PRRs such as TLR2 (Tsan and Gao 2004; Yu 
et al. 2006; Maitra et al. 2008). In this study, however, using an IP biomaterial 
implantation model such a strong response to injury alone was not observed. These 
findings are supported by others who have shown that TLR4 does not account for 
inflammation (recruitment of neutrophils) IP following injection of dead cells (Chen et al. 
2007). Overall, these findings imply that TLR4 was not responsible for the recruitment of 
leukocytes to the IP cavity or TNF-! production.  
Conversely, a differential profile of adherent phagocytes on IP-implanted PET 
discs was observed that was TLR4-dependent. It was surprising that an altered 
differential leukocyte profile was observed for TLR4- mice as compared to TLR4+ (Fig. 4-
4B). Implants in TLR4- mice had a significantly higher fraction of recovered adherent 
neutrophils (~0.58) and a lower fraction of recovered adherent monocyte/macrophage 
(~0.36) as compared to that of TLR4+ mice (Fig 4-4B). In contrast, TLR4+ mice had 
equivalent fractions of recovered adherent neutrophils and monocyte/macrophages 
(about 0.47 for both) (Fig. 4-4B) from discs. This was observed even though the total 
number of leukocytes attaching to PET disc was equivalent between TLR4+ and TLR4- 
mice (Fig. 4-4A), and the IP milieu surrounding the implants wherein neutrophil and 
monocyte/macrophage fractions were equivalent in TLR4+ and TLR4- mice (Fig. 4-2A 
and 4-2B). In support of a role for TLR4 in controlling the adhesive leukocyte profile, 
another common wild-type TLR4 strain, C57BL/6, exhibited the same neutrophil and 
monocyte/macrophage profile at 16hr on PET to that of the TLR4+ strain used here, 
C57BL/10 (APPENDIX 1). A limitation of this study is that trypsin removal of biomaterial-
adherent leukocytes did not allow for direct cell staining due to damage of surface 
molecules. This prevents the use of flow cytometry to better characterize the cell 
population which would be beneficial in future studies.  
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There are two possible explanations for the observed TLR4-dependence of the 
adherent phagocyte profile on PET discs implanted IP. First, as neutrophils account for 
the majority of inflammatory cells recruited during acute inflammation in response to an 
implanted biomaterial within the time frame studied here, endogenous ligands present 
on the material surface may trigger TLR4-induced activation of neutrophils to 
subsequently progress the inflammatory cascade (including stimulating 
monocyte/macrophages). Without TLR4, neutrophils would not be fully activated by 
proteins on the PET surface. In fact, TLR signaling also induces up-regulation of integrin 
(CD11b/CD18) expression in neutrophils (Ding et al. 1999; Sabroe et al. 2003) which 
may even control adhesion, along with optimal activation, to a material (McNally and 
Anderson 1994; McNally and Anderson 2002) and explain why an apparent “delayed” 
inflammatory response is seen in TLR4- mice. Numerous proteins adsorb to biomaterials 
from physiological fluids (Wilson et al. 2005). Most of these are considered adhesive 
substrates, but plasmin (Ward et al. 2006), fibrinogen (Smiley et al. 2001) and fibronectin 
(Okamura et al. 2001) are also ligands for TLR4. Hence, such biomaterial-adsorbed 
proteins may concurrently induce the inflammatory cascade. Interestingly, firm 
adhesions via integrins also leads to optimal TLR4 signaling (Monick et al. 2002) in 
macrophages further supporting their activity. Therefore, upon implantation of a 
biomaterial, a foreign surface may offer the perfect environment for TLR4/DAMP 
interactions to lead to leukocyte activation: by acting as a depot for DAMPs to elicit a 
‘danger’ response from the host as well as offering an adhesive substrate.  
Lastly, TLR4-mediated phagocyte accumulation on the surface may not be a 
product of direct interaction with DAMPs on biomaterials but as a result from the 
absence of TLR4 on many other cells in TLR4- mice. TLR4 is expressed on various cell 
types including most immune cells, some epithelial cells and even endothelial cells 
(Takeda et al. 2003). The adhesion to the material surface may be indirectly controlled, 
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for example, by endothelial cells which may act to prime neutrophils and 
monocyte/macrophages for adhesion to a material surface. It is well documented that 
endothelial cells stimulate neutrophil activation and integrin-mediated adhesion during 
an inflammatory response through secretion of chemokines. It is also believed that 
endothelial cells sense DAMPs (such as hyaluronic acid fragments) through TLR4 which 
induce chemokine (IL-8) secretion (Taylor et al. 2004). Therefore, endogenously 
activated endothelial cells may ready neutrophils for adhesion through paracrine 
chemokine interactions.  
The lack of TLR4-dependence on the fibrous capsule formation at 2 weeks to 
PET implanted subcutaneously was anticipated (Fig. 4-6 and Fig. 4-7) as other TLRs 
(such as TLR2) may compensate for DAMP interactions. A significant decrease in tissue 
reaction to an implanted biomaterial would be anticipated in mice which lack MyD88 (a 
common adapter molecule required for nearly all TLR family member signaling, with the 
exception of TLR3). MyD88-/- mice had an almost completely abrogated inflammatory 
response to DAMP-mediated inflammation (Chen et al. 2007). Interestingly, IL-1R (which 
shares identical signaling pathway with TLRs) was, and has been shown by others, 
linked to these effects. Specifically, intracellular inflammasome activation of IL-1/IL-1R 
signaling may be the cause for ‘danger’-induced effects including the adjuvanticity of 
alum (Li et al. 2007) and other biomaterial particulates (Sharp et al. 2009) used for 
vaccines. However, the potential for a flat and large surface such as the PET disc 
implanted herein to interact intracellularly with inflammasome components to induce IL-1 
activation in the absence of internalization of the material due to size remains to be 
determined but seems unlikely.  
In conclusion, TLR4 plays a role in determining the adhesive leukocyte profile on 
biomaterials implanted intraperitoneally during the acute inflammatory response. This 
may be mediated by a direct interaction with DAMPs adsorbed on the material surface or 
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indirectly affected by other cell types, which prime leukocytes for adhesion. TLR4 
blocking may be beneficial if trying to direct an acute host response that minimizes 
monocyte/macrophage adhesion to a biomaterial. Fibrous encapsulation following 
subcutaneous implantation of a biomaterial propagates normally in the absence of TLR4 
indicating other compensatory receptors for activation and support of the foreign body 
tissue response. Therefore, the window of activity for TLR4 in the host response to a 
biomaterial is only in the initial recognition of the foreign entity. 
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CHAPTER 5  
 
ROLE OF ‘DANGER SIGNAL’-TLR4 INTERACTIONS IN THE DENDRITIC CELL 






Dendritic cells act as a bridge to link the body’s innate immune response to its 
antigen-specific adaptive immune response. Similar to other leukocytes, they have 
evolved to respond directly to pathogen invasion by recognizing pathogen-associated 
molecular patterns (PAMPs) via pattern recognition receptors (PRRs) (van Vliet et al. 
2007).  The recognition process by PRRs induces internal signaling which culminates in 
the production of inflammatory cytokines, up-regulation of co-stimulatory molecules 
(CD80, CD86) and may also induce migration of DCs to the lymph nodes for the 
induction of an adaptive immune response (Banchereau and Steinman 1998). However, 
there is building evidence that many PRRs not only respond to PAMPs but also 
recognize endogenous ‘danger signals’. 
‘Danger signal’ molecules (or DAMPs) include fragmented/denatured ECM 
components or molecules normally sequestered in cellular cytoplasm which upon tissue 
damage or cell necrosis become visible to the environment (Skoberne et al. 2004). 
Intracellular molecules from stressed/dying cells can act as adjuvants and increase 
antibody production toward a model antigen in vivo (Gallucci et al. 1999). Previously, we 
have seen an adjuvant effect in vivo to ovalbumin co-delivery with biomaterial PLGA 
scaffolds or MPs but not with agarose scaffolds (Matzelle and Babensee 2004; 
Bennewitz and Babensee 2005; Norton et al. 2010), which are common materials used 
in tissue engineering devices. It is hypothesized that this response is due to DC 
interaction with biomaterials as materials such as PLGA or chitosan induce DC 
maturation while materials such as agarose or hyaluronic acid limit or do not significantly 
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affect DC maturation in vitro (Yoshida and Babensee 2004; Babensee and Paranjpe 
2005; Yoshida and Babensee 2006). The goal of the research presented here is to 
examine whether biomaterial-induced DC maturation is mediated by DC interaction with 
endogenous ‘danger signal’ molecules present on biomaterials as part of the adsorbed 
protein layer. Elucidating the mechanism behind the DC response to biomaterials may 
allow for improved biomaterial selection for tissue engineering scaffold in order to inhibit 
or minimize the biomaterial-induced adjuvant effect.  Conversely, biomaterial section can 
be support for vaccine delivery systems to enhance immune responses through an 
adjuvant effect. 
PRRs present on the surface of DCs which may be used to recognize both 
PAMPs and DAMPs include (but are not limited to) C-type lectin receptors (CLR), 
integrins / complement receptors (CR), scavenger receptors (SR) and Toll-like receptors 
(TLR) (Lee and Kim 2007) (see LITERATURE REVIEW). CLRs (such as DC-SIGN) 
recognize carbohydrate structures derived from bacteria (such as mannose) as well as 
carbohydrate structures present on the surface of apoptotic cells (Figdor et al. 2002; 
Gijzen et al. 2006; van Vliet et al. 2006). Specific $2 integrins (!M$2, !X$2, also known as 
CR3 and CR4, respectively) on DCs recognize C3b, which has opsonized bacteria for 
clearance (Gasque 2004; Bajtay et al. 2006) but can also bind fibrinogen, a host protein 
found in high local concentrations following tissue damage (Hu et al. 2001; Thacker and 
Retzinger 2008). The SR family can recognize numerous bacteria-derived polyanionic 
ligands (Peiser et al. 2002) such as lipoteichoic acid but may also bind intracellular 
chaperone proteins HSPgp96, HSP70 and HSP90 (Facciponte et al. 2005).  Lastly, the 
most well characterized PRR family is the TLR family, which consists of at least 12 
members in mammals which are believed to recognize ligands through leucine-rich 
repeats present in their horseshoe-shaped ectodomain (Akira et al. 2006; Park et al. 
2009). TLR members, in particular TLR2 and TLR4, have been found to bind a wide 
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variety of PAMPs and ‘danger signal’ molecules (Tsan and Gao 2004; Rock and Kono 
2008).  
Of the TLR family members, TLR4 is the most characterized including 
understanding its precise intracellular signaling pathway (Kawai and Akira 2006) (see 
Fig. 3-2) which concludes in the activation of two key transcription factors nuclear factor: 
(NF)-"B and AP-1 (see LITERATURE REVIEW). The prototypical ligand for TLR4 is 
LPS, a component of Gram-negative bacteria (Hoshino et al. 1999; Guha and Mackman 
2001); however, TLR4 has been linked to the recognition of a wide variety of 
endogenous molecules including fibrinogen (Smiley et al. 2001), fibronectin (Okamura et 
al. 2001), hyaluronic acid (Taylor et al. 2004; Jiang et al. 2005) and HMGB1 (Yu et al. 
2006) as well as others (see LITERATURE REVIEW). Recently, TLR4 was found to 
control the adherent leukocyte profile present on a biomaterial implant (Rogers and 
Babensee 2010) as well as being involved in macrophage recognition and inflammatory 
response to hydroxyapatite particles (Grandjean-Laquerriere et al. 2007) and alginate 
(Iwamoto et al. 2005). Thus, TLR4 has been shown to be participating, in part, in the 
induction of an inflammatory response to biomaterials.  
The overall goal of the work presented in CHAPTER 5 was to determine whether 
TLR4/’danger signal’ interactions occur on the surface of biomaterials and whether these 
interactions account, in part, for biomaterial-induced DC maturation. Specifically, TLR4-
expressing HEK293 cells were utilized to isolate the role of potential TLR4/’danger 
signal’-induced signaling via NF-"B and AP-1 activation. Bone marrow derived DCs 
(BMDC) were derived from TLR4+ or TLR4- mice and treated with PLGA films or MPs to 
assess the contribution of TLR4 to DC maturation in response to this biomaterial. Lastly, 
TLR-related gene expression patterns in PLGA or agarose treated human monocyte-
derived DCs were analyzed in order to determine other potential TLRs involved in the 
response to biomaterials. DC gene expression patterns in response to biomaterials were 
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also compared to LPS treatments to ascertain if the response to biomaterials is similar or 
different to that of PAMP stimulation. 
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A solution of 10% w/v PLGA (mole ratio 75:25, inherent viscosity 0.70 dL/g in 
trichloromethane; Durect/Lactel Absorbable Polymers, Birmingham, AL) was prepared in 
20mL dichloromethane overnight in sterile polypropylene tubes (Yoshida and Babensee 
2004). To form films, this solution was gently poured into a cleaned 100mm Teflon dish 
and allowed to sit for two days in fume hood until DCM had evaporated. PLGA films 
were either cut for use in 100mm dishes, or punched out with arch punches for 24 well 
plates (9/16’’) or 6 well plates (5/4’’) and rinsed for 1h with sterile water. Films were 
allowed to dry in biosafety cabinet, sterilized with UV (30min each side) and rinsed with 
endotoxin free water immediately prior to use. Films were placed in bottom of wells for 
treatment of cells as described below.  
PLGA MPs were prepared by a single emulsion solvent evaporation technique 
(Yoshida and Babensee 2004). Briefly, a 2.5%(w/v) solution of PLGA in dichloromethane 
(Sigma) was prepared by with dissolution overnight and homogenized in 0.3% poly(vinyl 
alcohol) (Sigma). Solvent was evaporated overnight, and MPs were collected and rinsed 
several times in endotoxin-free water and exposed to UV (1hr) immediately prior to DC 
treatment at a 5:1 MP:cell ratio. Size distribution was determined using Coulter Counter 
and found to be of a peak size of 3.8µm. 
Three percent (w/v) agarose (Type V) (Sigma, St. Louis, MO) films were 
prepared by microwaving agarose/water suspension for 30s. This solution was then cast 
in 6 well plates and allowed to cool at 4oC for 30min. The films were brought to room 
temperature for at least 1hr before use in cell culture. 
Endotoxin content was evaluated using Limulus Amebocyte Lysate (LAL) assay 
(QCL-1000, Lonza, Basel, Switzerland) with detected levels of approximately 0.1 EU/mL 
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for all biomaterials used and tested below the FDA endotoxin limit for medical devices 
(0.5 EU/mL).   
 
TLR4-expressing HEK293 Cell Examination of Biomaterial Effects 
Stable Silencing of HEK293 Cells 
HEK293 cells which stably over-expressed TLR4, CD14 and MD2 (InvivoGen) 
(TLR4-expressing HEK293 cells) were used for biomaterial and LPS treatments. A 
stably silenced transformation of TLR4-expressing HEK293 cells was created using an 
shRNA-expressing plasmid, which was directed toward MyD88 for knock-down 
(InvivoGen). The plasmid was pre-complexed with a lipid-based transfection delivery 
agent and also induced the production of green fluorescent protein (GFP) for 
determining transfection efficiencies and Zeocin resistance for stable selection. TLR4-
expressing HEK293 cells were transfected according to manufacturer’s instructions in 12 
well plates (Corning) at 2*105 cells per well. As another negative control, wild-type 
HEK293 cells (293-null, InvivoGen), which did not over-express any surface receptors, 
were also utilized. 
Cells were cultured in T-75s (BD Falcon) prior to treatment and collected using 
Trypsin/EDTA (0.25%) (Sigma) followed by addition of cell culture media (DMEM with 
high glucose, pyridoxine hydrochloride, without L-glutamine or sodium pyruvate, 
(Invitrogen) supplemented with 10% heat-inactivated FBS (Cellgro) containing selective 
antibiotic Blasiticidin S (InvivoGen) (10"g/mL) for 293-null, Blasticidin S + Hygrogold™ 
(InvivoGen) (50"g/mL) for TLR4-expressing HEK293 cells, or Blasticidin S + 
Hygrogold™ + Zeocin (InvivoGen) (100"g/mL) for MyD88-silenced TLR4-expressing 
HEK293 cells) to inactivate trypsin.  
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Transfected or non-transfected TLR4-expressing HEK293 cells were stably 
selected in 6 well plates using Zeocin (InvivoGen) (100 "g/mL) over 10-14 days following 
transfection, and selection was determined via flow cytometry for GFP expression.  
 
 
Biomaterial Treatment of HEK293 Cells 
 
HEK293 cells (TLR4-expressing HEK293 cells, MyD88-silenced TLR4-
expressing HEK293 cells, or wild-type HEK293 cells) were cultured in T-75 as described 
and trypsinized for collection and subsequent treatment. Cells were then resuspended at 
8*105/mL and plated in 100mm dishes (Primaria, BD Falcon) with 25mL per dish. Cells 
were left untreated, treated with LPS (Sigma, E. coli 055:B5) at 1"g/mL or plated on top 
of either PLGA films placed in dishes or agarose films prepared directly in dish for use. 
Cells were placed in 37oC incubator for 5 or 24hr. Cytosolic and nuclear extracts were 
prepared as described below. Supernatants were also saved and stored at -20oC for 
chemokine secretion analysis. 
 
 
Cytosolic and Nuclear Extraction Procedures 
 
To prepare either cytosolic or nuclear extract from HEK293 cells, cells were lysed 
using a protocol which specifically prepares both cytosolic and nuclear fractions of cell 
lysates (Clontech, Mountain View, CA). Ice-cold PBS was added to cells following 
treatment, and they were collected using cell scrapers (BD Bioscience). Cells were 
centrifuged at 450g for 5min and washed with cold PBS once again. Cell suspensions 
were counted using Coulter Counter. Cell pellet volume was estimated and the amount 
was be used for subsequent resuspension volumes. Lysis buffer (Clontech) (5x the cell 
pellet volume) was added to the cell pellet and incubated on ice for 15min. Cells were 
then centrifuged at 450g for 5min, and the supernatant carefully discarded. The cell 
pellet was then resuspended in lysis buffer (volume equal to 2x the original cell pellet) 
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and suspension was passed through a 28g needle 10 times to disrupt cell membranes. 
Lysed suspension was centrifuged at 10,500g for 20min, and the supernatant (cytosolic 
extract) collected and stored at -80oC. Nuclear extraction buffer (Clontech) was then 
added at 2/3 the volume of the original cell pellet to the remaining pellet, and the nuclear 
membranes disrupted with a 28g needle as before. Suspension was then shaken gently 
(1000rpm) for 30 min at 4oC using Thermomixer (Eppendorf, New York, NY). 
Suspension was centrifuged at 20,500g for 5min, and the supernatant (nuclear lysate) 
collected and stored in a fresh pre-chilled low retention microcentrifuge tube. 
Bicinchononic acid (BCA) assay (Sigma) was used to determine the protein 
concentration of both nuclear and cytosolic extracts. 
 
 
Western Blot to Verify MyD88 Knock-Down in TLR4-expressing HEK293 Cells 
 
To assure MyD88-knock down in the transformed TLR4-expressing HEK293 
cells, western blotting of cytosolic extract of stably selected cells was used to determine 
the expression of MyD88. Cytosolic extracts were prepared as described above and 
probed for MyD88 expression using common SDS-gel electrophoresis with subsequent 
immunoblotting techniques. SDS-PAGE was performed following manufacturer’s 
protocol (Invitrogen). A normalized amount of 20"g of protein was loaded per well for gel 
electrophoresis. NuPAGE% LDS sample buffer (4x), NuPAGE% Reducing agent (10x) 
(both from Invitrogen), and 20 "g of protein were added to a low-retention 
microcentrifuge tube followed by addition of deionized water for a total of 10"L solution 
per sample. The samples were then each heated to 70oC for 10min in a heat block and 
immediately used. MyD88 was probed using a low-molecular weight NuPAGE% 4-12% 
Bis-Tris Gel (Invitrogen), which has a resolution between 10-200 kDa. Prepared samples 
and protein standard (Precision Plus Protein Standards, Kaleidoscope, Bio-Rad, 
Hercules, CA) were loaded simultaneously into XCell SureLock& Mini-Cell apparatus 
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(Invitrogen) after filling the upper chamber with 200mL of MOPS SDS Running Buffer 
(Invitrogen). 200V (constant) was applied across the gel using a Power Source (250V) 
(VWR, West Chester, PA) for 45-50min.  
Following completion of electrophoresis, proteins were transferred to 
nitrocellulose membranes (Invitrogen) using the XCell SureLock& apparatus. Gels were 
removed from cassettes and immediately placed on top of filter paper, which was placed 
on top of two blotting pads. A nitrocellulose membrane was placed carefully on top of the 
gel, and the gel was kept wet with NuPAGE% transfer buffer (Invitrogen). A separate 
filter paper was placed on top of the membrane followed by two blotting pads. The entire 
“sandwich” was loaded into the cathode core of the blot module and placed into the 
apparatus. The upper chamber was then filled with transfer buffer while the lower 
chamber filled with deionized water. Transfer took place at 30V for 1hr. The membrane 
was carefully removed and blocked by gentle shaking in 0.1% PBS/Tween 20 (Sigma) 
with 5% (w/v) milk for 1hr. Next, membranes were incubated with appropriate dilutions of 
rabbit anti-human MyD88 (Santa Cruz Biotechnology, Santa Cruz, CA) or anti-$ actin 
(run in separate but simultaneously prepared membranes) in 0.1% PBS/Tween 20 
(Sigma) with 5% (w/v) milk overnight at 4oC. Membranes were then gently washed 3 
times for 5min in 0.1% PBS/Tween 20 followed by addition of diluted secondary 
antibodies conjugated to alkaline phosphatase (AP) (Southern Biotech, Birmingham, 
AL). Membranes were lastly washed 3 times for 5min as before following by addition of 
AP substrate (Bio-Rad, Hercules, CA) directly to membrane. Protein bands were 
detected using Hyperfilm ECL (GE Healthcare, Piscataway, NJ) placed in cassette with 
membrane and subsequently developed. 
 
Caspase Analysis 
 Cytosolic extracts were harvested and examined for early markers of apoptosis 
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(activated caspase 8 and caspase 3) by a fluorometric technique (BioSource). Briefly, 
equivalent amounts of cell lysates (50"g per 50"L) were added to a reaction buffer 
(50"L) containing 10mM DTT. Next, 5"L of synthetic peptide DEVD-AFC (7-amino-4-
trifluoromethyl coumarin) (for caspase 3 analysis) substrate or synthetic peptide (IETD)-
AFC (for caspase 8 analysis) substrate was added to cytosolic extracts. Samples were 
incubated for 30min at room temperature and read at 520nm following an excitation at 
492nm. Relative levels of activated caspase were compared to untreated cell lysates for 
each cell line. 
 
Transcription Factor Activation of Biomaterial-Treated HEK293 Cells 
 
Transcription factor activation (NF-"B and AP-1) was determined using an ELISA 
based technique in which DNA-oligomers are pre-coated to the bottom of wells and bind 
only activated NF-"B (Clontech) or AP-1 (TransAM& AP-1 Family kit, Active Motif, 
Carlsbad, CA). As determined by BCA assay, 20"g of nuclear extracts from treated cells 
was equivalently loaded onto plates. For NF-"B analysis, loaded extracts were 
incubated for 60min. Plates were washed and incubated with primary antibodies (in 
separate wells) recognizing each of the NF-"B family members (p50, p65, p52, RelB, 
and cRel) for 60min. After washing again, a secondary antibody was added and 
tetramethylbenzidine (TMB) substrate added and colorimetric development determined 
at 655nm. For AP-1 analysis, similar techniques were used except AP-1 primary 
antibodies added will recognize cFos, FosB, Fra-1, Fra-2, cJun, JunB, and JunD. 
Secondary antibody was incubated following addition of developing agent and stop 




Chemokine/Cytokine Detection in Supernatants 
IL-8 secretion (normalized to cell counts collected using Coulter Counter) was 
determined using sandwich ELISA-based technique. Briefly, supernatants were added to 
human IL-8 ELISA kit (R&D Systems) 96-well plates and incubated for 60min. After 
washing, plates IL-8 conjugate was added for an additional 60min. Lastly, developing 
solution (TMB) was added followed by stop solution. Optical densities were determined 
at 655nm. For biomaterial-treated BMDCs or human DCs, TNF-! concentration in 
supernatants was also determined via similar ELISA kits (R&D Systems). 
 




Male mice (6 weeks in age) of three strains were used as the source of bone 
marrow (BM): C57BL/10 and C57BL/10ScSn, both TLR4+ as well as the TLR4-defecient 
strain, C57BL/10ScN (TLR4-) (Poltorak et al. 1998) (all from The Jackson Laboratory, 




 BMDCs were prepared from TLR4+ or TLR4- mice concurrently on the same day. 
Mice were sacrificed at Emory University Whitehead biomedical research facility in 
accordance with an IACUC approved procedure (IACUC protocol #044-2006). This 
method is based on a previously established method with modifications (Inaba et al. 
1992; Yoshida et al. 2007). Femurs and tibias were collected and BM was harvested by 
flushing 5mL of mouse DC media [Dulbecco’s Modified Eagle Medium (DMEM) with 
10% (v/v) heat-inactivated fetal bovine serum (FBS), 1% (v/v) sodium pyruvate, 1% (v/v) 
non-essential amino acids, 1% (v/v) HEPES (all from Cellgro, Manassas, VA), 0.1% (v/v) 
2-mercaptoethanol (Invitrogen, Carlsbad, CA), and 1% (v/v) penicillin-streptomycin 
(Cellgro)] using a 26g needle and collected in a 60mm tissue culture dishes. BM was 
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passed through a 70"m filter. Red blood cells (RBC) were lysed using a sterile-filtered 
ammonium chloride solution (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, all from 
Sigma, St. Louis, MO) and rinsed twice with 2% FBS/Dulbecco’s-PBS (D-PBS, 
Invitrogen). Cells were then counted and resuspended at a concentration of 1.5*106 
cells/mL in mouse DC media and plated in 6 well plates (Costar, Corning, Corning, NY) 
with 3 mL/well and supplemented with murine GM-CSF (BD Biosciences, San Diego, 
CA) and murine IL-4 (Sigma) both at concentrations of 20ng/mL at 37oC and 5% CO2. 
On day 3 of culture, half of media from each well was carefully collected and re-
supplemented with fresh cytokine containing media. On day 6, non/loosely-adherent 
cells were collected by gentle swirling and rinsed twice with 2%FBS/D-PBS with 2mM 
EDTA. CD11c+ cells were isolated using CD11c-magnetic beads (Miltenyi Biotec, 
Auburn, CA) and LS columns (Miltenyi Biotec) in association with a midi-MACS magnet 
(Miltenyi Biotec) following manufacturer’s instructions. Collected CD11c+ cells were 
resuspended at a concentration of 106 cells/mL in mouse DC media containing cytokines 
and used as immature DC (or “iDC”) for remaining experiments performed in 24 well 
plates (Costar, Corning) with 1 mL of DC suspension per well.  
 
Biomaterial Treatment of BMDCs 
 On Day 6 of BMDC culture following CD11c-isolation, non/loosely-adherent iDCs 
from either TLR4+ or TLR4-mice were collected and resuspended at 106 cells/mL in 
mouse DC media containing cytokines and used as iDC for remaining experiments 
performed in 24 well plates (Costar, Corning) with 1mL of DC suspension per well. iDC 
were either left untreated, treated with ultrapure-LPS (InvivoGen) (1"g/mL), or treated 
with PLGA films or MPs for 24h at 37oC. Following treatment, non/loosely-adherent DCs 
were collected, rinsed with FACS buffer (96% (v/v) Hank’s HEPES Buffer (120mM NaCl, 
10mM KCl, 10mM MgCl2, 10mM glucose, and 30mM HEPES. All chemicals from 
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Sigma), 1% (v/v) Human serum albumin (HSA) (EMD Biosciences, La Jolla, CA), and 
1.5mM CaCl2) and supernatants collected for cytokine analysis. Cells were stained with 
antibodies recognizing murine CD11c (BD Pharmingen), I-Ab (BD Pharmingen), CD80 
(BioLegend, San Diego, CA), CD86 (BioLegend) or recombinant Annexin-V (BD) for 1hr 
at 37oC and run on flow cytometer (BD LSR II, BD Biosciences). Immediately prior to 
flow cytometry, cells were also stained with propidium iodide to assess cellular necrosis.  
 
Human Monocyte-derived DC Examination 
 
Toll-like Receptor Gene Expression in Human DCs 
 
Human peripheral blood was drawn at Georgia Institute of Technology Student 
Health Center in the phlebotomy laboratory following approved IRB protocol (H05012) 
procedures. Human DCs were cultured from peripheral blood mononuclear cells 
(PBMCs) as described previously (Romani et al. 1996) with some modifications. PBMCs 
were isolated from buffy coats following centrifugation at 400g for 30m using lymphocyte 
separation media (Cellgro). Red blood cells were lysed using sterile Lysis Buffer (155 
mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). After washing cells twice with D-PBS 
(Invitrogen, pH 7.4), they were resuspended at a concentration of 5*106/mL in human 
DC media (RPMI 1640 (Invitrogen) supplemented with 10% heat-inactivated (57oC, 30 
min) FBS (Cellgro) and 1% (v/v) penicillin/streptomycin (Cellgro). PBMCs were isolated 
based on adhesion to 100mm tissue culture plate (Primaria, BD Falcon) after 2 hr 
incubation at 37oC. Plates were washed 3 times with DC media to remove non-adherent 
cells, and resulting adherent cell population was reconditioned with DC media 
(10mL/plate) containing human GM-CSF (1000U/mL) and human IL-4 (800U/mL) (both 
from Peprotech, Rocky Hill, NJ) for 5 days at 37oC, 5% CO2. Loosely-adherent cells 
were dislodged by gentle swirling and collected carefully with pipettes and transferred to 
sterile 50mL centrifuge tubes. Cells collected were termed immature DC (iDC) and were 
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used directly for culture on biomaterials after being pelleted and resuspended in cytokine 
containing DC media (5*105/mL). 
Human monocyte-derived DCs were then treated as iDC, mDC (1"g/mL 
ultrapure-LPS, InivoGen) or treated with PLGA or agarose films in 6 well plates for 24hr. 
Loosely-adherent DCs were collected by pipetting and pooled with adherent DCs which 
were collected using cell dissociation solution (Sigma). These pooled cells were then 
collected at 1100rpm for 10min. To investigate the gene expression in treated DCs 
alone, DCs were purified by positive selection using DC-SIGN (CD209) microbeads 
(Miltenyi Biotec) with MACS. Cells were resuspended in 120"L of ice-cold MACS buffer 
followed by 40"L of human CD209 microbeads (Miltenyi Biotec) with 40"L of Fc-
receptor blocking buffer (Miltenyi Biotec) and incubated at 4oC for 15min. Cells were 
rinsed with 2mL of MACS buffer, collected at 400g for 10min and resuspended in 500"L 
of MACS buffer and passed through an LS column (Miltenyi Biotec) for purification. The 
efficiency of this purification procedure was confirmed using flow cytometry to assure 
purification of DC which was routinely >95% DC-SIGN+ (APPENDIX 2). 
Total RNA extracts were prepared from each treatment using RNeasy Mini kit 
(Qiagen). Briefly, cells were lysed and homogenized by passing cell pellets 
(resuspended in 400µL of Buffer RLT) through 21-gauge needles fitted to an RNase-free 
syringe 10x until obtaining a homogenous lysate. An equal volume of 70% ethanol 
(Sigma) was added to the lysate, mixed by gentle pipetting and transferred to an 
RNeasy spin column (Qiagen) placed in a 2mL collection tube for centrifugation at 9000g 
for 15s. After discarding the flow-through, this process was repeated using 700µL of 
Buffer RW1 and followed by Buffer RPE twice. Lastly, the spin column was placed in a 
new 1.5mL tube and 50µL of RNase-free water spun through column as before for 1 min 
to elute RNA. Concentration of RNA was determined by A260 method while RNA purity 
was determined using A260:A280 ratio (minimum value needed greater than 2) using a 
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NanoDrop 1000 (Thermo Scientific). RNA was stored at -80°C. cDNA was then prepared 
according to manufacturer’s guidelines using RT2 First Strand Kit (SuperArray 
Bioscience, Frederick, MD). Equivalent amounts of total RNA extracted for each 
treatment and trial (1"g per 96-well array) was incubated with GE Buffer and RNase-free 
water for 5 min at 42oC to remove genomic DNA contamination and chilled on ice for one 
minute. A reverse transcription cocktail containing BC3, P2, RE3 buffers (all from First 
Strand kit, proprietary buffers) was prepared in RNase-free water. First strand cDNA 
synthesis reaction was performed according to manufacturer’s protocol (incubation at 
42oC for 15 min followed by 95oC for 5 min), and cDNA was immediately loaded across 
96 well plate for Human Toll-like Receptor Signaling Pathway RT2 Profiler& PCR Array 
System (SuperArray Bioscience, Frederick, MD). This system allows for the evaluation 
of mRNA expression of 84 genes associated with TLR signaling pathway including all 
human TLRs, a variety of pro-inflammatory cytokines (IL-1, TNF-!), kinases such as 
JNK and IRAK4 and the common TLR adapter molecule MyD88. Each well of the PCR 
96-well plate contains a unique primer set for each gene allowing for the individual 
assessment using quantitative real-time PCR techniques (SYBR-green detection).  
Each of the four treatments were analyzed on a separate 96-well plate array and 
normalized to averaged $-actin and $2-microglobulin [B2M] expression which was not 
affected by treatment. For each treatment, 1275"L of 2X SuperArray RT2 qPCR Master 
Mix, 102"L of cDNA and 1173"L of ddH2O was added together into a sterile reservoir, 
mixed gently and distributed (25"L per well) using a multi-channel pipette across the 
plate assuring equal distribution. Using a StepOne Plus qPCR System (Applied 
Biosystems, Foster City, CA), samples were kept for 10min at 95oC to activate DNA 
polymerase followed by 40 cycles of alternating 95oC for 15s and 60oC for 1min. SYBR 
green fluorescence was detected and used to calculate the threshold cycle (Ct) for each 
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well after manually setting the baseline and threshold values (same settings used across 
all trials and treatments). Ct values were normalized to averaged Ct values of $-actin and 
B2M (!Ct) for inter-assay comparisons and up or down-regulation of gene expression 
was determined by comparing !Ct values from treated DCs’ for a specific gene with that 
of iDCs’ (!!Ct method). For statistical analysis of each gene, ANOVA (general linear 
model) was performed using Minitab to assess differences between -!Ct values of each 
treatment when donors were nested within treatment (n=3). Hierarchical 2D cluster 
analysis was performed using Matlab clustergram function assuming Pearson 
distribution function. 
 
Immunoblotting for Activated Transcription Factors in Biomaterial-Treated DCs 
 
Human monocyte-derived DCs were treated as described in text, purified, pooled 
and rinsed twice in ice-cold PBS. RIPA buffer (Pierce) was added and used to 
resuspend cell pellet at a ratio of 1mL per 5*106 cells, which was determined via Coulter 
Counter cell counts. This suspension was kept on ice and shaken for 15m. The resulting 
mixture was then centrifuged at 14,000g for 15m. Supernatants were collected and 
stored at -80oC for western blot analysis. Western blot procedure was performed as 
described, except with secondary antibodies conjugated to IRDye (Li-Cor, Omaha, NE). 
Membranes were then imaged using Odyssey Imaging system (Li-Cor). Primary 
antibodies used were as follows: anti-human total Elk-1 and anti-pS383 Elk-1 (Cell 
Signaling Technology, Danvers, MA); anti-human total NFkB1 and anti-pS939 NFkB1 
(Cell Signaling Technology); anti-human total cFos and anti-pT235 cFOS (Abcam, 
Cambridge, MA). An undergraduate student Ravi Patel was responsible for the 
completion of several of these western blots. DC lysates from three independent trials 




Statistical analysis was performed on all treatment-control ratios by comparing 
treatment values to (1) using a student t-test (using Excel software). To compare across 
treatments, a one-way ANOVA analysis will be performed using Minitab Software 




TLR4-Signaling Investigated Using HEK293 Cells 
To isolate the role of TLR4-induced signaling following biomaterial or an LPS-
positive control treatment, a stably transfected model cell line was used. HEK293 cells 
stably transfected with TLR4, MD2 and CD14 (InvivoGen) were treated with LPS, PLGA 
films or agarose films and analyzed for NF-"B activation and IL-8 secretion. Higher 
levels of active family members (p50, p65, cRel, p52) of NF-"B were found in nuclear 
extracts at both 5 and 24hr in LPS-treated TLR4-expressing HEK293 cells (Fig. 5-1). 
PLGA or agarose films, however, did not induce any significant alteration in NF-"B 
activation across the family members investigated (Fig. 5-1). Accordingly, PLGA or 
agarose films did not induce IL-8 secretion while LPS induced significantly higher levels 




Figure 5-1: Activation of NF-"B family members (p50, p65, cRel, RelB, p52) from 
nuclear extracts prepared of LPS, PLGA or agarose treated TLR4-expressing 
HEK293 cells. 5hr (A) and 24hr (B) time points. !, greater than TCPS, p # 0.05; ", less 
than TCPS, p # 0.05. N.D.= not detectable in assay. Representative results of three 






Figure 5-2: ELISA determined concentrations from cleared supernatants for IL-8 
from LPS, PLGA or agarose treated TLR4-expressing HEK293 cells. 5hr (A) and 
24hr (B) time points. ! indicates greater than TCPS, p # 0.05. Concentrations were 
normalized by collected cell counts at each time point for each experiment.  
Representative results of three independent experiments are shown.  
 
 
Next, since the TLR4-induced signaling pathway simultaneously activates the 
AP-1 transcription factor family through the MAPK pathway, AP-1 activation was 
similarly assessed in TLR4-expressing HEK293 cells following treatment with LPS, 
PLGA or agarose films for 5 or 2hr. It was found that most AP-1 family members (cFos, 
FosB, Fra-1, cJun and JunD) were activated by all treatments at 24hr. (Fig. 5-3B).  
 
 
Figure 5-3: Activation of AP-1 family members (cFos, FosB, Fra-1, Fra-2, cJun, 
JunB, JunD) from nuclear extracts of TLR4-expressing HEK293 cells analyzed by 
ELISA (ActiveMotif). 5hr (A) and 24hr (B) time points. ! greater than TCPS, p # 0.05; ", 
less than TCPS, p # 0.05. N.D.= not detectable in assay. Representative results of three 
independent experiments are shown. 
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In order to investigate if TLR4-signaling pathways were being utilized in the 
differential transcription factor response (LPS through NF-"B and AP-1 while 
biomaterials through only AP-1), stable MyD88 knockdowns of TLR4-expressing 
HEK293 cells were produced using a shRNA-expressing plasmid directed against 
MyD88 (Fig. 5-4). TLR4-expressing 293 cells were assessed for GFP expression via 
flow cytometry. It was found that the stably selected transfected TLR4-expressing 
HEK293 cells were 98% GFP+ (Fig. 5-4B) confirming plasmid uptake, expression and 
purity of the newly transformed cell population. Effective MyD88 knockdown was 
determined using western blotting techniques of cytosolic extracts (Fig. 5-5). MyD88-
silenced and non-transformed TLR4-expressing HEK293 cells were then treated with 
LPS, PLGA or agarose films for 24hr.  However, stably-silenced MyD88 TLR4-expessing 
HEK293 cells were still able to respond to LPS as seen with increased levels of NF-"B 
activation (p65 subunit only) in comparison to TCPS controls, and the response was 
similar to non-transformed TLR4-expressing HEK293 cells (Fig. 5-6). 
 
  (A) (B) 
Figure 5-4: MyD88 Plasmid Delivery and Stable Selection in TLR4-expression 
HEK293 Cells. Confirmed via flow cytometry. Non-transfected (A) and transfected 
TLR4-expressing HEK293 cells (B) were assessed for GFP expression. Cell population 






Figure 5-5: MyD88 protein expression in TLR4-expressing HEK293 cells (Control 
cells) or MyD88-silenced TLR4-expressing HEK293 cells.  MyD88 appeared at 33kD 
while $-actin appeared at 42kD. Two independent cytosolic extracts were prepared and 
run simultaneously for both control and silenced cells. MyD88 band is notably less 









Figure 5-6: Treatment Control ratios of active NF-"B (p65) in TLR4-expressing 
HEK293 cells or MyD88-silenced TLR4-expressing HEK293 cells. LPS, PLGA or 
Agarose treated TLR4-expressing HEK293 cells (Control Cells) or MyD88-silenced 
TLR4-expressing HEK293 cells (MyD88-silenced cells) at 24hr. * indicates p < 0.05 in 
comparison to control (1) (Student t-test), n=3. 
 
 
To investigate whether the over-expression of TLR4, MD2 and CD14 was 
necessary for the differential signaling between LPS and biomaterials, wild-type HEK293 
cells were cultured and similarly treated with LPS, PLGA films or agarose films for 24hr. 
Representative family members of AP-1 (cJun) and NF-"B (p65) which were found to be 
highly activated at 24hr in TLR4-expressing were analyzed following treatment. NF-"B 
was not activated in response to LPS, PLGA or agarose films in 293 nulls cells (Fig. 5-
7A); however, similar to TLR4-expressing 293 cells, wild-type HEK293 cells also had 





Figure 5-7: Treatment-Control Ratios for active AP-1 in wild-type HEK293 cells. 
Wild-type HEK293 cells were treated with LPS, PLGA or agarose films for 24hr and 
active levels of p65 (A) and cJun (B) were determined in nuclear extracts. Treatment 
control ratios were determined relative to TCPS controls for both subunits. * indicates p 




To examine whether the biomaterial-induced AP-1 activation was yielding 
increased apoptosis, each cell line (wild-type HEK293 cells TLR4-expressing HEK293 
cells and MyD88-silenced TLR4-expressing HEK293 cells) was treated with LPS, PLGA 
or agarose films or cultured on negative control TCPS for 24hr and assessed for 
caspase 8 and caspase 3 activation. Across all cell lines examined, agarose treatment 
induced significant reduction in activated caspase 8 presence (Fig. 5-8). MyD88-silenced 
TLR4-expressing HEK293 cells was the only cell line to exhibit significant differences in 
activated caspase 8 presence in cytosolic extract when treated with LPS or PLGA 




Figure 5-8: Treatment control ratios of activated Caspase 8. LPS, PLGA or Agarose 
treated TLR4-expressing HEK293 cells, MyD88-silenced TLR4-expressing HEK293 cells 
or wild-type HEK293 cells (293-null). Star indicates p < 0.05 in comparison to control (1) 




Figure 5-9: Treatment control ratios of activated Caspase 3. LPS, PLGA or Agarose 
treated TLR4-expressing HEK293 cells, MyD88-silenced TLR4-expressing HEK293 cells 





Activated caspase 8 cleaves the pro-form of caspase 3 into its activated form, 
which may then continue the signaling cascade of apoptosis. This was found for the 
MyD88-silenced cell line which showed that LPS or PLGA treatments induced similar 
increases in caspase 3 activity (Fig. 5-9) as was found for caspase 8; however, only 
TLR4-expressing HEK293 cells treated with agarose showed similar reduction in 
caspase 3 activity as was seen with caspase 8 (Fig. 5-9).  
 
The Role of in TLR4 in the Response of BMDCs to Biomaterials 
To isolated the role of TLR4 in biomaterial-induced DC maturation, BMDCs 
derived from TLR4+ (C57BL/10ScSn) or TLR4- (C57BL/10ScN) mice were treated with 
biomaterials PLGA films or MPs for 24hr. Following treatment, non/loosely adherent DCs 
were harvested and analyzed for expression of CD11c, I-Ab, CD80 and CD86 as well 
early apoptosis and death via annexin-V and propidium iodide, respectively. In TLR4+ 
DCs, ultrapure-LPS treatment resulted in increases in expression of CD11c, CD80 and 
CD86 as compared to iDC (Fig. 5-10). These effects were absent in TLR4- DCs. TLR4+ 
DCs treated with PLGA films expressed higher levels of CD86 while similarly treated 
TLR4- DCs showed no difference in expression of CD86 as compared to iDC (Fig. 5-10). 
Both biomaterial treatments also induced signs of early apoptosis as seen in the 
increases in positive staining with annexin-V, and this response was not found in TLR4- 






Figure 5-10: Response of TLR4+ (C57BL/10ScSn) or TLR4- (C57BL/10ScN) BMDCs 
to ultrapure-LPS (mDC), PLGA film or PLGA MP treatment at 24hr. Geometric mean 
fluorescence intensities (gMFI) of DCs, as measured by flow cytometry, were 
determined following treatment. gMFIs of treated DCs were normalized to that of 
untreated DCs (iDC) and pooled across all trials as Treatment Control Ratios. Data 
presented as mean+s.d. Statistical analysis was performed by comparing treatment 
control ratios to 1 (iDC) using Student t-test. ★ indicates greater than iDC, p < 0.05; ☆ 





As another measurement of DC maturation induced by ultrapure-LPS, PLGA 
films or PLGA MP, pro-inflammatory cytokines TNF-! and IL-6 concentrations were 
measured in cleared supernatants from treated TLR4+ or TLR4- DCs. TLR4+ DCs, but not 
TLR4- DCs, treated with LPS secreted significant amounts of TNF-! (Fig. 5-11) and IL-6 
(data not shown). PLGA films or PLGA MPs did not induce any significant production of 







Figure 5-11: Secreted TNF-!  concentrations from BMDCs determined from cleared 
supernatants using ELISA techniques. Concentrations were then normalized to 
non/loosely adherent DC counts using Coulter Counter. Bars indicate mean+s.d. 
Normalized TNF-! have units of pg/mL/10^6 cells. ! indicates greater than iDC, ANOVA 
p < 0.05. 
 
 
BMDCs from another TLR4+ control strain (C57BL/10) or TLR4- were derived and 
treated with ultrapure-LPS, PLGA films or MPs for 24hr. Non/loosely adherent BMDCs 
were collected and assessed for expression levels of I-Ab, CD11c, CD80 and CD86 as 
well as phosphatidylserine surface presence (annexin-V) and propidium iodide. 
C57BL/10 DCs treated with ultrapure-LPS (mDC) showed signs of DC maturation as 
seen by increases in expression of I-Ab, CD80 and CD86 (Fig. 5-12) while biomaterial 
treatments did not yield this effect. Also, TLR4- BMDCs, while lacking response to 
ultrapure-LPS as expected, showed up-regulation of CD80 expression when treated with 






Figure 5-12: Response of BMDCs derived from C57BL/10 or C57BL/10ScN to 
biomaterials. BMDCs from C57BL/10 (A) or C57BL/10ScN (B) were cultured with 
ultrapure-LPS (mDC), PLGA films or PLGA MP for 24 hr and assessed for a variety of 
markers. Results presented are pooled treatment-control ratios over iDC (1) from GMFI 
values (n=6, except CD11 for TLR4- (arrow) n=5). ! indicates significantly different from 
















The role of TLR4 in biomaterial-induced maturation was further examined by 
analyzing both the non/loosely-adherent and adherent BMDC fractions. BMDCs were 
cultured from C57BL/10 or TLR4- mouse strains and treated as iDC, treated with 
ultrapure-LPS (mDC) or treated with biomaterials PLGA films or MPs. Unlike adherent 
DCs from C57BL/6 mice (CHAPTER 6), adherent DCs from the C57BL/10 were not as 
responsive to PLGA films across all markers, with the exception of an MHC class II 
molecule (I-Ab) (Fig. 5-13). The expression of CD80 and CD86 of adherent DCs from 
C57BL/10 mice was unaffected by the PLGA film treatment as opposed to similarly 
analyzed adherent DCs from C57BL/6 mice (Fig. 5-13 vs. Fig. 6-6). The adherent DCs 
from C57BL/10 mice were more responsive to ultrapure-LPS than the corresponding 
loosely adherent DCs as seen in CHAPTER 6, and TLR4- adherent DCs did not respond 
to ultrapure-LPS as expected but yielded mixed results of maturation in response to 
PLGA films (increased I-Ab but decreased CD80) (Fig. 5-13). PLGA MPs induced 
decreases in I-Ab and CD86 expression in adherent BMDCs from both C57BL/10 and 
TLR4- mice (Fig. 5-13).  This is in contrast to adherent DCs from C57BL/6 mice (Fig. 6-
6), which showed no significant alteration in DC maturation marker expression in 








Figure 5-13: Response of Adherent and Non-Adherent BMDCs from C57BL/10 or 
C57BL/10ScN to biomaterials. TLR4+ (from C57BL/10) or TLR4- (from C57BL/10ScN) 
DCs were treated as iDC, mDC (UP-LPS), or PLGA films or PLGA MPs for 24hr. Non-
loosely adherent (top) and adherent (bottom) DCs were collected and analyzed via flow 
cytometer for CD11c, I-Ab, CD80, CD86 expression as well as Annexin V (AnnV) 
staining for signs of early apoptosis and propidium iodide (PI) staining for necrosis. All 
n=8 except MP, CD11c for TLR4+ cells (n=7). Star indicates statistically higher than iDC 
(1), while circle indicates statistically lower than iDC (1), Student t-test, p#0.05 NOTE: 
Data for TLR4+ mice in this Fig. 5-9 the same data used in Fig. 6-6. 
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TLR-Related Gene Expression in Human DCs in Response to Biomaterials 
To examine other TLR/DAMP interactions potentially accounting biomaterial-
induced DC maturation, as well as probing TLR-related signaling pathways involved in 
the response, an RNA expression analysis examining 84 TLR-related genes was 
investigated. Human monocyte-derived DCs were treated with ultrapure-LPS, PLGA or 
agarose films for 24hr, and RT-PCR used to examine relative biomaterial-mediated gene 
expression. Of the 84 genes examined, 33 of them were found to be statistically affected 
by at least one of the three treatments (Table 5-1). The number of genes affected by 
ultrapure-LPS treatment was higher than either agarose or PLGA treatment, and 
numerous TLRs (including TLR4,5,6) were significantly affected by the TLR4-specific 
ligand (Table 5-1). Following PLGA treatment, across the TLRs, only a significant 
change in TLR5 expression (down-regulation) was found while agarose was not found to 
induce any alteration any receptor/surface molecule expression (Table 5-1). Significant 
differential transcription factor activation was found across the three treatments: LPS 
induced up-regulation NF-"B family members as well as IRF1, PLGA induced up-
regulation of Elk1, and agarose induced up-regulation of cFos (an AP-1 family member).  
Significantly affected genes were then used to assess similarity in gene 
expression patterns between the treatments using hierarchical clustering. It was found 
that DC treatment with LPS (mDC) or PLGA-induced gene expression patterns that were 
similar across the three trials investigated as seen in their clustering (Fig. 5-14). Agarose 
treatment of DCs and iDC gene expression patterns, however, were also found to be 
similar to each other and showed even tighter clustering (lower nodes/branches) to one 





Table 5-1: Genes which were significantly affected by at least one of the three treatment 
(ANOVA, p<0.05; in comparison to iDC controls), and fold-increase values (treatment 
over iDC) averaged across the three trials are displayed. Genes were broken into 
categories and included receptors/surfaces molecules, adaptor/effector molecules, 
transcription factors and cytokines. Blank table values indicate no significant alteration in 







Figure 5-14: Hierarchical 2D cluster analysis of -#Ct for TLR-related gene 
expression.  These were investigated using TLR-SuperArray (SABiosciences) with $-
actin and B2M Ct values were used for normalized and -#Ct for each trial and treatment 












Purified pooled adherent and non/loosely adherent DCs were then used for 
whole-cell lysate preparation to determine both total and active transcription factor 
protein presence. This was done to validate, at the protein level, three transcription 
factors NFkB1, Elk-1 and cFos responses across each treatment. Total Elk-1 protein 
was unaffected by LPS or biomaterial treatment at 24hr as similar levels of protein were 
found across three independent trials in whole-cell DC lysates (Fig. 5-15). This result 
also matched the level of active Elk1 protein expression found following LPS or 




Figure 5-15: Total Elk-1 protein expression from LPS or biomaterial treated whole-
cell DC lysates. Elk-1 appears between 47-60kDa. Increased RNA expression of Elk1 
found following PLGA treatment did not translate to increase protein levels. Similar 
results were also found when examining activated Elk-1 (pS383) (data not shown).  
 
Total NFkB1 protein was increased by ultrapure-LPS but not biomaterial 
treatment at 24hr as seen in higher presence of both active and precursor NFkB1 across 
three independent trials (Fig. 5-16). This result also matched the level of active NFkB1 
protein expression found following ultrapure-LPS or biomaterial stimulation, which also 




Figure 5-16: Total NFkB1 protein expression from LPS or biomaterial treated 
whole-cell DC lysates. NFkB1 (both precursor and active version) shows increase in 
presence follow LPS stimulation (MDC) but not following PLGA or agarose treatment. 






Figure 5-17: Active (phospho-PS939) NFkB1 protein expression from LPS or 
biomaterial treated whole-cell DC lysates. Activated NFkB1 shows increase in 
presence follow LPS stimulation (MDC) for two of the three trials but not following PLGA 
or agarose treatment. This concurs with increased RNA expression of NFkB1 found 








Total cFos protein was unaffected by LPS or biomaterial treatment at 24hr as 
similar levels of protein were found across three independent trials (Fig. 5-18). This 
result also matched the level of active cFos protein expression found following LPS or 
biomaterial stimulation which did not alter at 24hr (data not shown).  
 
 
Figure 5-18: Total cFos protein expression from LPS or biomaterial treated whole-
cell DC lysates. cFos protein presence shows no significant alteration follow LPS or 
biomaterial stimulation for 24hr. Agarose-induced increases in cFos RNA expression 
were not translated at 24hr to increases in cFos protein expression.  Similar results were 





In order to isolate the role of TLR4-induced signaling in the potential cellular 
recognition of biomaterial-presented ‘danger signals’, TLR4-expressing HEK293 cells 
were treated with PLGA or agarose films as well as LPS, and the levels of activated 
NF-"B and AP-1 was assessed. The high levels of activated NF-"B and AP-1 found in 
nuclear extracts from TLR4-expressing HEK293 cells in response to LPS was expected 
(Fig. 5-1, Fig. 5-3), as was their induced secretion of IL-8 secretion (Fig. 5-2). 
Biomaterial treatments, however, seemed to preferentially stimulate AP-1 signaling 
pathway only as both PLGA and agarose treatments resulted in significantly higher 
levels of activated AP-1 family members (and not NF-"B family members) at 24hr (Fig. 
5-1, Fig. 5-3). To assess the TLR4 specificity in TLR4-expressing HEK293 cells, a stably 
silenced transform was created to knockdown MyD88, an important adaptor molecule in 
TLR signaling (Fig. 5-4 and Fig. 5-5) and was intended to inhibit TLR4-induced signaling. 
However, MyD88-silenced TLR4-expressing HEK293 cells were still responsive to LPS 
as seen in significantly increased NF-"B activation, which was similar to levels found in 
non-silenced TLR4-expressing HEK293 cells (Fig. 5-6). Therefore, it was not possible to 
prevent TLR4-induced signaling by silencing MyD88. This may be due to either 
incomplete knockdown, as noted in Fig. 5-5, or due to the involvement of another 
adaptor molecule Toll/IL-1R domain-containing adapter molecule (Trif, illustrated in Fig. 
3-2) which can cross-talk with the NF-"B pathway (Takeda et al. 2003; Akira and Takeda 
2004; Kawai and Akira 2006) and allow for TLR signaling propagation to by-pass 
MyD88.  
Due to wild-type HEK293 cells expressing little to no TLR4 protein (Devaney et 
al. 2003), they were used as a TLR4-deficient control to examine their response to LPS, 
PLGA or agarose treatment. As expected, wild-type HEK293 cells did not respond to 
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LPS as seen in lack of both activated NF-"B and AP-1 in nuclear extracts at 24hr (Fig. 5-
7) verifying the TLR4 specific response. However, while wild-type HEK293 cells showed 
no significant NF-"B activation (p65) across all treatments (Fig. 5-7A), they showed 
significant increase in the level of activated cFos (AP-1) present in their nucleus at 24hr 
following PLGA or agarose treatment (Fig. 5-7B). Thus, the over-expression of TLR4 in 
HEK293 cells was not necessary for the biomaterial-induced AP-1 response (Fig. 5-3).  
NF-"B and AP-1 signaling pathways regulate one another and following cell 
stimulation both NF-"B and AP-1 activation may be necessary for cell survival 
(Kriehuber et al. 2005). Unbalanced AP-1 activation, as occurred in biomaterial-treated 
HEK293 cells, may have resulted in increased cellular apoptosis. Signs of biomaterial-
induced apoptosis in TLR4-expressing HEK293 cells, MyD88-silenced TLR4-expressing 
HEK293 cells and 293 null cells were investigated by examining the level of both 
activated caspase 8 (early apoptosis marker) and activated caspase 3 (late apoptosis 
marker) in each cell line. Unexpectedly, agarose, which induced the highest level of AP-
1 activation, induced significantly lower levels of activated caspase 8 present across all 
cell lines at 24hr indicating lower levels of apoptosis (Fig. 5-8). Since caspase 8 cleaves 
the pro-form of caspase 3 into its activated form, one would expect the trends seen with 
activated caspase 8 in biomaterial-treated cells to also be seen when examining 
activated caspase 3. However, only agarose-induced lowering of activated caspase 8 
presence propagated to caspase 3 in TLR4-expressing HEK293 cells while no 
significant alteration in activated caspase 3 presence was found in agarose treated 
MyD88-silenced TLR4-expressing HEK293 cells or wild-type HEK293 cells (Fig. 5-9). 
Therefore, it appeared that AP-1 activation did not correlate directly to an increase in 
apoptosis for both markers examined. Caspase activation, however, may not be the 
most appropriate marker for biomaterial-induced apoptosis in HEK293 cells as other 
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apoptotic markers such as DNA fragmentation detection via terminal transferase dUTP 
nick end labeling (TUNEL) may be necessary. 
TLR4- mice were used as a source of BMDCs to isolate the role of TLR4 in 
biomaterial-induced DC maturation. BMDCs from TLR4+ or TLR4- mice were treated with 
ultrapure-LPS (a TLR4-specific ligand) or treated with PLGA films or MPs which have 
previously been shown to induce signs of BMDC maturation (Yoshida et al. 2007). The 
isolation of TLR4-induced activation using TLR4+ and TLR4- was verified by the 
treatment of ultrapure-LPS, which only induced signs of activation (increased MHC class 
II, CD80 ad CD86) in the non/loosely adherent BMDC population from TLR4+ but not 
TLR4- mice (Fig. 5-10). Furthermore, TLR4+ non/loosely adherent BMDCs were able to 
respond and mature in the presence of PLGA films which induced signs of DC 
maturation (increased CD86 expression), and this is absent in TLR4- BMDCs possibly 
implicating a role for TLR4 in biomaterial-induced DC maturation (Fig. 5-10). Treatment 
with PLGA MPs, however, did not induce signs of DC maturation in non/loosely adherent 
BMDCs from either mice strain (Fig. 5-10). Also, while ultrapure-LPS treatment induced 
production of TNF-! in a TLR4-dependent manner, neither PLGA film nor MP treatment 
resulted in the significant secretion of the pro-inflammatory cytokine from TLR4+ or TLR4- 
BMDCs (Fig. 5-11) which had previously been seen with similarly treated BMDC from 
C57BL/6 mice (Yoshida et al. 2007). Both biomaterial treatments, however, induced 
signs of early apoptosis as seen in the increased positive staining of annexin-V, and this 
response was not found in TLR4- BMDCs, which indicated a TLR4-dependent response 
(Fig. 5-10). Interestingly, while PLGA films induced increased expression of CD86 in 
TLR4+ BMDCs they simultaneously induced increased signs of apoptosis, both in a 
TLR4-dependent manner. This is in contrast to ultrapure-LPS treatment, which resulted 
in increased DC maturation and decreased signs of early apoptosis (Fig. 5-10). A similar 
response has also been found with NiCl2, which induced DC maturation and subsequent 
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DC allogeneic T-cell stimulation with a simultaneous induction of DC apoptosis (Manome 
et al. 1999). This response was speculated to be dependent on ERK, as ERK-inhibited 
DCs have impaired LPS-induced annexin-V staining without affecting DC maturation 
(Rescigno et al. 1998). Thus, increased activation through ERK pathway by PLGA 
treatment, may offer an explanation to the differential BMDC response between 
biomaterial and LPS treatments.  
The response of BMDCs from TLR4+ mice (again, the C57BL/10ScSn strain) to 
the ultrapure-LPS (as well as PLGA) was not as robust as had previously been seen 
with BMDCs from C57BL/6 mice (Yoshida et al. 2007). Therefore, this study was 
repeated using another appropriate TLR4-expressing strain, C57BL/10, as a source of 
BMDCs to examine if this strain would be a more sensitive control strain for TLR4- mice. 
Non/loosely adherent BMDCs from C57BL/10 did not appear to be responsive to PLGA 
film or MP treatment while they were still responsive to the ultrapure-LPS stimulation as 
seen with TLR4-depedent DC maturation marker increased expression for BMDCs from 
C57BL/10 mice (Fig. 5-12). However, non/loosely adherent iDCs collected appeared to 
be pre-activated as assessed by I-Ab expression (described in detail, CHAPTER 6). 
Therefore, characterization of both adherent and non/loosely adherent cell in BMDC 
culture was assessed, which revealed that adherent BMDCs were more responsive to 
stimuli than non/loosely adherent BMDC due to maintaining an immature status 
(CHAPTER 6).  
The role of TLR4 in biomaterial-induced DCs was thus further investigated with 
analysis of both adherent and non/loosely adherent treated BMDC fractions from 
C57BL/10 or TLR4- mice. Overall the effects of all treatments on non/loosely adherent 
DCs were less dramatic than seen in adherent BMDCs. However, the effects of the 
maturation-inducing stimulus, PLGA film induced increase in CD80/86 expression), on 
adherent BMDCs from C57BL/6 (Fig. 6-6) was not found with BMDCs from C57BL/10 
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strain (Fig. 5-13 and Fig. 6-6). The TLR4- adherent BMDCs actually showed signs of 
maturation in response to PLGA films as seen with a significant increase in I-Ab which 
was not found with their non/loosely adherent counterpart (Fig. 5-13). However, TLR4- 
adherent BMDCs also responded to PLGA films by significantly down-regulating CD80 
expression (Fig. 5-13). Therefore, there was contrasting evidence as to whether 
biomaterial-induced DC maturation was TLR4-dependent as TLR4- BMDCs showed 
signs of both maturation and becoming more immature. It may be possible that TLR4 
knockout (KO) strains developed by Shizuo Akira (Hoshino et al. 1999) and not TLR4-
hyporesponsive strains or TLR4-deficient (C3H/HeJ or C57BL/10ScN, respectively) 
(Poltorak et al. 1998) are more suitable for determining the role of TLR4 in biomaterial-
induced DC maturation due to the use of C57BL/6 as a background strain. The 
difference in background strain, of which genetic differences have been found between 
C57BL/6 and C57BL/10 (McClive et al. 1994), may allow for more prominent differences 
between biomaterial-mediated responses of BMDCs from the TLR4+ and the TLR4-KO 
strain. This is supported by a recent study which was successful in showing a role for 
TLR4 and TLR2 in the response of BMDCs to PLGA using TLR4-/- mice of C57BL/6 
background (Shokouhi et al. 2010). This may allow for increased sensitivity for BMDC 
response to biomaterials. However, another possible explanation for the less than 
anticipated response to biomaterials from all TLR4+ mice investigated may be due to 
analysis of a 24hr time point following stimulation. Earlier time points (such as 5 or 12hr) 
may potentially allow for increased sensitivity for determining biomaterial-induced BMDC 
maturation. 
TLR-related gene expression was examined to determine the effects of both LPS 
and biomaterial treatment on both specific TLR down-regulation, which may indicate a 
role in recognition, and overall gene expression patterns, which would determine if 
biomaterial treatment induced similar gene regulation to that of PAMP stimulation. 
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Ultrapure-LPS influenced a larger number of individual genes with altered expression 
than PLGA, which in turn also significantly affected a larger number of genes 
investigated than agarose (Table 5-1). PLGA is known to induce DC maturation to a 
similar degree to that of LPS (Yoshida and Babensee 2004; Babensee and Paranjpe 
2005; Yoshida and Babensee 2006) and here, the overall gene expression pattern 
induced by PLGA matched that of LPS more than either iDC or agarose treatment (Fig. 
5-14). Also, iDC and agarose treatments clustered tightly together which is expected as 
agarose does not tend to induce DC maturation (Babensee and Paranjpe 2005; Yoshida 
and Babensee 2006). These results further verify the activating (PLGA) or non-activating 
(agarose) potential for biomaterial control of an immune response by directing DC 
maturation through global gene expression manipulation. Furthermore, ultrapure-LPS 
treatment significantly affected expression of several TLRs (TLR4, TLR5 and TLR6) 
indicating that the TLR4-specific stimulation resulted in other non-specific TLR down-
regulation (Table 5-1). Therefore, conclusions cannot be drawn on the role of specific 
TLRs to recognize biomaterials through gene expression analysis alone. So while PLGA 
treatment induced significant decreases in TLR5 and TLR8 expression (Table 5-1) and 
not TLR4 or TLR2 as was anticipated due to their known role in the recognition of 
‘danger signals’, the role of TLR5 and TLR8 (Table 5-1) in the response of DCs to PLGA 
is inconclusive potentially due to compensatory down regulation of multiple TLRs. Also, 
gene expression at the mRNA level does not always translate to protein expression, as 
noted below for the transcription factor protein validation. This implies that though TLRs 
may be significantly down-regulated in the transciptome, TLR protein expression and 
subsequent role in recognition of biomaterial may not be correlated to expression at the 
mRNA level.  
Interestingly, differential transcription factor expression appeared across the 
three treatments. Ultrapure-LPS induced increases in NFkB1, PLGA induced increases 
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in Elk1 and agarose significantly increased cFos (AP-1) expression. LPS-induced NF-"B 
expression was anticipated as LPS increased NF-"B activation in TLR4-expressing 
HEK293 cells (Fig. 5-1). Also, an increase in cFos expression in DCs following agarose 
treatment matches similarly treated HEK293 cells (Fig. 5-7) implying that agarose 
potentially affects AP-1 pathway across many cell types. As previously mentioned, 
BMDC apoptosis caused by PLGA (Fig. 5-10) may potentially be linked to ERK activity 
(Rescigno et al. 1998). PLGA induced a significant increase in Elk-1 expression in 
human DCs (Table 5-1), which is directly controlled and activated by ERK (Cruzalegui et 
al. 1999). Therefore, it is possible that PLGA stimulated ERK/Elk-1 pathway and may 
explain its effect on DC apoptosis. 
Gene (RNA) expression confirmation at the protein level was determined by 
examining both total and activated NFkB1, cFos and Elk-1 presence. NFkB1 RNA 
expression was increased at 24hr following LPS treatment only, and protein levels (both 
total and active forms of NFkB1) were found to match these findings (Fig. 5-16 and Fig. 
5-17). However, increased Elk-1 RNA expression in human DCs following PLGA 
treatment and increased cFos RNA expression following agarose treatment were not 
validated at the protein level examining either total or active forms of the two 
transcription factors (Fig. 5-15 and Fig. 5-18). Therefore, these biomaterial-induced RNA 
responses were not translated to protein at 24hr. It is possible that only NFkB1 protein 
expression showed an increase at 24hr due to persistent activation while cFos and Elk-1 
might show increases in protein expression at an earlier time point than assessed in this 
study. However, all HEK293 cell line examined showed increased levels of active AP-1 
(cFos) in nuclear extracts following agarose stimulation at 5h and even more significantly 
at 24hr. Therefore, it may be that nuclear extraction from DCs may be necessary for 
analysis of specific transcription factor activation levels to note the differences across 
biomaterial treatments as opposed to whole-cell extract which was analyzed herein.  
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In conclusion, we sought to determine the role of TLR4/ ‘danger signal’ 
interactions in the response of DCs to biomaterials. Biomaterial treated HEK293 cells 
resulted in increases in AP-1 activation, which was found to be independent of TLR4 
expression. A role for TLR4 in biomaterial-induced DC maturation was shown in BMDCs 
treated with PLGA films, which showed TLR4-dependent signs of maturation and 
apoptosis. Further analysis of adherent BMDCs treated with PLGA revealed inconclusive 
evidence as TLR4- BMDCs showed signs of both increased and decreased DC 
maturation. Lastly, global gene expression analysis of PLGA and LPS treated human 
DCs revealed similarity indicating a comparable response to both the activating 
biomaterial and PAMP. However, key differences in this response may be dictated by 





ADHERENT FRACTION OF BONE MARROW-DERIVED DENDRITIC CELLS IS 
MORE RESPONSIVE TO LPS AND BIOMATERIAL STIMULI THAN THE 






Dendritic cells (DC) act as the sentinel cells of the body by constantly surveying 
their environment for foreign entities. Upon such an encounter, immature DCs (iDCs) 
may respond innately to pathogens through pattern recognition receptors (PRR), which 
induce their differentiation into mature DCs (mDC). An mDC may then migrate to a 
lymph node which allows for initiation of an adaptive immune response through co-
stimulation and MHC class II presentation of the pathogen by-products to T cells 
(Banchereau and Steinman 1998). Immature DCs may also play a role in the immune 
response through induction of self-tolerance by presenting self-peptides to T cells in the 
absence of additional stimuli (Hawiger et al. 2001; Steinman and Banchereau 2007). 
Thus, DCs may control both the occurrence and absence of an immune response.  
For these reasons, DCs have been investigated for use in therapies ranging from 
cancer vaccines to amelioration of autoimmune diseases (Ludewig et al. 2001; Ueno et 
al. 2010). In laboratory work investigating these therapies, murine conventional DC 
(cDC) cultures are used. Typically, murine cDCs are derived from BM progenitor cells 
(Inaba et al. 1992; Lutz et al. 1999) but have also been derived from blood mononuclear 
cells (Agger et al. 2000) through differentiation using GM-CSF alone or in combination 
with IL-4. Following cultures, which may vary in time frame, non/loosely adherent DCs 
are routinely collected as iDCs. In the case of DCs differentiated with both GM-CSF and 
IL-4, DCs have been shown to express higher levels of CD11c (Masurier et al. 1999), a 
                                                
* Modified from Rogers T, Babensee JE “Characterization Of Adherent And Non/Loosely 
Adherent Murine Bone Marrow Derived Dendritic Cells And Their Responsiveness To Maturation 
Stimuli” (Manuscript submitted J Immunol Methods) 
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mouse cDC marker, as well as possessing higher potency during mixed lymphocyte 
reaction (Mayordomo et al. 1997), than with GM-CSF alone. They can then further be 
purified to greater than 90% using CD11c magnetic-bead isolation (Menges et al. 2002; 
Yoshida et al. 2007).  
Previously, we have shown that certain biomaterials (e.g. PLGA, chitosan) may 
act as an adjuvant to enhance, while others may minimize (e.g. agarose), the immune 
response to a co-delivered biologic (Matzelle and Babensee 2004; Norton et al. 2010), to 
an extent which mimics the respective level of induced DC maturation (Yoshida and 
Babensee 2006; Yoshida et al. 2007). For BMDCs, the collection, treatment and analysis 
solely of the non/loosely adherent cell population is common. Many investigators often 
overlook the underlying adherent BMDC population. Adherent BMDCs are typically only 
examined when studying the effects of substrates which may directly influence adhesion 
such as extracellular matrix proteins (Acharya et al. 2008). However, on tissue culture 
polystyrene (TCPS) alone, adherent rat BMDCs were found to express high levels of IL-
10 and CD54 and seemed capable of inducing tolerance upon reinjection in contrast to 
their non/loosely adherent BMDC counterpart which maintained immunity (Yang et al. 
2000). Adherent rat BMDCs had a higher phagocytic capacity and lower MHC class II 
and CD86 surface presence than the non/loosely adherent BMDC counterpart (Muthana 
et al. 2004) while adherent mouse BMDC injections (and not non/loosely adherent 
BMDCs) have allowed prolongation of heart allografts (Peche et al. 2005). Thus, there is 
evidence that the phenotype of adherent BMDCs is more immature (or even tolerogenic) 
than the non/loosely adherent BMDC population. 
Presented here is a characterization of the cellular phenotypic profiles across the 
culture time frame of both adherent and non/loosely adherent DCs derived from different 
strains of murine BM. Specific cellular identification markers were examined as well as 
analysis of the maturation state of both adherent and non/loosely adherent BMDCs at 
94  
the initial time point of BM collection through the endpoint time of the culture following a 
24h treatment with PLGA films, PLGA MPs or LPS. The results indicate that not only are 
adherent BMDCs more “immature,” but they are in fact more receptive to stimuli than the 
non/loosely adherent BMDC population.  
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Materials and Methods 
 
Mice Strains 
Male mice (6 weeks in age) of two strains were used as the source of BM for the 
characterization study: C57BL/10 (n=3) and C57BL/10ScSn (n=3) (The Jackson 
Laboratory, Bar Harbor, ME). Both strains are relevant control strains for the toll-like 
receptor 4 (TLR4)-deficient mice C57BL/10ScN (Poltorak et al. 1998). For biomaterial 
treatments, C57BL/6 (n=7-8) and C57BL/10 (n=7-8) mice were used (The Jackson 
Laboratory). 
 
Bone Marrow Derived Dendritic Cell Culture 
 The BMDC culture method used here is based on a previously established method 
with modifications (Inaba et al. 1992; Yoshida et al. 2007). Femur and tibia collection (as 
well as animal housing) was performed at Emory University Whitehead animal facility 
(IACUC protocol 044-2006). For culture protocol, please see method section of 
CHAPTER 5 (BMDC culture), and Fig. 6-1. Immature DCs collected on Day 6 were 
induced into mDC through treatment with ultrapure-LPS at 1"g/mL or left untreated as a 
negative control for iDC.  
 
Characterization Procedure 
 At specific time points of BMDC culture (see Fig. 6-1), both adherent and 
non/loosely adherent fractions were collected and analyzed separately. Non/loosely 
adherent DCs were collected by swirling plates 10 times clockwise, 10 times counter 
clockwise, 10 times left/right and 10 times up/down followed by gentle pipette collection 
and counting using Coulter Counter (Multisizer 3, Beckman Coulter, Brea, CA). 
Immediately following, cell dissociation solution (Sigma) was added to wells (3mL for 6 
well plates, and 1mL for 24 well plate) and placed in 37oC incubator until remaining 
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adherent DC dissociation occurred following gentle tapping and pipetting. Adherent DCs 
were then collected and counted using Coulter Counter. Both adherent and non/loosely 
adherent DCs were rinsed with FACS buffer (96% (v/v) Hank’s HEPES Buffer (120mM 
NaCl, 10mM KCl, 10mM MgCl2, 10mM glucose, and 30mM HEPES. All chemicals from 
Sigma), 1% (v/v) human serum albumin (HSA) (EMD Biosciences, La Jolla, CA), and 
1.5mM CaCl2). Both collected populations were then double stained for 1hr in FACS 
buffer using the following pairs of antibodies, which recognize the noted murine 
molecules (Table 6-1). Flow cytometry was performed using LSR II (BD Biosciences). 
Geometric mean fluorescence intensity (gMFI) was used determined using FloJo 
software (Tree Star, Inc, Ashland OR) to quantify expression levels on gated (FSC/SSC) 








Figure 6-1: BMDC culture and characterization time points. Red star indicates 
characterization procedure performed by flow cytometry on cell suspensions. Blue star 
indicates flow cytometry analysis of both non/loosely adherent and adherent cells which 
were collected and also counted to measure percentage of adherent cells. Both fractions 
were stained with each of the following pairs of antibodies listed in Table 6-1. On Day 0, 
cell suspension prior to plating was analyzed. On Day 6, pre-sorted cells (adherent and 
non-adherent) and CD11c+ isolation fractions were characterized. On Day 7, cells that 




Table 6-1: Antibodies and markers used for flow cytometry characterization. 
Throughout BMDC culture time frame, presence of cell types were probed for using cell 
specific markers as noted in table. Cells were double stained with APC/PE antibodies as 
denoted by markers that are paired together (e.g. CD80-APC, CD86-PE). Clones, 
isotypes and vendor information is also provided.  
 
Cell Type MARKER CLONE Isotype Vendor 
B Cell CD19-PE 6D5 Rat IgG2a Miltenyi Biotec 
T Cell CD3-APC 145-2C11 Ham IgG1 Miltenyi Biotec 
          
RBC TER119-APC Ly-76 Rat IgG2b Miltenyi Biotec 
Macrophage F4/80-PE BM8 Rat IgG2a eBioscience 
          
Monocyte CD14-APC Sa2-8 Rat IgG2a eBioscience 
Platelets CD41-PE MWReg20 Rat IgG1 eBioscience 
          
DC CD11c-APC HL3 Ham IgG1 BD Bioscience 
DC/B Cell MHCII-PE AF6-120.1 
Ms. IgG2a, 
k BD Bioscience 
          
DC/B Cell CD80-APC 16-10A1 Ham IgG2 BioLegend 
DC/B Cell CD86-PE GL1 Rat IgG2a BioLegend 




1C2.4.1 Rat IgG2b Miltenyi Biotec 
NK Cells CD49b-PE DX5 Rat IgM Miltenyi Biotec 
          
Granulocytes GR-1-APC RB6-8C5 Rat IgG2b Miltenyi Biotec 
Stem Cell CD117-PE 3C1 Rat IgG2b Miltenyi Biotec 
          
Fb/Epithel CD121a-PE 35F5 Rat IgG1 BD Bioscience 

















Biomaterial Preparation and Treatment 
A solution of 10% w/v PLGA (mole ratio 75:25, inherent viscosity 0.70 dL/g in 
trichloromethane; Durect/Lactel Absorbable Polymers, Birmingham, AL) was prepared in 
20mL dichloromethane overnight in sterile polypropylene tubes (Yoshida and Babensee 
2004). To form films, this solution was gently poured into a cleaned 100mm Teflon dish 
and allowed to sit for two days in fume hood until DCM had evaporated. PLGA films of 
appropriate sizes were prepared using a flame-sterilized punch. Punched films were 
washed for one hour in endotoxin free water (Lonza, Basel, Switzerland).  
PLGA MPs were prepared as described in CHAPTER 5 using a single emulsion 
solvent evaporation technique (Yoshida and Babensee 2004).  
Endotoxin content of biomaterials was examined using the Limulus Amebocyte 
Lysate assay (QCL1000, Lonza) with the chromogenic substrate added in the presence 
of the materials. Endotoxin levels of all biomaterials used tested below 0.2 EU/mL. 
CD11c-isolated DCs (on day 6 of culture) were prepared from C57BL/10 or 
C57BL/6 mice and left untreated as iDC, or treated with ultrapure-LPS for mDCs, or 
treated with PLGA films or MPs for 24h. Following treatment, non/loosely adherent 
BMDCs as well as adherent BMDCs were collected. Cells were analyzed with flow 
cytometry after being double stained for I-Ab/CD11c or CD80/CD86 and gMFIs 
determined. Treatment control ratios were determined by dividing gMFI received 
following LPS or biomaterial treatment by the gMFI for iDC. Normalization was separate 
for the adherent and non/loosely adherent iDC populations. 
 
Statistical Analysis 
For most statistical analysis, an ANOVA analysis was performed (GraphPad, 
LaJolla, CA) using Tukey-post test (p<0.05) with mice nested within treatment. When 
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comparing data to a normalized value relative to iDCs (hence comparing to 1), a two-





Day 0 Cellular Characterization  
 The cell populations present during development of cDCs from C57BL/10 or 
C57BL/10ScSn mouse BM were characterized as well as the level of pre-activation in 
both the adherent and non/loosely adherent BMDC fractions. On Day 0, following 
removal of RBCs from BM, the majority of cells from both strains stained positive for a 
granulocyte marker (Gr-1) or B cell marker (CD19) (Table 6-2). Also, BM cells stained 
positive to varying degrees for a co-stimulatory molecule (CD80), a macrophage marker 
which is also present during myeloid development (F4/80) (Leenen et al. 1994), an MHC 
class II molecule (I-Ab), and a platelet/megakaryocyte marker (CD41) (Table 6-2). There 
was no detection of expression of CD3 (T cells), TER119 (RBCs), CD14 (monocytes), 
PDCA-1 (plasmacytoid DCs), CD49b (natural killer cells), CD117 (stem cells), CD121a 
(various cell types including fibroblasts) or CD138 (plasma cells) on cells from Day 0 






Table 6-2: Flow cytometry analysis for surface markers during BMDC culture. For Day 0, range of the percentage of total gated BM 
cells that were positive for stated marker are given (n=3 for both C57BL/10 and C57BL10ScSn strains). Percentages given were 
determined by the low and high values for pooled data for both strains. For Day 3, 6 and 7 relative expression levels for markers on 
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40%   F4/80 Mid Mid   F4/80 Mid Mid Mid   F4/80 Mid Mid Mid Mid 
CD19+ 
20-
25%   CD41 Low Low   CD41 Low Mid Low   CD41 Low Low Mid Mid 
CD80+ 
10-
15%   CD11c Low Mid   CD11c Mid High Mid   CD11c Low Low Mid+Low Mid+Low 
F4/80+ 
20-
40%   I-Ab High High+Low   I-Ab High+Low Low High-Low   I-Ab High High Low High 
I-Ab+ 
23-
31%   CD80 High Low   CD80 Mid Low Mid   CD80 High High Low Mid 
CD41+ 
20-








Adherent and Non/loosely Adherent BMDC Characterization Prior to Treatment  
 By Day 3, cDCs (CD11c+) appeared in the culture in both adherent and non/loosely 
adherent fractions (Table 6-2, Fig. 6-2A for C57BL/10 and Fig. 6-3A for C57BL/10ScSn). 
There were few cells that stained positive for granulocyte or B cell markers that had 
been present on Day 0 (not shown). BMDCs on Day 3 began to show signs of 
differential expression levels of co-stimulatory molecules CD80 and CD86 between both 
the adherent and non/loosely adherent DC populations. While non/loosely adherent DCs 
expressed high levels of an MHC class II molecule (I-Ab), CD80 and CD86, adherent 
DCs expressed lower levels of these markers (Table 6-2, Fig. 6-2B for C57BL/10, and 
Fig. 6-3B for C57BL/10ScSn). Adherent DCs, however, did express higher levels of 
CD11c than non/loosely adherent DCs (Table 6-2, Fig. 6-2A for C57BL/10 and Fig. 6-3A 
for C57BL/10ScSn).  
 By Day 6, expression of granulocyte or B cell markers did not appear to be present 
in either adherent or non/loosely adherent cell fractions (data not shown). The levels of 
maturation markers between the two BMDC fractions differed in a similar manner as had 
been observed on Day 3 in that the non/loosely adherent BMDC displayed high levels of 
CD80, CD86 and MHC class II (I-Ab) expression while adherent BMDCs exhibited low 
levels of expression of these markers (pre-isolation, Table 6-2, Fig. 6-2A,B for C57BL/10 
and Fig. 6-3A,B for C57BL/10ScSn). Adherent BMDCs maintained higher levels of 
CD11c expression than non/loosely adherent BMDCs (Fig. 6-2A for C57BL/10 and Fig. 
6-3A for C57BL/10ScSn). The non/loosely adherent DCs were used as the cell source 
for CD11c-isolation and immediately following purification maturation marker (CD80/86) 
expression were similar to pre-isolation levels (Table 6-2, Fig. 6-2B for C57BL/10 and 
Fig. 6-3B for C57BL/10ScSn). Simultaneously, the extent of cellular adhesion was 
calculated by collecting and counting both adherent and non/loosely adherent fractions 
throughout the culture time, and it was found that at least 40% of cells were adherent to 
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Figure 6-2: Dot plots of gated DC population showing expression levels of (A) 
CD11c/I-Ab or (B) CD80/CD86 for BMDCs from C57BL/10 over the culture 
conditions. Non/loosely adherent (Non-Adh) and adherent BMDCs were analyzed 
separately on Day 3, Day 6 (before and after CD11c-isolation, CD11c+) and on Day 7 
following treatment of CD11c+ isolated BMDCs with ultrapure-LPS for 24h. Quadrants 
drawn were used to show relative levels across the culture conditions. Representative 
images from one of three independent experiments. Similar data for C57BL/10ScSn 
mouse strain can be found in the Fig. 6-3. 
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Figure 6-3: Dot plots of gated DC population showing expression levels of (A) 
CD11c/I-Ab or (B) CD80/CD86 for BMDCs from C57BL/10ScSn over the culture 
conditions. Non/loosely adherent (Non-Adh) and adherent BMDCs were analyzed 
separately on Day 3, Day 6 (before after CD11c-isolation, CD11c+) and on Day 7 
following treatment of CD11c+ isolated BMDCs with ultrapure-LPS for 24h. Quadrants 
drawn were used to show relative levels across the culture conditions. Representative 




Figure 6-4: Percentage of adherent BMDCs across culture time frame. Non/loosely 
adherent and adherent DCs were collected and counted using Coulter Counter (10-
20!m) at Day 3, Day 6 and on Day 7 following treatment with LPS (mDC) or left 




Adherent and Non/loosely Adherent DC Response to LPS Treatment  
 The responsiveness of Day 6 plated, CD11c+ BMDCs, derived from C57BL/10 or 
C57BL/10ScSn mice, to the maturation stimulus, LPS, following a 24h treatment, was 
assessed. It was found that cultures of iDC derived from C57BL/10 or C57BL/10ScSn 
mice contained adherent BMDCs possessing higher levels of CD11c expression and 
decreased levels of I-Ab expression (Fig. 6-2A or Fig. 6-3A, respectively) which also 
exhibited lower levels of both CD80 and CD86 (Fig. 6-2B or Fig. 6-3B, respectively) than 
their non/loosely adherent DC counterparts. Particularly for iDCs from C57BL/10, 
adherent DCs were more responsive to LPS as increases in both I-Ab and CD86 for 
adherent cells were significantly higher than non/loosely adherent cells (Fig. 6-5A). For 
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iDCs from C57Bl/10ScSn mice, only I-Ab expression showed significantly higher 
increase in expression for adherent cells as compared to non/loosely adherent DCs in 
response to LPS (Fig. 6-5B). For iDCs derived from either strain, expression of CD11c 
(!X integrin) increased in response to LPS for non/loosely adherent DCs but decreased 
significantly for adherent DCs (Fig. 6-5). Extent of DC adhesion was unaffected by LPS 





Figure 6-5: Treatment control ratios (mDC/iDC) of either non/loosely adherent or 
adherent BMDCs for CD11c, I-Ab, CD80 and CD86 expression from (A) C57BL/10 or 
(B) C57BL/10ScSn. gMFIs were determined for ultrapure-LPS treatment (mDC) of 
BMDCs for non/loosely adherent or adherent BMDC fractions and divided by levels for 
untreated non/loosely adherent or adherent BMDCs fractions of iDC controls, 
respectively. Clear bars, non/loosely adherent DCs; filled bars, adherent DCs. Bars 
show mean+s.d. X indicates statistical difference from levels of iDC (1), Student t-test, 
p!0.05. Brackets indicate statistical difference between response of non/loosely 






Adherent and Non/loosely Adherent DC Response to Biomaterial Treatment  
 Previously, non/loosely adherent DCs derived from BM of C57BL/6 mice were 
found to respond to 24h biomaterial treatments of PLGA (Yoshida et al. 2007) . Since 
adherent DCs appeared to be more responsive to stimuli and biomaterials may be more 
of a moderate stimulus for DC maturation than TLR ligands, both the adherent and 
non/loosely adherent BMDC fractions were examined for their responsiveness to 
biomaterial treatments. Adherent BMDCs from C57BL/10 or C57BL/6 mice were more 
responsive to LPS treatment by showing greater increases in I-Ab and CD86 expression 
than their non/loosely adherent DCs counterparts (Fig. 6-6A,B or 6-6D,E, respectively). 
The response of adherent DCs to PLGA films was also more pronounced in comparison 
to non/loosely adherent DCs when examining I-Ab expression for C57BL/10-derived 
BMDCs (Fig. 6-6A,B) and CD86 expression on C57BL/6-derived BMDCs (Fig. 6-6D,E). 
While non/loosely adherent BMDCs from C57BL/6 mice did show a slight (but 
significant) increase in I-Ab in response to PLGA films, the increase observed for the 
adherent DCs was higher but not statistically different from level of iDC (Fig. 6-6D,E).  
 Adherent BMDCs from C57BL/10 showed a significantly lowered expression of 
CD11c in response to treatment with PLGA films or MPs (Fig. 6-6B) which was not 
observed for adherent BMDCs derived from C57BL/6 mice (Fig. 6-6E). Also, PLGA MPs 
induced no significant alterations in expression of the DC maturation markers 
investigated (CD80, CD86, I-Ab) on either cell fraction from C57BL/6 mice but did induce 
a lower expression level for several maturation markers (I-Ab, CD86) in the adherent 
BMDCs from C57BL/10 mice (Fig. 6-6). Lastly, levels of TNF-! secretion into culture 
supernatants in response to BMDC treatment with LPS or biomaterials were determined. 
For BMDCs derived from C57BL/10 or C57BL/6 strains, while treatment with LPS 
induced high levels of TNF-! secretion, treatment with PLGA films induced slight, but 
significant increases in TNF-! levels (Fig. 6-6C or Fig. 6-6F, respectively). Treatment of 
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BMDCs from either mouse strain with PLGA MPs did not induce a significant TNF-! 




Figure 6-6: Influence of biomaterial treatments on non/loosely adherent and 
adherent BMDCs. Treatment control ratios (Treatment/iDC) of non/loosely adherent or 
adherent BMDCs for CD11c, I-Ab, CD80 and CD86 expression from (A-B) C57BL/10 or 
(D-E) C57BL/6. gMFIs were determined following treatment with ultrapure-LPS (mDC), 
PLGA film (Films) or PLGA MPs (MP) of BMDCs for non/loosely adherent or adherent 
BMDC fractions and divided by levels for untreated non/loosely adherent or adherent 
BMDCs fractions of iDC controls. TNF-! concentration in supernatants of BMDCs from 
(C) C57BL/10 or (F) C57BL/6 was also determined for iDC, mDC or PLGA film or MP 
treatments, divided by total cells (both adherent and non/loosely adherent) collected and 
normalized to the levels of iDC control (1). Star indicates statistical difference from levels 
of iDC (1), Student t-test, p!0.05. Bars show mean+s.d, n=7-8 independent 







 Routinely, the non/loosely adherent fraction of murine BMDC cultures is used for 
analysis, wherein the adherent BMDC fraction is unused. However, here we have shown 
that adherent murine BMDCs may in fact be of more immature phenotype with more 
responsiveness to both pathogen and biomaterial stimuli potentially making them the 
more relevant BMDC fraction to study. Adherent BMDCs from C57BL/10 or 
C57BL/10ScSn mouse strains expressed higher levels of CD11c, a mouse DC marker, 
and lower levels of MHC class II as well as CD80/86 than their non/loosely adherent 
counterpart (Fig. 6-2 and Fig. 6-3, respectively). Upon stimulation with LPS, these 
molecules’ surface presence became relatively higher in the adherent DC fraction from 
three different mice strains than in the non/loosely adherent fraction (Fig. 6-5 and Fig. 6-
6). Also, biomaterial (PLGA) stimulation induced higher increases in surface expression 
of CD86 and MHC class II molecule for adherent BMDCs in comparison to their 
non/loosely adherent BMDCs counterparts (Fig. 6-6).  
 On Day 0 of culture, little to no presence of cDCs was found in BM by examining 
CD11c expression. This agrees with the findings of others who have shown that only 
about 0.5% of BM cells are CD11c+ (Diao et al. 2004). The BM from C57BL/10 or 
C57BL/10ScSn mice stained positive to varying degrees for granulocytes (Gr-1), B cells 
(or B cell precursors) (CD19), myeloid/macrophage marker (F4/80), and MHC class II (I-
Ab) (Table 6-2). The percentages of positive expression observed for Gr-1 and F4/80 
(Table 6-2) are in agreement with previous findings for BM cells (Li et al. 2004), and 
while Gr-1 can be present on monocytes during development (Auffray et al. 2009), BM 
cells were negative for CD14 (Table 6-2). It is believed that DCs are derived from MHC 
class II-negative precursors (Inaba et al. 1993; del Hoyo et al. 2002), and here the 
majority (69-77%) of BM cells were indeed negative for I-Ab (Table 6-2). There was also 
little to no positive staining for markers for other cell types including CD3, TER119, 
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PDCA-1, CD49b, CD117, CD121a and CD138 on Day 0 throughout the culture time 
frame. This is in agreement other BM cell characterization studies examining CD3, CD14 
and CD117 expression (Diao et al. 2004; Menges et al. 2005; Peche et al. 2005).   
 By Day 3 of BMDC culture, CD11c+ DCs had developed and differential levels of 
DC marker expression began to appear between the adherent and non/loosely adherent 
DC fractions for BMDCs from either mouse strain investigated (C57BL/10 or 
C57BL/10ScSn). While adherent BMDCs expressed primarily mid/high levels of CD11c 
and low levels of I-Ab, CD80 and CD86, non/loosely adherent BMDC expressed low 
levels of CD11c and higher levels of I-Ab, CD80 and CD86 (Table 6-2, Fig. 6-2, and Fig. 
6-3). Furthermore, by Day 6, the differences between adherent and non/loosely adherent 
BMDCs were more pronounced especially for the surface presence of CD11c and I-Ab 
(Fig. 6-2A, and Fig. 6-3A). The CD11c+ population of the non/loosely adherent DC 
population was then isolated via positive selection using magnetic beads on Day 6. This 
isolation did not seem to have an immediate effect on the DC maturation marker 
expression (Fig. 6-2 and Fig. 6-3). This implies the purification technique did not (at least 
immediately) activate BMDCs. However, the impact of the CD11c-isolation procedure 
was not fully characterized in this study, but may offer an explanation as to why the 
non/loosely adherent BMDC population was not as responsive to stimuli in comparison 
to others’ (Agger et al. 2000). In future studies, if using a CD11c-isolation procedure, it 
may be beneficial for the purification to utilize solely adherent BMDCs (or at least pooled 
adherent and non/loosely adherent BMDCs) on Day 6, as adherent BMDCs expressed 
higher levels of CD11c. Also, the non/loosely adherent cell population was only about 
40-50% of the DCs while the adherent fraction was composed of a purer DC population 
(about 70-80% DCs) as determined by CD11c expression and FSC/SSC combined data 
(data not shown) for C57BL/10 or C57BL/10ScSn mouse strains. However, adherent 
BMDCs would likely be more susceptible to activation during isolation due to their 
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immature state which may make this modification counter-productive. 
 Following isolation on Day 6, CD11c-isolated DCs were re-plated and treated with 
LPS for 24h to investigate the responses of both adherent and non/loosely adherent 
iDCs to TLR ligand stimulation. The adherent fraction of iDC controls from either mouse 
strain investigated once again were of a more immature phenotype while the non/loosely 
adherent fraction showed higher expression levels of DC maturation markers and lower 
expression levels of CD11c (Fig. 6-2 and Fig. 6-3). In fact, the adherent fraction was 
composed mostly of an I-Ab-low population of DCs. This is in agreement with other 
studies that have shown that MHC class IIlow DCs are more adherent than MHC class IIhi 
DCs (Masurier et al. 1999). Furthermore, while the non/loosely adherent fraction was 
responsive to LPS as far as all markers assessed, the adherent fraction was significantly 
more responsive especially seen through an increase in I-Ab surface expression (Fig. 6-
5). This is in contrast to Peche et al who have shown adherent BMDCs to be more 
immature but less-responsive to LPS stimulation than non/loosely adherent BMDCs 
(Peche et al. 2005). The difference in response here may be due to the treatment and 
analysis of adherent and non/loosely adherent BMDCs fractions combined versus the 
separation and re-plating of adherent and non/loosely adherent BMDCs prior to 
treatment performed by Peche et al. Paracrine and direct cellular interactions between 
non/loosely adherent iDCs and adherent iDC in the work presented here may aid in 
maintaining the responsive phenotype of the adherent iDC population. 
 The adherent fraction of BMDCs exhibited a significantly lower level of CD11c 
expression in response to LPS in contrast to non/loosely adherent DCs which exhibited 
an increase across the three strains investigated (Fig. 6-5 and Fig. 6-6). The non/loosely 
adherent BMDC’s increase in CD11c expression in response to LPS has previously 
been seen (Pendl et al. 2002); however, decreased CD11c response following LPS 
stimulation for the adherent BMDC population has not. Interestingly, these shifts in 
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integrin expression occur in the absence of any significant alteration in DC adhesion 
(Fig. 6-4). The adherent fraction possibly has higher basal level CD11c expression due 
to adhesion to underlying substrate, which is clearly limited in the non/loosely adherent 
cell population. While higher expression of an integrin (CD11b) negatively correlated to 
ovine BMDC responsiveness to TLR stimuli (Foulon and Foucras 2008), here, adherent 
BMDCs with increased integrin (CD11c) expression displayed increased sensitivity to 
stimulation with LPS (Fig. 6-2 & Fig. 6-5). Others have found that adherent BMDCs 
expressed lower levels of CD11c than their non/loosely adherent BMDC counterpart 
(Masurier et al. 1999). Some of the discrepancies between these results (which only 
utilize GM-CSF-induced differentiation) and the findings presented here may be in part 
to the addition of IL-4 during BMDC development, as IL-4 has been shown to increase 
expression of CD11c on BMDCs (Masurier et al. 1999). It was previously believed that 
GM-CSF alone was unable to produce an adherent BMDC population but rather an 
adherent population similar to macrophages (Inaba et al. 1992). However, recent 
findings point that GM-CSF alone may be capable of producing adherent and 
non/loosely adherent BMDCs which are similar across  many DC markers (Li and Lu 
2010). In vitro supplement of IL-4 in BMDC culture conditions used herein, in addition to 
use of GM-CSF, may modulate the phenotype and responsive of BMDCs by altering 
their integrin expression and subsequent adhesion properties. Perrot et al found that 
higher CD11c expression on infiltrating DCs directly purified from tumors correlated with 
increased responsiveness of DCs to LPS stimulation (Perrot et al. 2007). Thus, adherent 
BMDCs which expressed high levels of CD11c in the culture conditions presented here 
in the presence of IL-4, seemed to mimic this infiltrating DC phenotype in vivo. It is 
unknown whether there is direct interaction between CD11c integrin and substrate; 
however, CD11c does mediate adhesion to denatured proteins in response to ‘danger’ 
which may be adsorbed to the surface (Vorup-Jensen et al. 2005). It is possible then that 
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CD11c engagement may play a role in BMDC adhesion and influence its 
responsiveness to TLR stimulation. 
 The adherent and non/loosely adherent BMDC response to biomaterial treatments 
(PLGA film or PLGA MPs, which have previously been shown to induce DC maturation) 
was examined using BMDCs from C57BL/10 or C57BL/6 mice. Non/loosely adherent 
and adherent BMDCs from both strains were responsive to LPS treatment; however, 
adherent BMDCs from both strains were once again more responsive to LPS than 
non/loosely adherent BMDCs (Fig. 6-6). Accordingly, the response of adherent BMDCs 
to PLGA films was higher than non/loosely adherent DCs in either strain as seen in 
increases in I-Ab expression in C57BL/10 mice and increases in CD86 expression in 
C57BL/6 mice (Fig. 6-6). Previously, non/loosely adherent BMDCs from C57BL/6 
analyzed following BMDC culture on PLGA films had exhibited significant signs of DC 
maturation as seen through increased CD80 expression (Yoshida et al. 2007), and here 
PLGA films also induced a slight but significant extent of DC maturation with an increase 
in I-Ab expression for non/loosely adherent BMDCs from the same strain (Fig. 6-6D). 
However, analysis of adherent BMDCs from the C57BL/6 mice seemed to show even 
greater responsiveness to the biomaterial treatment (Fig. 6-6E). Though a potent 
stimulator of maturation, such as a TLR ligand, may induce increases in maturation 
marker expression of non/loosely adherent BMDCs, a more moderate maturation 
stimulus such as a biomaterial (e.g. PLGA), which may only be partially in contact with 
this non/loosely adherent population, may not induce further maturation due to their 
more “pre-activated” condition (high MHC class II, CD80 and CD86 expression). 
However, adherent BMDCs which took on a more “immature” phenotype (low MHC class 
II, CD80 and CD86 expression), would more likely have the ability to respond to such a 
biomaterial stimulus and here displayed signs of DC maturation which was mostly 
absent in the non/loosely adherent BMDC populations (Fig. 6-6). Furthermore, the 
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increased response to PLGA of adherent BMDCs may be due in part to directly 
interacting with biomaterial surfaces through adhesion receptors or other pertinent PRRs 
(Babensee 2008; Shokouhi et al. 2010). Of note, however, is the lack of increase in 
expression of all DC maturation markers investigated following biomaterial treatment, 
which was found in response to LPS. As a practical assessment of adherent BMDC 
maturation, to assure that PLGA films induce functionally stimulatory DCs, biomaterial or 
LPS treated adherent or non/loosely BMDCs could be collected and utilized in an 
allogeneic mixed lymphocyte reaction. This would allow for investigation into whether 
biomaterial treatment produces activated adherent DCs, and also assess whether 
treated adherent BMDCs are more stimulatory than treated non/loosely adherent 
BMDCs, as anticipated. 
 Similar to the response of adherent BMDC treatment with LPS, culture of BMDCs 
in the presence of PLGA films also induced significant decrease in the expression of 
CD11c in the adherent BMDC fraction from C57BL/10 mice (but not C57BL/6 mice).  
Presumably, these strain-dependent differences in responses to PLGA films are due to 
some genetic differences [e.g. identified at multiple loci on chromosome 4 (McClive et al. 
1994)] even though the two strains are genetically related.  
 PLGA MP treatment of BMDCs, which has previously been found to increase 
expression of DC maturation markers on human monocyte-derived DCs (Yoshida and 
Babensee 2004; Yoshida and Babensee 2006), did not induce any significant sign of 
maturation in adherent or non/loosely adherent fractions of BMDCs from either 
C57BL/10 or C57BL/6 mice. In fact, adherent BMDCs from C57BL/10 exhibited 
significant decreases in I-Ab and CD86 expression while adherent BMDCs from C57BL/6 
displayed no significant changes in DC maturation marker expression when in contact 
with PLGA MPs (Fig. 6-6B,E). The lack of DC maturation marker expression level 
changes effects in response to PLGA MP in both non/loosely adherent and adherent 
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BMDCs from C57BL/6 (Fig. 6-6D,E) matches the previous response found of BMDC 
from this strain to PLGA MP (Yoshida et al. 2007). The contrary decrease in level of 
maturation marker expression on adherent BMDCs from C5BL/10 (as opposed to no 
alteration in BMDCs from C57BL/6) in response to PLGA MP may also be related to the 
genetic differences noted between the strains (McClive et al. 1994). 
 Treatment of BMDCs with LPS induced high levels of pro-inflammatory cytokine 
(TNF-!) secretion, while their treatment with PLGA films also significantly induced 
(though to a lesser degree) TNF-! secretion for BMDCs from both C57BL/10 and 
C57BL/6 mice. These results further illustrate the inflammatory and maturation-inducing 
effect of both LPS and biomaterial film treatment on BMDCs. PLGA MPs, however, did 
not induce production of TNF-! from BMDCs of either strain corresponding to the non-
inflammatory response exhibited by lack or down-regulation of DC maturation marker 
expression from adherent BMDCs from C57BL/6 or C57BL/10, respectively. Therefore, 
the physical form of PLGA may influence the response elicited by BMDCs. 
 In conclusion, the findings presented here show evidence that during the BMDC 
derivation in culture under the influence of GM-CSF/IL-4 stimulation, adherent BMDCs 
remained immature and more responsive to either pathogen or biomaterial stimulus. 
This is in contrast to non/loosely adherent BMDCs, which appeared to take on a mature 
phenotype, and while being susceptible to potent TLR ligand stimulation, were not as 
responsive to biomaterial treatments in PLGA film or MP form. With this it is suggested 
that the adherent BMDC population be characterized and assessed following BMDC 
treatment due to their more responsive nature, particularly for more moderate stimulating 




THE ROLE OF INTEGRINS IN THE RECOGNITION AND RESPONSE OF DENDRITIC 





Dendritic cells are sentinels continuously surveying the body for pathogens. 
Upon recognition and uptake of foreign entities, their status as professional antigen-
presenting cells (Banchereau and Steinman 1998; Steinman and Banchereau 2007) 
serves to link the innate immune response to an antigen-specific adaptive response. 
DCs possess PRRs, which aid in their response to foreign entities (e.g. pathogens) by 
binding pathogen-associated molecular patterns (PAMPs) (Janeway and Medzhitov 
2002; Akira et al. 2006). Upon recognizing PAMPs, DCs undergo a phenotypic shift from 
an immature (iDC) to a mature (mDC) state. As iDCs, they lack T cell stimulatory 
capacity (with low CD80/CD86 and major histocompatibility complex (MHC) class II 
surface expression), have a high phagocytic capacity and also have a rounded 
morphology. But upon maturation, DCs up-regulate CD80/CD86 as well as MHC II 
expression (Mellman and Steinman 2001; Reis e Sousa 2006; Steinman and 
Banchereau 2007). Mature DCs also have a low phagocytic capacity and possess a 
“dendritic” morphology for increased interaction with T cells (Steinman and Banchereau 
2007).  The other side of maintaining immune homeostasis is that interaction of T cells 
with iDC or tolerogenic DCs maintains or induces immune tolerance through induction of 
T cell anergy or regulatory T cell induction (Banchereau and Steinman 1998). Thus, DCs 
may activate or passivate an immune response accordingly depending on their 
phenotypic status.   
 
                                                
* Modified from Rogers TH, Babensee JE “The Role of Integrins in the Recognition and Response 
of Dendritic Cells to Biomaterials” (Biomaterials, 2010. doi:10.1016/j.biomaterials.2010.10.014) 
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Tissue engineered devices utilize a biomaterial delivery vehicle (e.g. scaffold or a 
microparticle) for a biological component (Stock and Vacanti 2001; Nerem 2006). The 
host response to a tissue engineered device is composed of a non-specific inflammatory 
response toward the biomaterial component and an antigen-specific immune response 
toward the biologic (Babensee et al. 1998; Babensee 2008). In the case of non-
autologous biologics, an immune response toward the therapeutic cell or protein is a 
major challenge, for example in tissue engineering (Nerem 2007), and we have 
previously found that the biomaterial scaffold may act as an adjuvant toward the co-
delivered biologic (Matzelle and Babensee 2004). Biomaterial scaffolds of PLGA induce 
significantly higher and longer lasting humoral immune response toward a model 
antigen, ovalbumin, than scaffolds made of agarose (Norton et al. 2010). We 
hypothesize that the biomaterial-induced adjuvant effect (or lack thereof) is due to the 
DC response within the complex non-specific inflammatory reaction toward the 
biomaterial in vivo (Babensee et al. 1998; Babensee 2008). Furthermore, we have found 
that DCs treated with biomaterials used in combination products in vitro differentially 
induce or inhibit DC maturation (Babensee and Paranjpe 2005; Yoshida and Babensee 
2006; Yoshida et al. 2007). PLGA or chitosan films induced maturation of DC as seen in 
increases in cytokine production and CD86 expression, while this effect was not 
observed when DCs were treated with hyaluronic acid or agarose films. This illustrates 
the importance of material selection for tissue-engineered devices or vaccine delivery 
systems as biomaterials may influence the immune response toward the co-delivered 
biologic.  
To begin to understand biomaterial-induced DC maturation, an investigation was 
undertaken to understand DC adhesion to biomaterials and its contribution to DC 
phenotype. This direction was suggested by preliminary observations that indicated an 
increase in DC adhesion on PLGA compared to other substrates (TCPS or agarose 
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films). Cellular adhesion to biomaterials has been extensively studied as it mediates 
cellular responses with beneficial effects (e.g. endothelial coverage on vascular grafts) 
or detrimental effects (e.g. fibrous encapsulation) (Anderson et al. 2008). The most well-
characterized adhesion molecules used by leukocytes to mediate their adhesion to 
biomaterials are integrins (Springer 1990), which are transmembrane heterodimer 
receptors composed of both ! and " subunits (Plow et al. 2000; Abram and Lowell 
2009). Leukocytes uniquely possess the "2 family of integrins (!L"2, !M"2, !X"2) which 
allow for transmigration in response to infection or inflammation (Anderson 2001). "2 
integrins have been shown to be involved in the adhesion of monocyte/macrophages to 
biomaterials (Davis 1992; Annenkov et al. 1996; McNally and Anderson 2002) and 
phagocyte accumulation on implants in vivo (Tang et al. 1996). Circulating or monocyte-
derived myeloid DCs, which are particularly relevant in the response to biomaterial 
implants, possess integrins of both the "1 and "2 family (McCarthy et al. 1997; Ammon et 
al. 2000). DC integrin-mediated adhesion to known ligands such as fibronectin 
(Swetman Andersen et al. 2006; Kohl et al. 2007) and fibrinogen (Thacker and Retzinger 
2008) pre-coated on material surfaces has been shown. Furthermore, while different 
plasma/serum protein substrates elicit similar DC adhesion, they are capable of 
differentially influencing cytokine production (Acharya et al. 2008); thus, different protein 
substrates may influence the response of DCs. As PRRs, !M"2 (complement receptor, 
CR3) and !X"2 (CR4) play a role in DC recognition of opsonized foreign entities, and 
CRs have been shown to play a role in monocyte recognition of a biomaterial (McNally 
and Anderson 1994). However, to date the role of integrin-mediated adhesion in 
substrate-induced DC maturation remains unknown.  
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Materials and Methods 
 
Biomaterial Preparation 
For more detailed description of biomaterial preparation, see CHAPTER 5. 
Briefly, 10% (w/v) PLGA (mole ratio 75:25, inherent viscosity 0.70 dL/g in 
trichloromethane; Durect/Lactel Absorbable Polymers, Birmingham, AL) was prepared 
(Yoshida and Babensee 2004). PLGA films (2mm in thickness) for use were punched 
out with arch punches for 24 well plates (9/16’’) or 6 well plates (5/4’’) and rinsed for 1h 
with sterile water. Films were allowed to dry in biosafety cabinet, sterilized with UV 
(30min each side) and rinsed with endotoxin free water immediately prior to use. PLGA 
films were tested for endotoxin content using Limulus Amebocyte Lysate (LAL) assay 
(QCL-1000, Lonza, Basel, Switzerland) with detected levels of approximately 0.1 EU/mL. 
Three percent (w/v) agarose (Type V) (Sigma) films were prepared by microwaving 
agarose/water suspension for 30s. This solution was then cast in plates and allowed to 
cool at 4oC for 30 min. The films were brought to room temperature for at least 1h before 
use in cell culture. Resulting films were distributed across the wells with an average 
thickness of 3mm (approximately 2mm in the center of well and 4mm at edges).  
 
Human Monocyte-Derived Dendritic Cell Culture 
Human peripheral blood was drawn from healthy donors with informed consent at 
Georgia Tech Student Health Center by trained phlebolotomist in accordance with 
Georgia Institute of Technology Institutional Review Board (IRB) protocol #H10011. 
Dendritic cells were differentiated from monocytes as previously described (Romani et 
al. 1996) with modifications (Yoshida and Babensee 2004). For detailed description of 
culture, please see methods section of CHAPTER 5 (Human Monocyte-derived DC 
Examination of Biomaterial Effects). 
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Dendritic Cell Treatment and RNA Extraction, cDNA Synthesis 
Dendritic cells were collected on Day 5 of culture and treated in 6 well plates 
(Costar) (Corning, Corning, NY) with fresh complete media as untreated iDC for negative 
control, treated with ultrapure-LPS (a TLR4-specific ligand, 1µg/mL) (InvivoGen, San 
Diego, CA) as a positive-control for maturation to provide mature DCs (mDCs), or 
cultured on PLGA or agarose films for 24h at 37oC and 5% CO2. Cell viability is routinely 
> 95% following treatment as assessed via propidium iodide staining or trypan blue 
exclusion.  Non-adherent DCs were collected by gentle pipetting and pooled together 
with adherent DCs which were collected by addition and pipetting with cell dissociation 
solution (Sigma, St. Louis, MO). This pooled fraction was then purified for DCs using 
magnetic bead isolation. Briefly, cells were incubated with dendritic-cell specific ICAM 
grabbing non-integrin (DC-SIGN) microbeads along with Fc-receptor blocking solution 
(Miltenyi Biotec) per manufacturer’s protocol, rinsed and passed through an LS column 
placed in a midiMACs (Miltenyi Biotec) magnet to purify DC-SIGN+ DCs and remove B 
cells. To assess purity, DC-SIGN+ fraction was double-stained with DC-SIGN-FITC (R&D 
Systems, Minneapolis, MN, clone 120507) and CD19-APC (Miltenyi Biotec, clone LT19). 
Final purified cell population was at least >95% DC-SIGN+ and <1% CD19+ (APPENDIX 
2).  
Purified DCs were used for RNA isolation using RNeasy Mini kit (Qiagen, 
Valencia, CA) according to manufacturer’s instructions. RNA concentration (A260nm) and 
quality (A260nm/A280nm > 2) was measured using NanoDrop 1000 (Thermo Scientific, 
Waltham, MA) and stored at -80oC. The Quantitect RT Kit (Qiagen) was used to prepare 
cDNA according to the manufacturer. For each DC treatment, 10ng of RNA (per single 
qRT-PCR reaction) multiplied by the number of reactions needed total was used for 
cDNA synthesis immediately following genomic DNA removal by DNAse I treatment 
(Qiagen). Reverse transcription was undertaken at 42oC for 20min in a water bath 
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followed by immediate placement in 95oC heat-block for 3min to inactivate reverse 
transcriptase. cDNA was then used for q-RT-PCR. 
 
Primer Selection and Gene Expression Analysis 
Integrins, adhesion molecules, integrin-related signaling molecules as well as two 
housekeeping genes (!-actin and !2-microglobulin) were selected for primer design 
partially based on known monocyte-derived DC integrin expression (Ammon et al. 2000). 
Primers were chosen using Harvard PrimerBank (Wang and Seed 2003) (Table 7-1) and 
appropriate forward and reverse pairs were chosen which minimized hairpin and primer-
dimer formation as assessed using NetPrimer (Premier Biosoft International, Palo Alto, 
CA), were less than or equal to 250bp in amplicon size and had a melting temperature 
(Tm) of approximately 60oC. Forward and reverse primer synthesis was outsourced 
(Sigma) and pairs pooled. For validation/sequencing, primer pairs (1µM final 
concentration) were used to amplify an iDC sample cDNA prepared using HotStarTaq 
Plus PCR kit (Qiagen) following manufacturer’s instructions. Amplicons were shipped 
overnight to Eurofins MWG Operon (Huntsville, AL) and sequences were validated using 
Basic Local Alignments Search Tool (BLAST) (Altschul et al. 1990). 
Following validation, primer pairs were then used for experimental analysis of 
relative gene expression. QuantiFast SYBR-Green PCR kit (Siegen) was used to 
measure PCR amplification of converted cDNA from each treatment via StepOne Plus 
RT-PCR system (Applied Biosystems, Carlsbad, CA). Briefly, cDNA from each treatment 
from a single donor was mixed with SYBR-green master mix and aliquoted into a single 
MicroAmp Fast Optical 96 well plate (Applied Biosystems) along with primer pairs (1µM). 
An initial activation step was performed at 95oC for 5 min followed 40 cycles of RT-PCR 
at 95oC for 10s and 58oC for 30s. Melt curve analysis was performed automatically 
following RT-PCR, and each gene product exhibited single-peak Tm’s. Baseline and 
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threshold level were set manually, and settings used were constant for each sample 
analyzed.  
Threshold cycles (Ct) for each gene were determined and normalized to the 
average Ct of !-actin and !2-microglobulin (!Ct) across treatments (which did not 
significantly change). Inter-donor comparison of up or down-regulation of gene 
expression was determined by comparing !Ct values from treated DCs for a specific 
gene with that of iDCs.  
Hierarchical cluster analysis was performed using Matlab (The Mathworks, 
Natick, MA) to perform a 2D clustergram using -!Ct data. Cluster analysis was 
performed using a Pearson correlation distance calculation for both genes and 
treatments. Heat maps were generated in Matlab but bin size and colors were manually 
chosen.  
 
Table 7-1: Primer pairs for integrins, adhesion molecules and related signaling 
molecules as well as house keeping genes. Primer pairs were chosen from Harvard 
Primer Bank (Wang and Seed 2003) with PrimerBank ID listed in table. For detailed 
information/sequences on each primer pair, please see 
http://pga.mgh.harvard.edu/primerbank/. 
 
Gene PrimerBank ID 
ITGB1 (CD29) 19743813a3 
ITGB2 (CD18) 4557886a1 
ITGAL (CD11a) 4504757a2 
ITGAM (CD11b) 4504759a3 
ITGAX (CD11c) 34452173a3 
ITGA4 (CD49d) 4504749a3 
ITGA5 (Cd49e) 4504751a1 










Intracellular/Extracellular Immunofluorescence of Adherent DCs 
Extracellular staining of adherent DCs was completed following culture of human 
monocyte-derived DCs in 24 well plates on TCPS surface or PLGA films. For noted time 
points, non/loosely-adherent cells were removed by aspiration and adherent cells were 
rinsed twice with cold PBS. Cells were then fixed in 4% paraformaldehyde in PBS 
(Polysciences Inc, Warrington, PA) for 10min and rinsed three times with PBS. Non-
specific sites were blocked with 3% human serum albumin (HSA) (EMD Chemicals, 
Darmstadt, Germany) in PBS at room temperature for 1h. A fluorochrome conjugated 
antibody for DC-SIGN-(FITC) (R&D Systems, clone 120507) was diluted in 3% HSA, 
added to wells and incubated for 2h at room temperature. Surfaces were rinsed three 
times in cold PBS and immediately mounted and coverslip added directly onto sample 
using ProLong Gold Antifade kit with DAPI (Invitrogen). Bright field and fluorescent 
images were taken using Nikon Eclipse Ti microscope (Nikon, Melville, NY). 
Early (1.5h) DC integrin (extracellular) and F-actin (intracellular) co-localization 
was monitored with immunofluoresence following DC treatment with PLGA films as 
described above with the following modifications. DCs were treated with PLGA films in 
24 well plates for 1.5hr, rinsed with PBS, and fixed with 4% paraformaldehyde in PBS for 
5min. Cells were permeabilized with 0.5% Triton X-100 (Sigma) for 10min, rinsed, and 
non-specific sites blocked with 5% FBS in PBS for 1hr, 37oC. Subsequently, cells were 
stained with either monoclonal !1-FITC (TS2/16, BioLegend, San Diego, CA) or 
monoclonal !2-FITC antibodies (TS2/18, BioLegend) in combination with phalloidin-
TRITC (Sigma) to visualize F-actin for 1h, 37oC in 5% FBS. Surfaces were then rinsed, 
and PLGA films were mounted on glass slides and images taken with Zeiss LSM 510 UV 
confocal microscope (Zeiss, Thornwood, NY). 
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Integrin Antibody-Blocking Experiments 
To undertake integrin antibody blocking, biomaterial treatments of DCs took 
place in 24 well plates (Corning Costar). Human DCs were cultured as before up to Day 
5 and collected and pre-treated with anti-integrin antibodies for 1h at 37oC prior to 
treatment on either TCPS or PLGA films for 24h. Monoclonal integrin blocking antibodies 
included: anti-!1 (Clone: P5D2; Abcam, Cambridge, MA), anti-!2 (Clone: TS1/18; 
BioLegend), anti-"M (Clone: 44 or CBRM1/5; BioLegend), anti-"L (Clone: HI111; 
BioLegend), anti-"X (Clone: 3.9; BioLegend), or isotype mouse IgG1,# (BioLegend). All 
antibodies came purified and endotoxin-free except for anti-!1 which was purified using 
Protein G column (Pierce) and dialyzed in sterile D-PBS for 2h to remove contaminants. 
Anti-!1 and anti-!2 pre-treatment on TCPS or PLGA were initially tested at increasing 
concentrations ranging from 10-120µg/mL to determine appropriate blocking 
concentration. !1 antibodies were used then at 10µg/mL while anti-!2 antibodies were 
used at 10, 20 or 40 µg/mL, as noted in text. 
The effect of integrin blocking on DC adhesion was first assessed 
microscopically.  Images were taken of DCs at 3 and 24h on TCPS and PLGA 
substrates using an Axiovert 135 (Zeiss). Also, the effect of integrin blocking was 
assessed via cell counting of non/loosely adherent DCs. The number of adherent DCs 
was not directly assessed because adhesion to TCPS was, for some donors, extremely 
limited, yielding difficult analysis of adherent cell counts. At 24h, non/loosely-adherent 
DCs were collected by rocking and gentle pipetting of DCs off the surface. Non/loosely 
adherent DCs were counted using Multisizer 3 Coulter Counter (Beckman Coulter, Brea, 
CA) analyzing population between 10-20µm in diameter only. These DCs were pelleted 
by centrifugation at 400g for 10min while the remaining adherent DCs were collected 
using addition of cell dissociation solution (Sigma), pipetting and incubation at 37oC to 
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remove DC from the surfaces. Adherent and non/loosely adherent DCs were pooled 
together and stained with anti-CD86-PE (Ancell, Minneapolis, MN) for 1h, 4oC to assess 
DC maturation. DCs were also double stained when necessary with CD86-PE/!2-FITC 
(BioLegend) or CD86-PE/!1-FITC (BioLegend) to indirectly test the binding of anti-!2 or 
anti-!1 blocking antibodies as well as level of maturation with CD86. Flow cytometry was 
then performed, and DC population gated on the FSC/SSC plot for analysis of CD86 
expression. For TCPS-cultured DCs, CD86 expression was defined as “low” (CD86low 
gate) if CD86 levels were below an intensity of 50. For PLGA-treated DCs, using the 
same setting for flow cytometry, since CD86 expression increases on the activating 
biomaterial PLGA, the CD86low gate was doubled to include any cell with intensity below 
100. The percentage of total DCs in the CD86low gate (defined as “% immature DCs”) 
was then normalized for each pre-treatment to the levels found on isotype. 
 
Integrin Cross-linking to Biomaterial Surface 
To demonstrate direct integrin engagement at the DC-biomaterial interface, a 
cellular-substrate cross-link was performed and integrins visualized (Keselowsky and 
Garcia 2005). Specifically, DCs were cross-linked to PLGA using an amine reactive 
cross-linker with a 12Å spacer arm length, DTSSP (3,3´- Dithiobis 
[sulfosuccinimidylpropionate]) (Pierce, Rockford, IL). For this method, DCs were treated 
with PLGA films in 24 well plates for 1.5h and subsequently non-adherent cells were 
removed via D-PBS rinses. Adherent DCs were then cross-linked to PLGA surface via 
1mM DTSSP in 2mM glucose in D-PBS (30 min, room temperature). Unreacted DTSSP 
was then quenched with 50mM Tris (Sigma) in D-PBS (15min). Non-cross-linked cellular 
material was then extracted in 0.1% sodium dodecyl sulfate (SDS, Sigma) with 
350!g/mL phenylmethylsulfonyl fluoride (Sigma) in D-PBS. Surfaces were then rinsed 
with D-PBS, and blocked with 5% FBS in PBS for 1h, 37oC. For this experiment only, 
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polyclonal goat anti-human antibodies against !1 and !2 integrins (both from R&D 
Systems, Minneapolis, MN) were incubated at 1:400 dilution in 5% FBS for 1h, 37oC. 
Following three D-PBS rinses, surfaces were incubated with donkey anti-goat-FITC 
secondary antibody (kindly provided by Dr. Robert Nerem of Georgia Institute of 
Technology) at 10!g/mL (Invitrogen) in 5% FBS for 1h, 37oC. Surfaces were rinsed, 
mounted as previously described and surfaces visualized with LSM 510 UV confocal 
microscope (Zeiss). Non-cross-linked controls were also performed as negative controls 
and yielded no positive integrin staining, indicating cross-linking was necessary to detect 
integrins engaged by the material surface. 
 
Statistical Analysis 
For statistical analysis of DC adhesion and maturation data, an ANOVA analysis 
was performed (GraphPad, LaJolla, CA) using Tukey-post test (p<0.05) with donors 
nested within treatment (n=5-8). When comparing data to a normalized value (1), a two-




To initially investigate the level of DC adhesion to biomaterials, the adherent cell 
fraction on either TCPS or PLGA surfaces was imaged using microscopy. Adherent cells 
on both substrates were fixed and stained with DC surface marker (DC-SIGN) to assure 
the specific assessment of DCs. As shown in Figure 7-1, DCs present on TCPS surface 
mostly appeared round in morphology (Fig. 7-1A). This is in contrast to DCs treated with 
PLGA films, which showed more cellular adhesion to the surface and nearly all DCs 
exhibited dendrites reaching over 100µm (Fig. 7-1B). On both substrates, each adherent 
cell was DC-SIGN+ (a human DC marker) (Fig. 7-1C,D) while being negative CD19 (B 
cells) (APPENDIX 6, Fig, A6-1), a contaminating cell population in this culture system.  
 
 
Figure 7-1: Adherent DC morphology on TCPS or PLGA films. DCs were cultured on 
TCPS (A,C) or treated with PLGA films (B,D) for 24h, stained with DC-SIGN-FITC and 
DAPI for nuclei visualization (representative of n=3). Microscopy was performed at 20X. 
Scale bar denotes 100!m. 
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In order to pinpoint adhesion molecules potentially responsible for the recognition 
of biomaterials by DCs, a gene expression analysis was undertaken to determine how 
DC adhesion and/or DC activation influences integrin and other adhesion molecule 
mRNA expression (chemokine receptor expression was also examined simultaneously, 
with results in APPENDIX 4). Dendritic cells were cultured on TCPS as a negative 
control for iDC, treated with PLGA or agarose films (Babensee and Paranjpe 2005; 
Yoshida and Babensee 2006), or cultured on TCPS and stimulated with ultrapure-LPS 
as a positive control for mDCs. As shown in Figure 7-2, DCs cultured on TCPS (iDC) or 
treated with agarose films showed similar gene expression patterns (qualitative analysis 
as seen through tight cluster) across all adhesion-related molecules investigated. In 
contrast, the activating treatments of PLGA films or ultrapure-LPS (mDC) clustered 
together, though to a lesser extent than agarose and TCPS (Fig. 7-2). Adhesion-related 
signaling molecules (such as FAK) were down-regulated in response to ultrapure-LPS 
but unaffected upon PLGA treatment. There was a noted difference in the integrin gene 
expression pattern to PLGA and ultrapure-LPS. While ultrapure-LPS induced down-
regulation of integrin subunits (!M, "1, "2, !X, and !5), PLGA treatment induced an up-




Figure 7-2: Hierarchical cluster analysis of RT-PCR (-!Ct) data for integrins and 
adhesion-related signaling molecules in DCs cultured on TCPS (iDC), treated with 
ultrapure-LPS (mDC), or treated with PLGA or agarose films for 24h. Heat map and 
2D cluster analysis were performed using Matlab clustergram function assuming 
Pearson correlation distance calculation for both genes and treatments. Scale bar and 









Next, the role of integrin families was investigated in DC adhesion to biomaterials 
using antibody-blocking techniques to inhibit !1 and !2 integrin family members.  DC 
adhesion was measured by assessing the number of non/loosely adherent DCs (an 
inverse measurement of the number of cells adhering to the substrates) and compared 
to isotype control treatments. An anti-!1 blocking antibody (clone P5D2) was unable to 
affect extent of DC adhesion to both serum-coated (from the culture medium) TCPS or 
PLGA (Fig. 7-3A) but was able to inhibit DC adhesion and spreading to plasma 
fibronectin (pFN) coated glass cover slips (Fig. 7-4) which has been shown by others 
(Swetman Andersen et al. 2006), demonstrating functionality of the mAb with this ligand 
pre-coating. Two other monoclonal anti-!1 blocking antibodies (clones AIIB2 and JB1A) 
were similarly unable to inhibit DC adhesion to TCPS or PLGA (data not shown). Anti-!2 
pre-treatment using blocking mAb TS1/18 (Beals et al. 2001), however, at all 
concentrations investigated (10, 20 and 40!g/mL) was able to inhibit adhesion of DCs to 
both TCPS and PLGA films (Fig. 7-3B,C) to levels significantly above isotype controls. 
The binding ability of anti-!2 was confirmed via flow cytometry using a fluorescently 
labeled antibody of the same clone which was unable to bind to DCs when pre-treated 
with anti-!2 but successfully bound in the presence of isotype (Figure 7-5). The 
morphology of DCs treated with PLGA films was altered from being adherent and spread 








Figure 7-3: !1 or !2 integrin antibody blocking of DCs cultured on TCPS or treated 
with PLGA films for 24h. (A) Anti-!1 (or isotype) at 10µg/mL treatment was performed 
and DCs were subsequently on cultured on TCPS or treated with PLGA films for 24h. 
Non/loosely adherent DCs were collected and counted and values were normalized to 
that of isotype control (n=2 independent determinations, mean+range). (B) DCs were 
cultured on TCPS for 24h following anti-!2 (or isotype) at 10, 20 or 40µg/mL treatment. 
Non-adherent DCs were collected, counted and averaged. Star indicates statistical 
difference from respective isotype and TCPS control (ANOVA, p<0.05) (n=5 
independent determinations, mean+s.d.) (C) DCs were cultured on PLGA for 24h 
following anti-!2 (or isotype) at 10, 20 or 40µg/mL treatment. Non-adherent DCs were 
collected, counted and averaged. Star indicates statistical difference from respective 
isotype and PLGA control (ANOVA, p<0.05) (n=5 independent determinations, 
mean+s.d.) (D&E) Morphology of DCs cultured on PLGA following isotype (D) or anti-!2 




Figure 7-4: Functionality of the purified anti-!1, the ability to block known !1-
mediated DC adhesion to plasma fibronectin (pFN). Briefly, autoclaved glass cover 
slips were coated overnight (in 24 well plates) with 10!g/mL human pFN (Sigma) in 
Hank’s balanced salt solution (HBSS) or HBSS only as negative control. DCs at a 
concentration of 100,000/mL were then pretreated for 1h with anti-!1 (P5D2) in complete 
DC media. DCs were then cultured on pFN-coated glass slides for 2h, and non/loosely 
adherent DC counts were collected and normalized to that collected from glass alone 
with no pFN-coating (A), mean+s.d. Representative micrographs (n=3) are shown of 
DCs adhering to pFN in absence of pretreatment (B), pretreated with isotype (C) or 
anti-!1 (D) antibody. Stars indicate statistical difference between values and glass alone 
(1), Student t-test, p<0.05. Brackets designate statistical difference between groups, 
ANOVA p"0.05 (n=3). 
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Figure 7-5: !2 integrin antibody staining on DCs following anti-"  and anti-!2 pre-
treatments and treatment with PLGA films for 24h. DCs were stained with anti-!2-
FITC (TS1/18) and expression levels determined via flow cytometry (GMFI) and 
normalized to that of isotype control.  Star indicates significantly lower !2 staining from 
that of isotype control, Student t-test, p!0.05 (n=3-4). 
 
 
To investigate whether !2-mediated DC adhesion plays a role in biomaterial-
induced DC maturation, CD86 expression was also examined in !2-blocked DCs 
cultured on TCPS or treated with PLGA films. On both substrates, a CD86low population 
was associated with DCs that were pre-treated with anti-!2, which exemplifies the 
appearance of immature DCs (Fig. 7-6A). The percentage of DCs in the CD86low gate 
(shown in Fig. 7-6A, B) was normalized to that of isotype controls for each donor and 
averaged for quantification. With increasing concentrations of anti-!2, DCs became more 
“immature” as the percentage of CD86low DCs increased for DCs cultured on TCPS or 
treated with PLGA and particularly at 40"g/mL exhibited significantly higher levels of 
“immature” DCs on both substrates (Fig. 7-6C).  
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Figure 7-6: DC maturation marker (CD86) expression following anti-!2 treatment. 
Representative flow cytometry results of DC CD86 expression at 24h treatment on 
TCPS (A) or PLGA (B) following pre-treatment of 40!g/mL of anti-!2 (blue), isotype 
(green) or no treatment (red). CD86low gate for PLGA was double that of TCPS since 
PLGA induces increases in CD86 expression. (C) The percentage of DCs in CD86low 
gate was determined for each donor and normalized to that of isotype controls for each 
concentration examined. Star denotes statistical difference from isotype (1), Student T-
test p"0.05 (n=5, mean+s.d). 
 
 
To attempt to identify the " subunit ("L, "M and "X) which pairs with !2 and 
determine the complete integrin molecule responsible for DC adhesion and activation by 
biomaterials, antibody-blocking techniques were also explored. Blocking antibodies 
against "L, "M and "X were used along with anti-!2 and the number of non/loosely-
adherent DCs were measured as well as the percentage of CD86low DCs for DCs treated 
with TCPS or PLGA. For DCs cultured on TCPS, antibodies toward "L, "M or "X alone or 
in combinations with each other were not able to alter extent of DC adhesion (Fig. 7-7A). 
Once again, blocking !2 alone (or in combination with "L or "X) significantly increased 
the number of non/loosely-adherent DCs (therefore, decreasing the number of adherent 
DCs) (Fig. 7-7A). Surprisingly, anti-"M treatment seemed to lessen the inhibitory capacity 
of anti-!2 to prevent adhesion, which was found to possess similar levels of adhesion to 
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that of isotype (Fig. 7-7A). As expected, the inhibition of DC adhesion to TCPS by !2 
antibody-blocking matched the reduction in CD86 expression (Fig. 7-7B). Dendritic cells 
pre-treated with antibodies toward "L, "M or "X showed no shift in the percentage of 
iDCs (CD86low) while DCs pretreated with anti-!2 (or in combination with "L or "X) 
exhibited a significant increase in the percentage of iDCs (Fig. 7-7B). Also, the anti-"M 
pre-treatment, which seemed to prevent anti-!2 from inhibiting adhesion, similarly 
appeared to reduce anti-!2 lowering in CD86 expression by DCs on TCPS to levels 
found with isotype. For PLGA treatments, similar results were found in that while " 
subunit antibody-blocking did not affect adhesion (Fig. 7-8A) blocking !2 alone, or in 
combination with "X but not "L, significantly decreased adhesion and simultaneously 
lowered CD86 expression (Fig. 7-8A,B). Surprisingly, anti-"M in combination with either 
anti-"L or anti-!2 showed a slight but significant lowering (compared to isotype) in 
percentage of CD86low DCs on PLGA which was not found for DCs cultured on TCPS. 
Overall, while anti-!2 pre-treatment affected adhesion to a similar degree on both TCPS 
and PLGA films, it was not as effective in lowering CD86 expression in DCs treated with 
PLGA as for DC cultured on TCPS (Fig. 7-7B and 7-8B). 
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Figure 7-7: DC adhesion (A) and maturation (B) level following anti-!L/!M/!X and/or 
anti-"2 blocking on TCPS. (A) Following anti-!L/!M/!X blocking in combination with anti-
"2 (each at 20!g/mL) as denoted by table (+) under graph, non-adherent DC counts 
were collected. Values were normalized for each donor to that of isotype (1), n=8, 
mean+s.d. (B) Following anti-!L/!M/!X blocking in combination with anti-"2 as denoted by 
table (+) under graph, the percentage of DCs in CD86low gate was determined by flow 
cytometry and normalized to that of isotype (n=6-8, mean+s.d). Stars for (A) & (B) 
denote statistical difference from all anti-! combination treatments (ANOVA, p<0.05). # 
designates statistical difference from isotype (1), Student T-test p"0.05. 
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Figure 7-8: DC adhesion (A) and maturation (B) level following anti-!L/!M/!X and/or 
anti-"2 blocking data on PLGA. (A) Following anti-!L/!M/!X blocking in combination 
with anti-"2 (each at 20!g/mL) as denoted by table (+) under graph, non-adherent DC 
counts were collected. Values were normalized for each donor to that of isotype (1), n=5-
6, mean+s.d. (B) Following anti-!L/!M/!X blocking in combination with anti-"2 as denoted 
by table (+) under graph, the percentage of DCs in CD86low gate was determined by flow 
cytometry and normalized to that of isotype (n=5-6, mean+s.d). Stars for (A) denote 
statistical difference from all lower values (ANOVA, p<0.05). X indicates statistical 
difference from anti-!L + anti-!M (ANOVA, p<0.05). Arrows for (B) indicates statistically 
above or below isotype (1), Student t-test p"0.05. 
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Lastly, to further verify the role of integrins in DC adhesion to biomaterials, both 
!1 and !2 integrin expression and their direct interaction with PLGA films was visualized 
on PLGA-adherent DCs using confocal microscopy. As shown in Figure 7-9, DCs 
expressed low levels of !1 integrins which did not appear to co-localize with F-actin (Fig. 
7-9A) in DC podosomes. In contrast, co-localization of F-actin with !2 was commonly 
present in DCs at the sites of adhesion and spreading on PLGA (Fig. 7-9B). 
Furthermore, cross-linking adherent DCs to the surface of PLGA and removing non-
cross-linked cellular components via an SDS solution showed high-levels of !2 presence 
at the cross-linked contacts between DCs and PLGA (Fig. 7-9D). The outlines of DC 
remnants on PLGA were visible with !2 visualization but were not observed when 






Figure 7-9: !1 vs. !2 integrin expression on DCs adhering to PLGA films. DCs were 
allowed to adhere to PLGA films for 1.5h and subsequent were fixed, permeabilized and 
stained with either anti-!1-FITC (A) or anti-!2-FITC (B) both (green) in combination with 
phalloidin-TRITC (red) and nuclei (blue). White arrowheads indicate areas of co-
localization. To examine receptors at DC-biomaterial interface alone, DCs were treated 
with PLGA films for 1.5h and cross-linked to surface using DTSSP. Non-cross-linked 
components were then extracted using 0.1% SDS. Polyclonal antibodies (goat) against 
!1 (C) or !2 (D) were used in combination with anti-goat-FITC secondary to detect 
integrin presence remaining on films. All films were imaged using confocal microscopy at 






The results presented in CHAPTER 7 illustrate the role and significance of !2 
integrins in the recognition and response of DCs to biomaterials. A biomaterial which 
supports maturation of DCs, such as PLGA, induced up-regulation of integrin adhesion 
molecules which is in contrast to the response to surfaces that do not support DC 
maturation such as agarose or TCPS (Fig. 7-2). This may be related to the increase in 
DC adhesion which occurred on PLGA in comparison to TCPS substrate (Fig. 7-1). 
Using antibody-blocking techniques, adhesion to both TCPS and PLGA was found to be 
!2-dependent (Fig. 7-3B and 7-3C) and !1-independent (Fig. 7-3A) which has similarly 
been shown for monocytes (McNally and Anderson 2002). Notably, a role for !2 was 
found not only in adhesion but also in contributing to determining the state of DC 
maturation as the percentage of CD86low expressing DCs was significantly increased 
during !2 antibody blocking of DCs on both TCPS and PLGA substrates (Fig. 7-6, Fig. 7-
7, & Fig. 7-8). Biomaterial integrin-mediated adhesion in leukocytes has been 
established for monocytes/macrophages and neutrophils (Davis 1992; McNally and 
Anderson 1994; McNally and Anderson 2002; McNally et al. 2007). Particularly, !2 
integrins (but not !1) are present on monocytes at early time points (1.5h) during 
adhesion to biomaterials (McNally and Anderson 2002). The current work adds to the 
field of biomaterials by illustrating the importance of !2 integrins at not only mediating 
adhesion of DCs to biomaterials but also more importantly contributing to their 
maturation state.  
Possible "-subunits ("L, "M, "X) were also targeted to determine which may pair 
with !2 to mediate such DC response to biomaterials; however, no subunit examined 
appeared to affect either adhesion or maturation on TCPS (Fig. 7-7) or PLGA (Fig. 7-8). 
This may be due to anti-" antibodies not binding the appropriate epitope for effective 
142  
inhibition of adhesion of DCs to biomaterials. Also, while double combinations of anti-! 
antibodies were tested (Fig. 7-7 and Fig. 7-8), it is possible that compensatory 
mechanisms across distinct integrin family members were contributing to adhesion when 
only one or two ! subunits were blocked. A triple cocktail of anti-(!L, !M, !X), which was 
not tested, may prevent these compensations and potentially decrease adhesion of DCs 
to biomaterials. However, anti-"2 treatment in combination with anti-(!Lor !X) still lowered 
extent of adhesion and the state of maturation on TCPS (Fig. 7-7) and on PLGA (Fig. 7-
8). Anti-!M treatment either inhibited or counteracted the effect of anti-"2 and maintained 
levels of DC adhesion and maturation to that of isotype controls. One possible 
explanation is that anti-!M may preclude anti-"2 binding through steric hindrance, as 
noted with flow cytometry for "2 antibody-staining which is somewhat lowered in the 
presence of anti-!M (Fig. 7-5). This seems likely as anti-!M did not appear to affect DC 
adhesion or maturation on its own. To assure this, another blocking mAb for !M (clone 
CBRM1/5, (Oxvig et al. 1999)) was also examined and was found to not prevent DC 
adhesion to TCPS while also inhibiting anti-"2 binding to DCs (data not shown). Though 
this seems to potentially indirectly link !M to "2-mediated DC adhesion to biomaterials, 
others have shown that MAC-1 (!M"2) requires !M for spreading while adhesion is 
primarily mediated through the "2 subunit (Solovjov et al. 2005). Here, anti-!M treatment 
did not lower the extent of DC spreading on biomaterials though it did induce slight 
clustering (data not shown).  
Interestingly, "1 and "2 mRNA were both up-regulated in DCs treated with PLGA 
(Fig. 7-2); however, a role for "1 was not found while utilizing three known "1 blocking 
monoclonal antibodies (P5D2 as well as JB1A, AIIB2). Dendritic cell adhesion to pFN-
coated glass, however, was found to be "1-dependent (Fig. 7-4) as has been previously 
shown (Swetman Andersen et al. 2006) which suggests that DC adhesion to the 
143  
complex serum-adsorbed surfaces on biomaterials may be !1/FN-independent. The 
results received through mRNA expression analysis emphasize the need, particularly for 
integrins, for investigation at the protein level but even further at the cell surface using 
antibody-blocking or through other techniques such as RNAi. However, it is possible that 
at times greater than 24h, not studied here, that !1 protein and surface expression 
becomes relevant. !1 integrin expression has been shown to increase and become a 
relevant factor in adhesion as biomaterial-adherent monocytes differentiate into 
macrophages at one week (McNally and Anderson 2002). Dendritic cells also have 
higher levels of expression of !2 than macrophages (Ammon et al. 2000). These may be 
important and applicable differences between macrophage and DC interactions with 
biomaterial surfaces. Biomaterials, designed to limit !1-mediated adhesion, may allow for 
DC presence via !2 but avoid macrophage and foreign-body giant cell accumulation via 
!1.   
It appears that for DCs, !2-mediated adhesion is a requirement for biomaterial-
induced maturation. Furthermore, even the less-adhesive and less-activating substrate 
TCPS may require a basal level of !2 signaling to maintain CD86 expression (Fig. 7-3B). 
This is an important finding not only for the biomaterials and tissue engineered device 
community, but also indicates how DCs in general may utilize integrins to maintain their 
immunostimulatory capacity. It is accepted that DC adhesion and migration ability is 
heavily influenced by the maturation state. However, these results indicate there is 
interplay between adhesion and maturation. Others have found that particular adhesive 
protein substrates, such as collagen (Brand et al. 1998) and many others (Acharya et al. 
2008), can induce increases in DC stimulation of T cells. In the current work, the 
biomaterial component is manipulating the DC phenotype through potentially numerous 
adhesive ligands presented as part of the adsorbed protein layer on biomaterials. 
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Surface chemistry of biomaterials is known to influence protein adsorption and 
conformation to potentially influence differential cellular integrin engagement at the 
surface (Keselowsky et al. 2003; Keselowsky et al. 2005). Substrate physical properties 
such as elasticity and hydrophobicity may contribute to both cellular adhesion and 
subsequent gene expression by altering the adsorption and presentation of adhesive 
serum ligands for !2 integrins such as FN or inactive complement component 3 (iC3b) 
(Wilson et al. 2005; Engler et al. 2006). The PLGA 75:25 material used herein is more 
hydrophobic than TCPS (71.6o (Yoshida and Babensee 2006) versus 59o (Nuryastuti et 
al. 2009) contact angle, respectively). Others have found that PLGA 50:50, which has an 
equivalent contact angle to TCPS, 60o (Lam et al. 2002), does not alone induce DC 
maturation in vitro (Sharp et al. 2009). Thus, hydrophobicity of PLGA 75:25 may explain, 
in part, why DC adhesion is more prevalent on this composition of PLGA and also 
potentially why expression levels of CD86 was more difficult to lower for DCs treated 
with PLGA following !2 blocking than for DCs cultured on TCPS.  
The visualization of integrin presence for DCs upon contact with PLGA films was 
investigated at an early time point (1.5h) to further verify the role of !2 integrins in DC 
adhesion and spreading on a biomaterial surface. !2 was found in preferentially high 
levels at podosomes in contact (within 12Å) with biomaterials and co-localized with F-
actin (Fig. 7-9B,D). In contrast, the distribution of !1 was not able to be determined 
through this cross-linking to PLGA from adherent DCs and was found independent of 
actin (Fig. 7-9A,C). The morphology and expression patterns are very similar to what 
has been found on DC podosomes present when cultured on FN-coated surfaces which 
exhibit !2, "M, "X and actin co-localization while being absent of !1 (Burns et al. 2004). 
Here, the authors did not examine the effect of FN-coating on maturation marker 
expression, but DCs cultured on FN-coated surfaces did appear at least morphologically 
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similar to DCs treated with PLGA films (Fig. 7-4). While !1 binding to FN is well known 
(shown in Fig. 7-4), !2 integrins, particularly "M!2, have also been established as 
receptors for FN (Lishko et al. 2003). Thus, the !2-mediated adhesion to FN may be one 
possible ligand present upon serum-adsorption to biomaterials, which may play a role in 
the adhesive response of DCs. Other ligands for !2-integrins include fibrinogen and 
iC3b; the former is unlikely to be present in the serum used here for culture and active 
complement activation was prevented by heat inactivation of the serum, but activation 
fragments could adsorb to the surfaces to mediate recognition. 
Lastly, the intracellular link between integrin engagement and DC maturation 
remains unknown. In monocytes, integrin adhesion to ECM components (such as FN) is 
known to stimulate nuclear factor (NF)-#B and Jak/STAT signaling pathways (de 
Fougerolles et al. 2000). The NF-#B pathway plays a particularly important role in 
inflammatory signaling and, in DCs, controls the expression of numerous DC maturation 
markers such as CD80 and CD86 (van Vliet et al. 2007). The link between DC integrins 
and NF-#B is less characterized; however, DCs which were treated with PLGA films for 
24h, did not show increases in activated NF-#B presence in nuclear extracts (Yoshida 
and Babensee 2006). This implies that either NF-#B is not involved in DC adhesion-
induced maturation or that NF-#B activation occurs earlier than 24h. However, another 
explanation is that adhesion alone is not enough to activate DCs, and adhesion simply 
allows for other co-receptors to be localized to biomaterial surface for engagement. As a 
an example, toll-like receptor (TLR)-4, a PRR which can recognize not only LPS but 
many proteins such as fibrinogen (Rock and Kono 2008) and induce DC maturation, is 
one such potential receptor. In fact, TLR4 has been shown to play a role in leukocyte 
recognition of biomaterials as TLR4-deficient mice display a delayed biomaterial-
adherent leukocyte profile (Rogers and Babensee 2010). Integrin subunit "M (CD11b) 
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has recently been found to negatively regulate TLR triggered inflammatory responses 
(Han et al. 2010); however, the role of other ! subunits and "2 in TLR signaling remain 
unknown. Here anti-"2 and isotype pre-treated DCs yielded a similar increase in CD86 
expression upon treatment with ultrapure-LPS (data not shown), implying "2 inhibition 
may not have influenced TLR4 responsiveness. Overall, while integrin-mediated 
adhesion may be required for DC maturation in response to biomaterials, other co-
receptors may contribute to the state of DCs in contact with biomaterials. 
In conclusion, we have shown that DC integrin-mediated adhesion to 
biomaterials plays a role in determining the maturation state of DCs. "2-integrins (but not 
"1) were involved in DC recognition of both TCPS and PLGA films and blocking "2 
lowered the extent of induced maturation of DCs. This has important relevance in 
determining criteria for material selection in the field of vaccine design and in the field 




CONCLUSIONS AND FUTURE WORK 
 
 
Understanding events required for the initial host recognition of biomaterials is 
critical in design and implementation of effective biomaterial treatments and applications. 
In particular, elucidation into the mechanism behind the inflammatory response to 
biomaterials and its role in the adjuvant effect would be of utmost importance to material 
selection for tissue-engineered devices. Since DCs function in vivo to initiate an adjuvant 
response by linking both an increased innate response to a heightened adaptive immune 
response, the direct receptor recognition of biomaterials by DCs was investigated. 
Dendritic cells possess many PRRs, which bind not only PAMPs but also many 
endogenous molecules (‘danger signals’ or DAMPs), which are capable of leading to an 
adjuvant effect by increasing DC maturation. The objective of this thesis research was, 
in part, to investigate the relevance of biomaterial-associated DAMPs in the overall host 
response to an implant in vivo and the response of DCs to biomaterials in vitro. The 
interactions between host and DC receptors to these endogenous molecules were 
isolated through the investigation of TLR4. Concurrently, an attempt was made to probe 
biomaterial surfaces in vitro for serum ‘danger signal’ adsorption. A major finding of this 
thesis was that TLR4 contributes to the acute inflammatory response to a biomaterial 
implant in vivo. TLR4-deficient mice possess a delayed adherent leukocyte profile on the 
biomaterial surface in comparison to TLR4+ mice. It is believed that biomaterials may act 
as a depot for DAMPs that are potentially induced following the surgical implantation 
procedure or produced in situ at the biomaterial-interface through adsorption-induced 
protein denaturation. Biomaterials may, thus, present DAMPs to leukocytes and 
stimulate acute inflammatory signaling through TLR4; however, other compensatory 
receptors (potentially other TLRs) may also contribute as seen in the perpetuation of 
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chronic inflammation (fibrous capsule formation) in TLR4-deficient mice. This finding 
further adds complexity to the body’s response to a biomaterial and how it recognizes a 
material as a foreign object. The major implication may be that molecules produced by 
an implantation procedure potentially contribute, at least initially, to the body’s response 
to an implant. Therefore, it is hypothesized that minimizing implant-induced production of 
DAMPs, through use of minimally invasive surgical techniques, may potentially lessen 
TLR4’s contributions to acute inflammation.   
Also, as DC adhesion and integrin expression increased following culture on 
PLGA but not agarose films in vitro, which mimicked the humoral immune response 
induced by these biomaterials (Matzelle and Babensee 2004; Norton et al. 2010), an 
investigation into integrin-mediated adhesion in biomaterial-induced DC maturation was 
employed. Overall, these experiments presented herein aimed to investigate, at the cell 
receptor level, how the body’s innate response toward a biomaterial may influence its 
adaptive immune response to a co-delivered biologic.  
One of the major findings of this thesis work was that !2 integrin-mediated 
adhesion to biomaterials contributes to the state of DC maturation. DCs appeared to be 
utilizing !2 integrin family members to recognize and respond to biomaterial substrates in 
a manner that has previously not been identified. This may be an important finding for 
potentially predicting the adjuvanticity of a biomaterial utilized in a tissue-engineered 
construct. PLGA, which has been found to elicit an increased immune response to a co-
delivered biologic, displayed increased levels of !2 mediated adhesion by DC in vitro. It 
is believed that increased DC adhesion in vivo may contribute to increased maturation 
and subsequent elicitation of an immune response. Agarose, which does not display 
similar adjuvanticity to a co-delivered biologic, does not elicit high levels of DC adhesion 
in vitro. Therefore, it is hypothesized that appropriate material selection for a tissue-
engineered construct may depend on minimizing the level of DC adhesion in order to 
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minimize the biomaterial-induced mediation of the immune response. However, in the 
context of a biomaterial vaccine-delivery vehicle, an increased immune response would 
be appropriate, and thus, DC recognition and adhesion to a biomaterial would likely be 
maximized.  
Though an overriding biomaterial property contributing to DC adhesion is 
unknown, it is believed that material properties do influence the adsorption and 
presentation of plasma/serum proteins to DCs. In the context of this thesis, it is believed 
that the hydrophobicity of a biomaterial (as stated in CHAPTER 7) may influence the 
level of DC adhesion to a biomaterial, and thus influence a subsequent supported 
immune response to an associated biologic. The level of DC adhesion and maturation 
correlates to increases in contact angle across agarose (0o), TCPS, (60o) and PLGA 
(72o). A major roadblock for determining the contribution of hydrophobicity to DC 
maturation across these materials rests in their diverse surface chemistry. The degree of 
hydrophobicity and its influence on DC adhesion and maturation across one particular 
material, such as PLGA, may potentially be examined by treating DCs with PLGA with 
differing lactide to glycolide ratios, which would alter hydrophobicity utilizing similar 
surface chemistry. Across differing materials, however, no single surface property may 
be isolated for comparison without modifying their surface chemistry. Therefore, isolating 
a single surface property of biomaterials, which both influences DC adhesion and helps 
modulate an immune response, is not likely to be successful.   
Another major finding of this thesis was that TLR4 played a role in the acute 
inflammatory response to a biomaterial implant as seen in the altered adherent 
leukocyte profile (Fig. 4-4), which seemed to be surface dependent as the milieu 
surrounding the implant (lavage) displayed similar leukocyte profiles across TLR4+ and 
TLR4- mice (Fig. 4-2). It is hypothesized that biomaterial-associated ‘danger signal’ 
molecules mediated these effects. Further examination into potential murine 
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endogenous molecules, which potentiate this response, would be beneficial. PET discs 
should be pre-adsorbed with known murine DAMP ligands of TLR4 such as HSPs 
(Facciponte et al. 2005), hyaluronan (Taylor et al. 2004), denatured fibronectin 
(Okamura et al. 2001), or fibrinogen (Smiley et al. 2001), and the differential adherent 
leukocyte profiles determined following 16hr implantation into TLR4+ and TLR4- mice. 
This technique has been used to determine the role of fibrinogen in the acute 
inflammatory response to biomaterials (Tang and Eaton 1993). Molecules which induce 
heightened acute inflammatory response, as seen in both increased leukocyte adhesion 
and increased monocyte/macrophage presence, may point towards relevant ‘danger 
signals’ interacting with TLR4. In contrast, a specific molecule’s role in the host response 
to biomaterials may be investigated using knockout-mice for molecules such as HSPs 
[e.g. hsp72-/- mice (Oh et al. 2004) which is known to interact with TLR4 (Williams and 
Ireland 2008)], using biomaterial implantation techniques as investigated herein.  
 As other TLRs besides TLR4, such as TLR2, are capable of recognizing 
endogenous ‘danger signals’ (Rock and Kono 2008), the role of many TLRs in the host 
response to a biomaterial implant should be investigated using MyD88-/- mice, which 
have impaired TLR responsive due to the lack of the common adaptor molecule (Kaisho 
and Akira 2001). These mice display severely inhibited DAMP-mediated inflammation 
(neutrophil recruitment) in the peritoneal cavity following injection of necrotic cells (Chen 
et al. 2007). It is hypothesized that mice lacking MyD88 would show severely inhibited 
acute inflammatory following biomaterial implantation through lack of TLR-induced 
inflammation. Furthermore, unlike with TLR4-deficient mice used here, which displayed 
persistent chronic inflammation similar to that of wild-type mice through potential 
compensatory mechanisms by other TLRs, MyD88-/- mice would also inhibit other 
TLR/ligand signaling. Thus, MyD88-/- mice are anticipated to display inhibited fibrous 
capsule formation, unlike in TLR4-deficient mice (Fig. 4-6 and Fig. 4-7). Due to identical 
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signaling pathway shared between TLRs and IL-1R family members, however, the 
discrepancy between these two receptor families would need further investigation. This 
should be done with simultaneous examination of the host response to biomaterials in 
IL-1R-/- mice (Labow et al. 1997) to assure TLR-specificity. 
Direct TLR4 interaction with biomaterial surfaces in vivo following 16hr 
intraperitoneal implantation should further be determined to assess if TLR4-biomaterial 
interactions are potentially the source for controlling adhesive leukocyte profile. This 
should be done using similar techniques as described in CHAPTER 7 for cross-linking 
integrins to the biomaterial surface (Keselowsky and Garcia 2005). Briefly, PET discs 
implanted in the peritoneal cavity in TLR4+ mice for 16hr would be explanted and rinsed 
three times in D-PBS to remove non/loosely adherent cells. Subsequently, discs would 
be submerged in a solution of 0.1% SDS for 5m to gently extract cellular material. 
Remaining bound receptors on PET discs would be cross-linked to the surface using 
1mM DTSSP (12Å, Pierce). To assess the presence TLR4, a polyclonal antibody toward 
murine TLR4 (Abcam) would be added to biomaterial surface for 1hr followed by a 
fluorophore conjugated secondary antibody. Biomaterial surface would be mounted and 
presence of TLR4 assessed via confocal microscopy via comparison to non-crosslinked 
control surfaces. This should also be done for similarly implanted PET discs in TLR4-
deficient mice to assure the specificity of the primary antibody. As DCs were shown to 
utilize !2 integrins to recognize and adhere to the biomaterials in vitro (Fig. 7-6C, Fig. 7-
7, and Fig. 7-8), these integrins could be verified in vivo using the same cross-linking 
technique to illustrate direct integrin engagement by adherent cellular material (though 
not necessarily DC-specific).  
 An attempt was made to determine the differential presence of biomaterial-
adsorbed serum proteins across PLGA and agarose surfaces, which may mediate their 
distinct DC responses in vitro (APPENDIX 3). However, while it was found that protein 
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could be eluted from the biomaterial surfaces, equivalent loading (as determined via 
protein assay) across individual eluates run on western blots could not be assured (Fig. 
A3-2). So while eluates from agarose surfaces were found to possess higher presence 
of IgG (Fig A3-3), this is most likely due to the increased loading of total protein. In future 
work, to determine the presence of adsorbed serum proteins, such as fibronectin, across 
different biomaterials, radiolabeled-versions (I125) of these molecules should be spiked 
into 10% serum prior to adsorption on PLGA or agarose films. Following three vigorous 
PBS rinses of films, presence of radiolabeled proteins would be determined using a 
scintillation counter. It is anticipated that PLGA, a DC activating material, would induce 
increased adsorption of many serum proteins in comparison to agarose. Also, an ELISA-
based detection method, previously used to detect the presence of adsorbed fibronectin, 
may also prove useful (Grinnell and Feld 1982).  
Though the role of DCs in the host response to biomaterials is presumed, further 
assessment of their involvement in initial biomaterial recognition should be investigated. 
Currently, the Babensee lab is examining the role of DCs in the biomaterial adjuvant 
effect using genetically engineered mice possessing CD11c-dependent diptheria toxin 
(DT) receptor expression (Jung et al. 2002). By delivering DT, mouse DCs (CD11c+) 
may be temporarily depleted, and their role may be assessed during both the innate and 
adaptive immune response to a combination product. Though DC (DEC-205+) presence 
is found in the cellular infiltrate of implanted PLGA scaffolds in mice (Babensee 2008), 
direct DC recognition of biomaterials in vivo has yet to be examined as has been shown 
in vitro (CHAPTER 7). This should be done utilizing implantation of PLGA discs (1cm) in 
the peritoneal cavity of C57BL/6 mice and examination of bound cellular fraction at early 
time points (1-24hr). Following explant and three separate D-PBS rinses, adherent 
cellular fraction should be fixed using 4% paraformaldehyde (Polysciences Inc). 
Adherent cells on PLGA should be permeabilized with Triton X-100 as described in 
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CHAPTER 7 and stained using fluorophore conjugated antibodies for DC markers DEC-
205 and CD11c as well as phalloidin for cytoskeleton determination and DAPI nuclei 
stain. Using confocal microscopy, one could determine the presence of DCs (up to 
24hr), which are directly recognizing the biomaterial in vivo. This would further contribute 
to elucidating the role of DCs in the inflammatory response to biomaterials.  
In the context of DC-biomaterial interactions in vivo, while the direct recognition 
may determined through microscopy, the response (or maturation) of DCs to biomaterial 
implantations should also be investigated.  As distinct biomaterials, such as PLGA or 
agarose, may differentially influence an immune response (Bennewitz and Babensee 
2005; Norton et al. 2010), DC presence and response to both PLGA and agarose should 
further be examined in vivo. This should be examined following a 16-24hr implantation of 
either PLGA or agarose discs (separately) in the peritoneal cavity of C57BL/6 mice. 
Though biomaterial-induced DC maturation may require adhesion in vitro (CHAPTER 7), 
even non/loosely adherent human monocyte-derived DC fraction still exhibit signs of 
maturation potentially through paracrine effects initiated by the adherent fraction 
(Yoshida and Babensee 2004). In an in vivo intraperitoneal implantation setting, this 
relates to biomaterial-adherent cells eliciting a response to cells in the surrounding 
milieu, which may not be in direct in contact with the biomaterial. Therefore, both 
biomaterial-adherent and lavage DC presence and response to PLGA or agarose disc 
implantation should be investigated.  
Prior to explanation, peritoneal cells should be collected via PBS lavage, as 
performed in CHAPTER 4. Peritoneal cells should be examined for DC presence via flow 
cytometry through CD11c or DEC-205 expression in comparison to isotype controls. 
Following the determination of the DC population from both DC marker expression and 
size from forward scatter via flow cytometry, DC maturation marker expression should 
concurrently be determined by double staining with anti-CD86. While the analysis of 
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lavage cells for DC presence and response by flow cytometry may be trivial, biomaterial-
adherent cell fractions may be difficult to collect for similar analysis. First, trypsin addition 
followed by light cell scraping to explanted PLGA and agarose discs to collect adherent 
cells should be attempted as described in CHAPTER 4. Biomaterial-adherent cell 
fractions should subsequently be examined for CD11c and CD86 expression via flow 
cytometry. Relative levels in vivo of biomaterial-induced DC maturation, determined via 
CD86 expression, should be compared between PLGA and agarose implants. Also, 
comparison to sham surgery and naïve control mice should be used to assess 
biomaterial-induced responses specifically. It is speculated, however, that cell collection 
using trypsin may destroy the extracellular domains of both CD11c and CD86. If this 
occurs, then collection of biomaterial-adherent cell fractions may require a non-
enzymatic cell dissociation solution (Sigma) with vigorous pipetting to assure collection 
of cells for flow cytometric analysis.  
 Human monocyte-derived DCs and murine BMDCs interestingly displayed very 
different adhesion-mediated maturation responses. Human monocyte-derived DCs 
seemed to require !2-mediated adhesion to biomaterials in order propagate biomaterial-
induced maturation, and in fact inhibiting adhesion to surfaces resulted in lower DC 
maturation marker expression (CHAPTER 7). In contrast, adherent BMDCs showed 
increased signs of immaturity and had significantly increased responsiveness to both 
LPS and biomaterial stimulation in comparison to non/loosely adherent BMDCs 
(CHAPTER 6). The reason for this discrepancy between human and murine derived DC 
adhesion and responsiveness to biomaterial stimuli is unknown, but future work may 
help determine its nature.  
One possible explanation is that BMDCs adhere to biomaterial surfaces using 
different integrins than human monocyte-derived DCs, which may allow for maintenance 
of their immature status following adhesion. CD11b("M)-deficient macrophages are more 
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responsive to maturation-inducing stimuli (TLR ligands) due to a negative cross-talk 
found between !M engagement and TLR signaling pathway (Han et al. 2010). 
CD11b(!M)-mediated adhesion to surfaces in BMDCs would thus decrease their 
responsiveness to ultrapure-LPS. The opposite was found for adherent BMDCs (Fig. 6-
5, and Fig. 6-6), and therefore, it is unanticipated that !M is involved in the adhesion to 
biomaterial surfaces. In fact, BMDC adhesion to an increasing surface density of RGD-
peptides led to increased signs of maturation and slightly correlated with !V integrin 
binding (Acharya et al. 2010). For human monocyte-derived DC adhesion, it was shown 
that "2 integrins mediate adhesion contribute to biomaterial-induced DC maturation (Fig. 
7-6, Fig. 7-7, and Fig. 7-8); however, an integrin ! subunit partner was not definitively 
discovered. Anti-!M antibody treatment did significantly prevent anti-"2 inhibition of 
adhesion and reduction in maturation (Fig. 7-7 and Fig. 7-8) through potential steric 
hindrance of anti-"2 binding, as supporting evidence hinted (Fig. 7-5). It is possible that 
this slight steric hindrance implies a role for !M (and thus MAC-1, !M/"2) in human DC 
biomaterial interactions but it was not able to determined using antibody-blocking 
techniques.  
To screen different integrins utilized by human monocyte-derived DCs and 
BMDCs to attach to biomaterial-surfaces, both DC types should be cultured on PLGA 
films and cross-linked using DTSSP following SDS extraction as described previously 
(CHAPTER 7). Direct binding between integrin ! subunits and biomaterial surfaces 
should be identified using fluorophore conjugated polyclonal antibodies against !M, !L, 
!X and !V as well as "2 and "1 integrins and compared to non-cross-linked controls. This 
could be a starting point for determining relevant integrins involved in differential 
interaction between human monocyte-derived DCs and BMDCs. This technique would 
also be a powerful tool to analyze surface binding of potential DC maturation-inducing 
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receptors (such as Fc-receptors or CLRs), which may be involved in the direct 
recognition of biomaterials and used as a preliminary investigation into their relevance of 
DC/biomaterial interactions. However, the cross-linking reagent used may have to be 
altered (lengthened or shortened from length of DTSSP, 12Å) to assure proper 
connection with the appropriate receptor of interest.  
Lastly, though !2 integrin-mediated adhesion was shown to influence the 
maturation state of DCs (CHAPTER 7), a direct link between adhesion and maturation 
was not determined. Further analysis would be required to attempt to decouple integrin-
inducing signaling from DC maturation. To accomplish this, a technique employed by 
Miyamoto et al utilizing non-inhibitory monoclonal integrin antibodies has been shown to 
induce integrin clustering and adhesion without the induction of major integrin 
intracellular signaling (Miyamoto et al. 1995; Miyamoto et al. 1996). This may be tested 
in DCs by coating substrates (such as TCPS) with distinct monoclonal antibodies against 
integrin subunits (both " and !2 subunits), which should allow for integrin-mediated 
adhesion, but not allow intracellular recruitment of signaling components such as talin. 
DC adhesion to the coated substrate would assessed using cell counts as well as 
confocal microscopy which would also allow for examination of key phosphorylation sites 
of intracellular molecules (e.g. FAK) to assure integrin signaling was not propagated. 
The time point of analysis is critical as phosphorylation of intracellular molecules may 
occur in as little as 5-15 min following treatment. Also, Fab fragments of antibodies may 
be required for coating to avoid Fc-receptor interaction and stimulation of DCs. Following 
assurance of integrin binding and adhesion without subsequent signaling, the DC 
maturation state following treatment on antibody-coated surfaces would be assessed for 
maturation marker expression (CD80/CD86), at potentially a later time point (>1hr) to 
determine specifically if DC integrin-mediated adhesion is alone capable of inducing 
maturation. 
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 If integrin-adhesion alone is not responsible for the maturation of DCs on 
biomaterials, a major roadblock may exist in attempting to decouple collaborative 
receptors, which may be involved in the response of DCs to biomaterials. There are 
numerous maturation-inducing receptors, which may be involved in the recognition of 
biomaterial-associated molecules as noted in Section 3.5. The research presented here 
focused on the role of integrins and TLRs because of their major role in adhesion and 
maturation of DCs, respectively. However, other receptors (e.g. Fc-receptors, scavenger 
receptors, CRLs) may contribute to the maturation response of DCs to biomaterials. 
While individual members of these receptor families may be assessed through the use of 
antibody-blocking techniques, which is not feasible owing to the number of potential 
receptors, pinpointing an entire family of receptors through a screening process would 
be critical in order narrow the scope of the research. Families of receptors could be 
screened by inhibiting signaling molecules, which are common across a particular family, 
such as MyD88 for TLRs or FAK for integrins. Inhibition would likely be accomplished via 
RNAi techniques. However, a roadblock for this analysis in DCs is that the technique 
required for inhibition may alone influence the maturation state of DCs. For example, 
current work in the Babensee lab has shown that electroporation of human monocyte-
derived DCs, which is required for the delivery of siRNA in primary DCs, may induce 
both maturation/necrosis of DCs. Though certain aspects of electroporation may be fine-
tuned to minimize these detrimental effects, it is possible that successful delivery of 
siRNA, which would be required to specifically inhibit families of receptors in a screening 
process, may not be compatible with maintaining an immature DC phenotype. Therefore, 
a major roadblock may exist which will not allow for screening of families of receptors 
that may collaborate with integrins for DC recognition and response to biomaterials.  
The research presented in this thesis aims to address how the body’s initial 
inflammatory response to a biomaterial may influence its subsequent immune response 
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in the context of a combination product. For this endeavor, DC receptor recognition and 
response to biomaterials was investigated to elucidate the mechanism behind the 
biomaterial adjuvant effect. The sum of these results allows for further understanding of 






A.1 HOST RESPONSE TO BIOMATERIAL IMPLANTATION IN C57BL/6 MICE 
 
 
PET discs (10mm) were implanted into C57BL/6 mice (The Jackson Laboratory) 
as described in CHAPTER 4 for 16hr. IP lavage was performed and total and differential 
leukocytes counts were determined (Fig. A1-1A). Also, the biomaterial-adherent 
leukocyte population was similarly assessed for total and differential leukocyte profile 
(Fig. A1-1B). Both the IP lavage and adherent leukocyte profiles were consistent with 
TLR4- control strain C57BL/10 at 16h. IP lavage consisted primarily of neutrophils (Fig. 
A1-1A) while biomaterial-adherent leukocyte population was made up of equivalent 
fractions of monocyte/macrophages and neutrophils (Fig. A1-1B). This is in contrast to 
the TLR4- strain (C57BL/10ScN) which showed significantly higher fraction of neutrophils 
and significantly lower fraction of monocyte/macrophages at 16h in adherent leukocyte 
profile in comparison to TLR4+ C57BL/10 mice. This may further indicate a delayed 
inflammatory response to biomaterials in TLR4- mice as noted in CHAPTER 4. 
 
Figure A1-1: Total and differential leukocyte profiles in C57BL/6 mice. These were 
determined in IP lavage (A) or adhering to biomaterial (B) following a 16hr IP 
implantation of a PET disc. For detailed description of method, see CHAPTER 4. 




A.2 PURIFICATION OF HUMAN DCS USED FOR GENE EXPRESSION OR LYSATE 
PREPARATION 
 
In order to determine DC-specific gene expression either at the RNA or protein 
level, pooled adherent and non/loosely human DCs were purified following biomaterial or 
LPS treatment for 24hr. To do this, magnetic beads (MACS) isolation was utilized which 
positively selects DC-SIGN (a human DC marker) expressing cells. For the detailed 
procedure, please see CHAPTER 5. Following isolation of DCs using MACs, purity was 
assessed via flow cytometry through expression of DC-SIGN and CD19. The primary 
contaminating cell population in human monocyte-derived DC culture is B cells. 
Therefore, pre- and post-isolation levels of DC-SIGN and CD19 (B cell marker) were 
determined (Fig. A4-1). Routinely, >95% of cell population post-isolation was DC-SIGN+ 
while only about 1% of population was CD19+. Pre-isolation percentages of relative 
populations of DCs and B cells were donor dependent; however, the purification 
procedure maintained similar percentages of DCs across all donors after purification. 
These purification results were consistent for isolation of DC used for both RNA 








Figure A2-1: Purification of DCs using DC-SIGN microbead isolation. Pre-isolation 
(A) and post-isolation (B) levels of DC-SIGN vs. CD19 cellular population. Cells were 
double-stained with DC-SIGN-FITC (R&D Systems) and CD19-APC (Miltenyi Biotec) 
antibodies were stained. Following isolation, cell population was routinely >95% DC-
SIGN+ and generally about 1% CD19+. This purification procedure was used for both 





A.3 ELUTION OF SERUM PROTEINS FROM BIOMATERIALS 
 
 
In Specific Aim 1, it was hypothesized that serum adsorbed TLR4/ ‘danger signal’ 
interactions may mediate the response of DCs to biomaterials. Numerous plasma/serum 
proteins such as FN (Okamura et al. 2001; Lasarte et al. 2007), fibrinogen (Smiley et al. 
2001), and heat shock proteins (Asea et al. 2002; Tsan and Gao 2004) are known to 
stimulate cells (specifically DCs) through TLR4, and this may offer an explanation as to 
why certain biomaterials, such as PLGA, trigger DC maturation while other materials, 
such as agarose, preserve DCs in an immature state. Therefore, an attempt was made 
to elute adsorbed serum proteins from the surface of biomaterials in order to determine if 
specific ‘danger signal’ proteins were present in higher levels on biomaterials which are 
known to induce DC maturation. 
10% (w/v) PLGA films or 3% (w/v) agarose films were prepared 6 well plates 
(Corning, Costar) as described in CHAPTER 5. A 10% (v/v) human serum solution in 
PBS (Invitrogen, pH 7.2) pooled from 3 donors and heat-inactivated (56oC, 30 min) was 
prepared. Serum solution was stored at -20oC prior to making this solution. Biomaterials, 
in 6 well plates, were incubated with the 10% serum solution (3mL) for 1hr at room 
temperature. Uncoated TCPS controls were also incubated with serum solution. Serum 
was removed serum via pipette aspiration and collected. PLGA and agarose films were 
carefully removed with clean forceps and transferred to another 6 well plate for washing. 
The films (and TCPS of original plate) were rinsed three times (5 min each) with PBS 
(Sigma) (1mL for each wash) at room temperature flipping the films over carefully each 
time. The films were then transferred to a fresh 6 well plate and surfaces (films and 
original TCPS well) were treated with 10% SDS/2.3% dithioerythritol (Sigma) mixture on 
a shaker (1mL per well) for 24hr at room temperature. Samples of pre-incubated serum, 
163  
serum removed from surfaces (eluates) and non-adsorbed protein fraction (removed 
during wash) were saved and stored in 1.7ml low-retention tubes at -20oC. 
In order to determine protein concentration of eluates (which has high SDS and 
DTE presence), a protein assay (Bradford-based) was developed accordingly which 
would accurately determine levels of protein in serum alone or protein-containing 
eluates. Standards of BSA (Bio-Rad) from 1.5!g/!L to 0.2 !g/!L were prepared in the 
SDS/DTE solution (same as eluates). 100!L of standard or samples were placed in 
acetone-compatible microcentrifuge tube (polypropylene). 400ul of ice-cold acetone 
were added to each, vortexed and incubated at -20oC for 30 min. These were then 
centrifuged for 10 min at 15,000g. Tubes were then turned upside down on soak pad to 
drain and dried for at least 10min until acetone had evaporated. The protein pellet was 
resuspended in 100!L of water. 40!L of this resulting solution was placed into a fresh 
tube and 1mL of Bradford reagent (Sigma) was added to each tube. These were 
incubated for a several minutes and then transferred (200!L) to a 96 well plate for 
optical density determination at 595nm.  
Three independent trials were completed and eluates collected following serum 
adsorption to TCPS, PLGA or agarose surfaces. Using the protein assay described 
above, protein concentrations were able to be accurately determined within the range of 
the assay (1.5!g/!L to 0.2!g/!L) for all eluates. As shown in Fig. A3-1, eluates 
contained very low levels of protein (between 0.2-0.5!g/!L) depending on the surface; 
however, no statistical difference was found across the surfaces. This work was 
completed with the assistance of an undergraduate student Elizabeth Bosworth. 
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Figure A3-1: Protein concentration determined for pre-adsorbed 10% serum 
(pooled from three donors), as well as eluates from TCPS, PLGA or agarose 
surfaces. 10% serum samples were diluted to a range that was within the standard 
curve to accurately determine the concentration while eluates were run undiluted. Bars 
are mean+s.d., n=3. 
 
 
To assure equivalent protein loading in gels across all samples, 3!g of protein 
from each sample was loaded into SDS-PAGE gels and transferred to a nitrocellulose 
membrane, as described in CHAPTER 5. The membrane was removed from transfer 
apparatus and immediately stained with Colloidal Gold Total Protein Stain (Bio-Rad) for 
1hr. Membranes were quickly washed and imaged. As shown in Fig. A3-2, though the 
eluates and 10% serum samples were “equivalently” loaded, there is a significantly 
higher protein presence in eluates from agarose surfaces than in all other lanes. This 
was also found when staining similarly loaded gels with Coommassie blue (data not 
shown). Initial western blots to determine protein presence of IgG in eluates from TCPS, 
PLGA or agarose showed only significant IgG presence for agarose eluates (Fig. A3-3). 
The higher protein level in the agarose eluates could explain this result. The reason for 
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the higher protein presence in eluates agarose surfaces run through gel may be that 
agarose by-products from the elution procedure interfere with protein assay and cause 
under-estimation of the protein concentration. However, this was briefly examined and 
found that eluates from agarose surfaces with no serum adsorption added to proteins of 
known concentration did not significantly affect the protein assay (data not shown). 
Therefore, the reason for agarose-eluates showing higher levels of protein than TCPS or 
PLGA remains unknown. Without reliance of equivalent protein loading during gel 
electrophoresis, the outcome of any immunoblotting for specific biomaterial-adsorbed 




Figure A3-2: Gold stained nitrocellulose membrane of 10% serum, or eluates from 
TCPS, PLGA or agarose surfaces. 10-200kDa standard was also simultaneously run 
(left). Note the much larger protein presence in eluates from agarose surfaces compared 
to TCPS or PLGA. 
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Figure A3-3: Western blot for IgG determination of eluates from TCPS, PLGA or 
agarose surfaces from three independent trials. 10-200kDa standard was also 
simultaneously run. Note the much larger IgG presence in eluates from agarose 







A.4 CHEMOKINE RECEPTOR EXPRESSION HIERACHERCAL CLUSTER ANALYSIS 
 
Chemokine receptors (CCRs) are important markers for in vivo phenotype and 
play an important role in cellular honing (Allen et al. 2007). For this, CCR expression 
analysis may be able to further yield descriptive in vivo significance for where DCs hone 
or how they react following interactions with biomaterials. CCR RNA expression levels 
from purified human DCs treated with LPS, PLGA or agarose films were measured 
simultaneously with adhesion and integrin related molecules using the same RT-PCR 
techniques as described in detail in CHAPTER 7. Primers used for PCR were also 
chosen from Harvard PrimerBank (Wang and Seed 2003) and are listed in Table A4-1.  
 
Table A4-1: Primer pairs for chemokine receptors and house keeping genes. Primers 
were chosen from Harvard Primer Bank (Wang and Seed 2003) with PrimerBank ID 
listed in table. For detailed information/sequences on each primer pair, please see 
http://pga.mgh.harvard.edu/primerbank/. 
 






 CXCR2 4504683a1 
CXCR4 3059120a1 
CXCR5 4502415a1 




Following -!Ct normalization, as described in CHAPTER 7 to "-actin and B2M, a 2D 
hierarchical cluster analysis was performed using Matlab (v. 2009a, MathWorks) as 
shown in Fig. A4-1.  
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Figure A4-1: Hierarchical 2D cluster analysis for CCR expression.  These were 
investigated simultaneously with integrins and adhesion-related signaling molecules as 
described in CHAPTER 7. !-actin and B2M Ct values were used for normalized and -"Ct 







iDC and agarose treatment resulted in very similar CCR gene expression 
patterns as appeared for both TLR (CHAPTER 5) and integrins (CHAPTER 7) (Fig. A4-
1). However, here PLGA-induced CCR gene expression did not cluster or relate closely 
with ultrapure-LPS induced expression patterns (Fig. A4-1), unlike was previously found 
for TLRs and integrins. This may be a key difference between PLGA and PAMP 
stimulation. In particular, CCR7 up-regulation in gene expression is highly associated 
with DC maturation and contributes to DC committed chemotaxis towards lymph nodes 
(Sanchez-Sanchez et al. 2006). This was found for DC treated with ultrapure-LPS, as 
expected, but not found when DCs were treated with PLGA films or agarose films (Fig. 
A4-1). However, low to mid levels of CCR7 on DCs may play a role in steady-state DC 
migration to lymph nodes as has been shown in iDCs (Sanchez-Sanchez et al. 2006). It 
is possible that levels of CCR7 found following PLGA stimulation maintain this DC 
steady-state migration similar to iDCs. But as was mentioned in CHAPTER 7, RNA gene 
expression does not always lead to functional protein regulation. Therefore, flow 
cytometry analysis would be needed to determine CCR7 protein expression on PLGA-




A.5 ANTIBODY BLOCKING OF TLR4 ON TLR4-EXPRESSING 293 CELLS 
 
 
As another method to determine if the response of TLR4-expressing HEK293 
cells to both LPS and biomaterials was in fact TLR4-dependent (CHAPTER 5), antibody-
blocking techniques against TLR4 were utilized. Briefly, TLR4-expressing HEK293 cells 
were pre-incubated with a-TLR4 blocking antibody (HTA-125, eBioscience, San Diego, 
CA) or isotype controls for 1hr at a concentration of 20!g/mL. TLR4-expressing HEK293 
cells were plated in 100mm TCPS dishes and left untreated or treated with LPS 
(1ug/mL) as described in CHAPTER 5. The ability for anti-TLR4 to inhibit LPS-induced 
activation was examined via ability to inhibit L-8 secretion. LPS stimulated the production 
of IL-8 in TLR4-expressing HEK293 cells; however, the amount of IL-8 secreted by these 
cells with an a-TLR4 or isotype pre-treatment was the same as with no antibody (Fig. 
A5-1). Therefore, a-TLR4 blocking techniques using this particular mAb, were ineffective 
in preventing LPS/TLR4 interactions in TLR4-expressing HEK293 cells, but it has been 
shown to be effective in primary cells (Termeer et al. 2002; Mirlashari and Lyberg 2003). 
This difference may be due to TLR4 over-expression which may be above physiological 
relevance, and therefore difficult to completely inhibit using antibodies. Others have had 
success in blocking TLR4-expressing 293 cells response to LPS using a lipid A-like 
compound, E5531 (Uehori et al. 2003) which may prevent TLR4/LPS interactions by 
binding with higher affinity than a-TLR4. Furthermore, there has been success with 
antibody blocking to prevent TLR4-induced IL-8 secretion in TLR4-expressing HEK293 
cells with a non-LPS ligand (neutrophil elastase) (Devaney et al. 2003). Here, it was 
possible that impurities in LPS, which are known to include other TLR-stimulatory 
ligands such as lipoproteins (Hirschfeld et al. 2000), were inducing IL-8 secretion in a 
TLR4-independent manner. As another explanation, the over-expression of TLR4 in 
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HEK293 cells may make it unlikely to inhibit their response to LPS as physiological 
TLR4/LPS interaction on monocytes can easily be prevented using antibody blocking 




Figure A5-1: IL-8 Secretion of LPS-stimulated TLR4-expressing 293 cells in the 
presence of a-TLR4. Concentrations were determined from supernatants as measured 
by ELISA (and normalized to collected cell counts) of TLR4-expressing 293 cells left 
untreated (TCPS), treated with 1 !g/mL LPS, pre-treated with TLR4-antibody (aTLR4) or 
isotype for 1 hr followed by treatment with LPS. TLR4-antibody did not block LPS-





A.6 IMMUNOFLUORESCENCE OF ADHERENT HUMAN DCS ON PLGA 
 
 
Adherent DCs on PLGA films were further imaged using immunofluorescence 
and analyzed by either standard fluroscent microscopy or confocal microscopy as 
described in detail in CHAPTER 7. To determine whether B cells, the contaminating cell 
population in the human-monocyte derived DC culture, adhere to PLGA, the adherent 
cells on PLGA were stained with CD19-FITC/CD86-PE and DAPI nuclei stain. As shown 
below, there was no detection of B cells (CD19-) among the adherent cell population 
(Fig. A6-1) at 24hr following culture. This was in contrast to detection of DC-SIGN+ DCs 
which adhered readily to PLGA at 24hr (Fig. 7-1). Therefore, it is believed that the 
primary cellular/biomaterial interaction in the human DC culture occurs between DCs 
and the biomaterial, as B cells do not tend to directly adhere to the PLGA surface.  
 
 
Figure A6-1: CD19/CD86 staining of PLGA film adherent cells. Cells were imaged 
with CD19-FITC (green), CD86-PE (red) or DAPI nuclei stain (blue) and imaged 
according to method described in detail in CHAPTER 7, 10X.  Fluorescent image (left) 





Further evidence of !2/F-actin podosome co-localization seen in CHAPTER 7 is 




Figure A6-2: !2 integrin expression on DCs adhering to PLGA films. DCs were 
allowed to adhere to PLGA films for 1.5h and subsequent were fixed, permeabilized and 
stained with anti-!2-FITC in combination with phalloidin-TRITC (red) and nuclei (green). 












Lastly, lack of !1/F-actin podosome co-localization seen CHAPTER 7, is further 
visualized below in Fig. A6-3. 
 
 
Figure A6-3: !1 integrin expression on DCs adhering to PLGA films. DCs were 
allowed to adhere to PLGA films for 1.5h and subsequent were fixed, permeabilized and 
stained with anti-!1-FITC in combination with phalloidin-TRITC (red) and nuclei (green). 





A.7 PROBING BIOMATERIAL ‘DANGER SIGNAL’/RECEPTOR INTERACTIONS 
USING CELL-FREE SYSTEMS  
 
 
As an independent method to determine the presence of biomaterial ‘danger 
signal’/ receptor interactions, a cell-free system was attempted which utilized soluble 
recombinant cellular receptors to recognize biomaterial-adsorbed proteins. Specific 
receptors that recognized adsorbed molecules could then be cross-linked to the surface, 
and their presence determined using ELISA-based techniques. This system was based 
off a previously published method, which was used to determine integrin-specific binding 
to particular pre-adsorbed ligands (Eble et al. 1998). Two receptors of interest, which 
were shown to be relevant in DC-biomaterial interactions (TLR4, CHAPTER 4/5; and an 
integrin family member, !M"2, CHAPTER 7), were chosen for examination. Though !M"2 
was not directly shown to be involved in DC recognition of biomaterials (CHAPTER 7), 
the biology of integrin binding indicates the need for both an ! and " subunit. Biomaterial 
recognition by monocytes has been determined to be mediated, in part, by !M"2 
(McNally and Anderson 1994); therefore, it is relevant integrin pair for investigation.  
Ligands for recombinant TLR4/MD2 (R&D Systems) or !M"2 (R&D Systems), 
(LPS (Sigma, 20!g/mL) or fibrinogen (Sigma, 100!g/mL), respectively) as well as PBS 
controls were pre-incubated across wells of 96-well plate (100!L per well) overnight at 
4oC with plates sealed. For TLR4/LPS trials, negative control ligands were also 
examined using BSA (1%w/v) pre-coating. The next day, wells were washed 3 times in 
PBS (without Mg/Mn, Invitrogen) and sites were blocked using with 5% non-fat dry milk 
in PBS/Tween 20 (0.1%) (Sigma) for 1.5hr. Wells were immediately washed with PBS 
three times. Soluble TLR4 at increasing concentrations (0-100nM, 100!L) was added to 
wells, in the presence of MgCl2 (2mM) and MnCl2 (1mM), pre-coated with LPS, BSA or 
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PBS or to LPS-coated wells in the presence of 1mM EDTA to chelate divalent ions and 
determine integrin-specific binding for 2hr, Soluble !M"2 (20nM concentration, 
appropriately determined through titration experiment) was added to wells coated with or 
without fibrinogen and with or without the presence of Mn++, all diluted in 1% BSA/PBS 
for 2hr. Wells were washed with 25mM HEPES (Sigma) with Mg/Mn three times. Bound 
receptors were fixed with 2.5% glutaraldehyde (Polysciences Inc) for 10min and further 
rinsed three times in HEPES. Polyclonal antibodies against hTLR4 and h"2 (both from 
R&D Systems) were added at 1:300 dilution in 1% BSA for 90 min at room temperature. 
Wells were then washed three times with PBS/Mg (2mM) buffer. Appropriate secondary 
antibodies conjugated to alkaline phosphatase were diluted (1:300) in 1% BSA and 
added to wells for 1hr at room temperature. After a final rinsing procedure, signal was 
processed using pNpp substrate (Sigma) addition and read at 405nm.  
For !M"2, specific detection of the bound integrin was determined by testing all 
combinations of receptor (with or without Mn), primary and secondary additions following 
the pre-incubation of fibrinogen or PBS controls (Fig. A7-1). It was found that !M"2 was 
specifically being detected by this ELISA-based technique; however, !M"2-fibrinogen 
binding (a known ligand pair) gave a lower signal in the presence of fibrinogen than 
without its pre-coating (Fig. A7-1). Also, Mn presence was not found to affect the binding 
of !M"2 to fibrinogen (Fig. A7-1).  
The detection of bound recombinant TLR4 on LPS, BSA or PBS pre-coated 
surfaces using increasing concentrations of TLR4 did not result in significant increase in 
signal (Fig. A7-2). The presence of EDTA, which chelate ions necessary for integrin 
binding had no significant effect TLR4 binding/detection  (Fig. A7-2). LPS coated 
surfaces yielded similar signal to uncoated surfaces as well as surfaces coated with BSA 
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indicating that only non-specific adsorption of TLR4 to surface may be being detected 




Figure A7-1: Specific detection of !M"2 binding on fibrinogen or PBS (No Ligand) 
surface. Plates were coated with or without fibrinogen and !M"2 was added to the wells 
with or with the presence of Mn. Lastly, specific detection of !M"2 (Rec.) was determined 
by analyzing wells with primary (1o) or secondary (2o) alone or in combination to 
determine specific. The receptor (Rec) in the presence of both primary and secondary 
























Figure A7-2: Detection of increasing concentrations of recombinant TLR4 binding 
to LPS, BSA (Albumin) or No Coating Surfaces. Plates were coated with LPS (blue), 
BSA (red) or PBS (purple) and recombinant TLR4 was added to the wells in the 
presence of Mn/Mg or in the presence of 1mM EDTA (LPS coated + EDTA, green). Dots 
indicate mean±s.d.  
 
Using this cell-free ELISA-based system, the ability to detect recombinant 
receptors was possible as shown in Fig. A7-1. However, for either receptor investigated 
(TLR4, or !M"2), pre-adsorbed known ligand did not lead to increases in receptor 
detection. !M"2 is known to bind to fibrinogen (Tang et al. 1996) and TLR4 is well known 
to recognize LPS. However, !M"2 was detected at a higher level on uncoated surfaces 
than on surfaces coated with fibrinogen (Fig. A7-1), and TLR4 was found at similar 
levels regardless of surface coating (Fig. A7-2). Therefore, the detection of either !M"2 or 
TLR4 is not dependent on specific substrate recognition as would be needed to verify 
role in biomaterial recognition but instead is based on non-specific protein adsorption. 
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For this reason, the use of this cell-free system for the detection of specific receptor-
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